data_1med_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1med _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . 0.373 2.6 t80 . . . . . 0 N--CA 1.487 1.404 1 N-CA-C 93.958 -6.312 . . . . 0.0 93.958 . . . . . . . . . 2 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.2 t -102.81 154.14 5.41 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 CA-C-N 113.083 -1.871 . . . . 0.0 106.883 179.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp 3.79 64.09 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.398 0 O-C-N 126.547 2.404 . . . . 0.0 113.076 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 37.61 28.52 0.04 OUTLIER Glycine 0 N--CA 1.494 2.509 0 N-CA-C 117.828 1.891 . . . . 0.0 117.828 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.5 ' HA ' ' HB2' ' A' ' 18' ' ' GLN . 9.0 m -157.74 164.67 36.86 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 53.3 t -89.08 85.85 0.14 Allowed Pre-proline 0 N--CA 1.493 1.705 0 CA-C-O 122.223 1.011 . . . . 0.0 111.484 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -54.08 -26.97 43.78 Favored 'Trans proline' 0 C--N 1.299 -2.032 0 C-N-CA 122.402 2.068 . . . . 0.0 116.735 -138.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 23.9 tptp -74.48 -36.0 63.28 Favored 'General case' 0 N--CA 1.504 2.249 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 27.4 p -100.31 -36.21 9.34 Favored 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . 0.318 29.1 tttt 49.82 76.09 0.15 Allowed 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 115.965 -2.294 . . . . 0.0 115.207 178.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.2 t -90.63 89.4 0.28 Allowed Pre-proline 0 C--N 1.304 -1.382 0 N-CA-C 103.304 -2.85 . . . . 0.0 103.304 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -21.96 -41.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.592 1 C-N-CA 126.112 4.542 . . . . 0.0 121.378 -129.368 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -130.07 84.81 2.23 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -179.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.5 ' HB2' ' HA ' ' A' ' 9' ' ' THR . 4.3 mm-40 -100.63 73.77 1.63 Allowed 'General case' 0 N--CA 1.504 2.274 0 CA-C-O 122.841 1.305 . . . . 0.0 108.972 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -97.64 -59.54 1.75 Allowed 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 100.838 -3.764 . . . . 0.0 100.838 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -131.69 29.4 3.42 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 105.754 -2.938 . . . . 0.0 105.754 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.483 ' HB2' ' HA ' ' A' ' 18' ' ' GLN . 14.4 m-20 -117.8 45.58 1.93 Allowed 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -8.99 99.06 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.434 0 N-CA-C 116.842 2.164 . . . . 0.0 116.842 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.477 ' HA ' HE21 ' A' ' 18' ' ' GLN . 32.1 t -26.18 107.71 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 116.422 2.008 . . . . 0.0 116.422 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.3 pm0 -110.61 36.68 3.01 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.114 0.483 . . . . 0.0 111.113 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.7 t -118.53 -58.42 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.258 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 31.4 p -114.35 -49.61 2.83 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 124.088 0.867 . . . . 0.0 109.192 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 119.03 59.24 0.26 Allowed Glycine 0 N--CA 1.498 2.804 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.817 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.504 2.266 0 N-CA-C 116.373 1.99 . . . . 0.0 116.373 179.887 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . 0.256 3.4 t80 . . . . . 0 N--CA 1.495 1.814 0 CA-C-O 122.742 1.258 . . . . 0.0 109.773 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -82.17 68.77 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.371 1 N-CA-C 123.865 4.765 . . . . 0.0 123.865 -177.748 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.2 tptt -140.26 40.09 1.92 Allowed 'General case' 0 CA--C 1.587 2.396 3 N-CA-C 90.553 -7.573 . . . . 0.0 90.553 178.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 41.07 10.59 0.01 OUTLIER Glycine 0 N--CA 1.484 1.896 0 C-N-CA 130.48 3.895 . . . . 0.0 118.861 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.51 HG22 ' H ' ' A' ' 10' ' ' CYS . 6.6 m -154.14 -177.04 6.16 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.51 ' H ' HG22 ' A' ' 9' ' ' THR . 53.4 t -89.87 85.15 0.14 Allowed Pre-proline 0 C--N 1.306 -1.324 0 N-CA-C 105.268 -2.123 . . . . 0.0 105.268 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -70.92 3.11 3.54 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 124.458 3.439 . . . . 0.0 113.915 -133.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 53.4 tptt -97.77 -25.46 15.06 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 123.681 0.613 . . . . 0.0 109.747 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 27.7 p -114.47 -40.27 3.65 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.443 ' HA ' ' CG2' ' A' ' 9' ' ' THR 0.264 20.5 tttm 57.3 76.57 0.31 Allowed 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 121.298 3.814 . . . . 0.0 121.298 178.883 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 22.3 t -90.79 91.05 0.36 Allowed Pre-proline 0 N--CA 1.496 1.856 0 N-CA-C 105.493 -2.04 . . . . 0.0 105.493 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -27.44 -36.57 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.515 2 C-N-CA 126.167 4.578 . . . . 0.0 122.52 -126.854 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -132.03 79.75 1.88 Allowed 'General case' 0 N--CA 1.503 2.218 0 N-CA-C 116.166 1.913 . . . . 0.0 116.166 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -109.4 113.56 26.48 Favored 'General case' 0 N--CA 1.504 2.233 0 CA-C-O 122.067 0.937 . . . . 0.0 109.402 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -113.44 -60.83 1.83 Allowed 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 101.731 -3.433 . . . . 0.0 101.731 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -128.43 45.97 1.11 Allowed Glycine 0 N--CA 1.489 2.19 0 N-CA-C 103.617 -3.793 . . . . 0.0 103.617 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.411 ' O ' ' C ' ' A' ' 22' ' ' ASN . 7.3 m-20 -109.73 39.16 2.18 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 118.643 -0.694 . . . . 0.0 111.474 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.411 ' C ' ' O ' ' A' ' 21' ' ' ASP . 86.1 m-20 1.1 69.23 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.765 0 O-C-N 126.009 2.068 . . . . 0.0 112.949 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 53.1 t -1.84 127.73 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.328 0 N-CA-C 119.423 3.12 . . . . 0.0 119.423 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -116.52 35.82 4.39 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.154 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 10.7 t -124.28 -59.38 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 N-CA-C 114.757 1.392 . . . . 0.0 114.757 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 24.2 p -108.4 -46.08 3.77 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 114.563 1.32 . . . . 0.0 114.563 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 120.84 50.61 0.26 Allowed Glycine 0 N--CA 1.503 3.118 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.274 . . . . . . . 0 N--CA 1.496 1.839 1 N-CA-C 132.421 7.934 . . . . 0.0 132.421 -179.984 . . . . . . . . 2 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.401 ' CE1' ' HD3' ' A' ' 11' ' ' PRO . 2.0 t80 . . . . . 0 N--CA 1.488 1.464 1 N-CA-C 100.052 -4.055 . . . . 0.0 100.052 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.478 ' HB ' ' HB3' ' A' ' 11' ' ' PRO 0.257 3.6 t -105.19 121.81 57.67 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.99 0 CA-C-N 113.501 -1.681 . . . . 0.0 106.608 179.548 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 23.8 pttm 25.45 62.01 0.06 Allowed 'General case' 0 N--CA 1.509 2.483 0 CA-C-O 123.095 1.426 . . . . 0.0 111.602 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.405 ' HA3' ' CE1' ' A' ' 19' ' ' TYR . . . 30.31 38.18 0.02 OUTLIER Glycine 0 N--CA 1.499 2.892 0 CA-C-N 111.193 -2.73 . . . . 0.0 115.952 -179.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.527 ' HA ' ' HB2' ' A' ' 18' ' ' GLN . 35.3 m -152.4 157.64 41.53 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 115.142 1.534 . . . . 0.0 115.142 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.477 ' SG ' ' CG2' ' A' ' 25' ' ' VAL . 7.4 t -49.38 91.6 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.805 0 N-CA-C 103.384 -2.821 . . . . 0.0 103.384 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.478 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . 10.8 Cg_endo -41.09 -56.13 1.84 Allowed 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.572 2.182 . . . . 0.0 116.564 -150.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 21.8 ttmm -107.67 -1.17 21.34 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 124.671 1.232 . . . . 0.0 109.536 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -127.33 39.64 3.86 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 126.626 3.108 . . . . 0.0 109.6 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.412 ' N ' ' O ' ' A' ' 10' ' ' CYS 0.316 25.9 tttt -44.12 80.34 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.916 3 CA-C-N 104.198 -5.91 . . . . 0.0 119.411 179.657 . . . . . . . . 4 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.451 ' HG ' HG23 ' A' ' 25' ' ' VAL . 3.0 m -90.31 169.23 12.57 Favored Pre-proline 0 C--N 1.296 -1.718 1 CA-C-N 107.311 -4.495 . . . . 0.0 108.158 179.741 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -38.73 -58.42 0.75 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 123.666 2.911 . . . . 0.0 118.913 -167.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -150.13 86.8 1.44 Allowed 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.527 ' HB2' ' HA ' ' A' ' 9' ' ' THR . 18.6 mp0 -99.08 72.39 1.88 Allowed 'General case' 0 N--CA 1.501 2.104 0 CA-C-O 124.748 2.213 . . . . 0.0 112.488 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.405 ' CE1' ' HA3' ' A' ' 8' ' ' GLY . 79.0 m-85 -101.18 -48.81 4.28 Favored 'General case' 0 N--CA 1.49 1.572 1 N-CA-C 96.783 -5.266 . . . . 0.0 96.783 179.124 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -124.72 1.97 8.64 Favored Glycine 0 CA--C 1.552 2.374 0 CA-C-N 113.185 -1.825 . . . . 0.0 110.572 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.423 ' HB2' ' HA ' ' A' ' 18' ' ' GLN . 8.6 m-20 -92.31 39.76 1.03 Allowed 'General case' 0 N--CA 1.509 2.479 0 CA-C-N 118.699 1.249 . . . . 0.0 112.198 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.411 ' O ' ' C ' ' A' ' 23' ' ' CYS . 37.0 m-20 2.42 65.74 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.813 0 C-N-CA 125.854 1.662 . . . . 0.0 115.316 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.461 ' SG ' ' HD2' ' A' ' 11' ' ' PRO . 2.4 t 26.18 52.24 0.03 OUTLIER 'General case' 0 N--CA 1.521 3.107 0 O-C-N 124.651 1.219 . . . . 0.0 108.175 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.52 52.77 2.42 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-O 123.658 1.694 . . . . 0.0 113.923 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.477 ' CG2' ' SG ' ' A' ' 10' ' ' CYS . 44.6 t -123.57 -39.54 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 102.759 -3.052 . . . . 0.0 102.759 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.437 ' SG ' ' N ' ' A' ' 27' ' ' GLY . 20.6 p -123.77 -52.68 1.79 Allowed 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 110.977 -2.829 . . . . 0.0 109.555 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.437 ' N ' ' SG ' ' A' ' 26' ' ' CYS . . . 138.15 124.99 2.31 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 108.532 -1.827 . . . . 0.0 108.532 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.507 2.413 0 CA-C-O 117.405 -1.284 . . . . 0.0 111.598 -179.964 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.496 ' CD1' ' HD3' ' A' ' 11' ' ' PRO . 1.5 t80 . . . . . 0 CA--C 1.561 1.396 1 N-CA-C 98.295 -4.706 . . . . 0.0 98.295 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.447 ' H ' ' HD1' ' A' ' 5' ' ' PHE . 55.7 t -119.37 84.01 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 CA-C-N 112.267 -2.242 . . . . 0.0 107.494 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 71.5 tttt 98.03 71.5 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 112.003 -2.362 . . . . 0.0 105.117 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.411 ' HA3' ' CZ ' ' A' ' 19' ' ' TYR . . . 40.47 -58.08 0.0 OUTLIER Glycine 0 N--CA 1.495 2.611 0 C-N-CA 129.176 3.274 . . . . 0.0 118.866 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.433 ' HA ' ' H ' ' A' ' 18' ' ' GLN . 12.3 m -100.92 172.88 6.77 Favored 'General case' 0 C--N 1.295 -1.787 0 O-C-N 124.484 0.755 . . . . 0.0 109.163 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.459 ' HA ' ' CE1' ' A' ' 5' ' ' PHE . 49.5 t -74.08 94.45 0.06 OUTLIER Pre-proline 0 N--CA 1.487 1.38 0 N-CA-C 102.59 -3.115 . . . . 0.0 102.59 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.496 ' HD3' ' CD1' ' A' ' 5' ' ' PHE . 94.9 Cg_endo -62.61 -7.14 10.18 Favored 'Trans proline' 0 CA--C 1.556 1.576 0 O-C-N 124.077 1.567 . . . . 0.0 111.958 -147.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.426 ' N ' ' O ' ' A' ' 10' ' ' CYS . 1.3 ttmp? -95.1 -46.9 6.6 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 124.331 1.02 . . . . 0.0 109.87 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.552 ' SG ' ' HB ' ' A' ' 25' ' ' VAL . 19.3 p -102.11 6.76 41.07 Favored 'General case' 0 N--CA 1.511 2.579 0 C-N-CA 119.439 -0.904 . . . . 0.0 113.137 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . 0.343 25.1 tptt 6.52 77.19 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 118.907 2.929 . . . . 0.0 118.907 178.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 29.1 t -90.24 94.67 0.61 Allowed Pre-proline 0 C--N 1.3 -1.55 0 CA-C-N 111.155 -2.748 . . . . 0.0 104.119 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -15.45 -40.48 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.357 1 C-N-CA 127.495 5.463 . . . . 0.0 121.978 -136.588 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -142.23 96.5 2.97 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 123.383 0.673 . . . . 0.0 110.538 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.535 HE21 ' HA ' ' A' ' 23' ' ' CYS . 7.8 mm100 -100.94 65.96 1.13 Allowed 'General case' 0 N--CA 1.507 2.417 0 CA-C-O 123.365 1.555 . . . . 0.0 106.912 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.411 ' CZ ' ' HA3' ' A' ' 8' ' ' GLY . 0.5 OUTLIER -109.09 -56.29 2.3 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 103.516 -2.772 . . . . 0.0 103.516 179.831 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -117.0 19.97 11.74 Favored Glycine 0 N--CA 1.496 2.673 0 CA-C-N 113.642 -1.617 . . . . 0.0 110.104 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.427 ' HB2' ' HA ' ' A' ' 18' ' ' GLN . 12.7 m-20 -117.19 -49.78 2.58 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 106.214 -1.773 . . . . 0.0 106.214 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 59.6 m-20 64.94 124.64 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 O-C-N 125.997 2.061 . . . . 0.0 110.142 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.535 ' HA ' HE21 ' A' ' 18' ' ' GLN . 39.2 t -18.43 102.26 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 118.737 2.865 . . . . 0.0 118.737 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -112.01 15.9 20.48 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.528 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.552 ' HB ' ' SG ' ' A' ' 13' ' ' CYS . 16.6 t -112.2 -49.02 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 CA-C-O 118.903 -0.57 . . . . 0.0 112.349 -179.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 26.7 p -116.15 -37.83 3.74 Favored 'General case' 0 N--CA 1.502 2.128 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 124.32 89.99 0.87 Allowed Glycine 0 N--CA 1.501 3.021 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.539 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.261 . . . . . . . 0 N--CA 1.499 1.98 1 N-CA-C 132.072 7.805 . . . . 0.0 132.072 179.82 . . . . . . . . 2 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.482 ' CZ ' ' SG ' ' A' ' 10' ' ' CYS . 1.4 t80 . . . . . 0 C--O 1.218 -0.602 1 N-CA-C 98.574 -4.602 . . . . 0.0 98.574 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.426 ' O ' ' HB2' ' A' ' 7' ' ' LYS . 73.9 t -124.12 78.15 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.033 0 N-CA-C 100.476 -3.898 . . . . 0.0 100.476 179.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.426 ' HB2' ' O ' ' A' ' 6' ' ' VAL . 1.0 OUTLIER 85.17 89.53 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 112.096 -2.32 . . . . 0.0 110.848 -179.948 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 33.69 -54.76 0.0 OUTLIER Glycine 0 N--CA 1.506 3.322 0 C-N-CA 129.879 3.609 . . . . 0.0 120.763 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.455 HG22 ' H ' ' A' ' 10' ' ' CYS . 19.9 m -103.34 -173.42 2.31 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.482 ' SG ' ' CZ ' ' A' ' 5' ' ' PHE . 46.5 t -85.9 81.75 0.03 OUTLIER Pre-proline 0 N--CA 1.484 1.267 0 CA-C-O 121.34 0.59 . . . . 0.0 110.383 -179.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -55.97 -20.11 28.56 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.545 2.163 . . . . 0.0 115.121 -132.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 15.5 ttmm -85.1 -34.25 22.24 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 27.4 p -105.04 -47.01 4.11 Favored 'General case' 0 N--CA 1.505 2.292 0 N-CA-C 102.208 -3.256 . . . . 0.0 102.208 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . 0.264 4.1 tttp 52.57 87.83 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.586 1 N-CA-C 122.44 4.237 . . . . 0.0 122.44 178.498 . . . . . . . . 3 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.417 ' HB3' ' NE2' ' A' ' 18' ' ' GLN . 12.6 t -90.62 118.31 68.6 Favored Pre-proline 0 N--CA 1.49 1.555 0 N-CA-C 101.239 -3.615 . . . . 0.0 101.239 178.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -10.05 -56.59 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.506 1 C-N-CA 125.988 4.459 . . . . 0.0 121.994 -153.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -138.62 94.33 2.83 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 123.335 0.654 . . . . 0.0 111.348 -179.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.515 HE21 ' HA ' ' A' ' 23' ' ' CYS . 3.8 mm100 -102.31 70.72 1.19 Allowed 'General case' 0 N--CA 1.507 2.375 0 CA-C-O 123.694 1.711 . . . . 0.0 111.103 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -102.62 -54.65 2.61 Favored 'General case' 0 N--CA 1.492 1.668 1 N-CA-C 99.848 -4.13 . . . . 0.0 99.848 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -124.77 22.46 6.45 Favored Glycine 0 N--CA 1.491 2.317 0 CA-C-N 113.183 -1.826 . . . . 0.0 109.137 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.411 ' HB2' ' HA ' ' A' ' 18' ' ' GLN . 2.2 m-20 -120.15 39.94 3.57 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -8.69 82.62 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.54 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.515 ' HA ' HE21 ' A' ' 18' ' ' GLN . 43.8 t -3.19 100.41 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 118.887 2.921 . . . . 0.0 118.887 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -101.46 41.06 1.23 Allowed 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 19.3 t -120.21 -58.17 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 CA-C-N 114.462 -1.244 . . . . 0.0 111.567 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 26.6 p -121.21 -39.03 2.72 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 124.184 0.927 . . . . 0.0 111.557 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 129.22 118.06 2.04 Favored Glycine 0 N--CA 1.496 2.669 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.383 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.916 0 CA-C-O 116.235 -1.841 . . . . 0.0 109.07 179.773 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.549 ' CZ ' ' HA ' ' A' ' 10' ' ' CYS . 1.1 t80 . . . . . 0 C--O 1.219 -0.543 0 N-CA-C 101.243 -3.614 . . . . 0.0 101.243 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . 0.254 6.3 t -88.32 85.98 2.55 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 N-CA-C 102.043 -3.318 . . . . 0.0 102.043 179.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.481 ' O ' ' N ' ' A' ' 9' ' ' THR . 1.4 tmtp? 101.54 86.01 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 110.444 -3.071 . . . . 0.0 104.049 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 12.55 -52.41 0.0 OUTLIER Glycine 0 N--CA 1.51 3.627 0 N-CA-C 120.485 2.954 . . . . 0.0 120.485 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.481 ' N ' ' O ' ' A' ' 7' ' ' LYS . 30.9 m -95.88 175.27 6.56 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.549 ' HA ' ' CZ ' ' A' ' 5' ' ' PHE . 49.3 t -83.55 90.25 0.13 Allowed Pre-proline 0 C--N 1.305 -1.349 0 N-CA-C 104.386 -2.45 . . . . 0.0 104.386 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.454 ' CD ' ' CE1' ' A' ' 5' ' ' PHE . 98.2 Cg_endo -64.24 -7.88 15.06 Favored 'Trans proline' 0 CA--C 1.557 1.673 0 O-C-N 123.756 1.398 . . . . 0.0 111.825 -143.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.406 ' N ' ' O ' ' A' ' 10' ' ' CYS . 21.9 ttmm -86.18 -46.41 10.42 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.715 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.496 ' SG ' ' HB ' ' A' ' 25' ' ' VAL . 23.6 p -104.26 -2.97 24.88 Favored 'General case' 0 N--CA 1.508 2.458 0 C-N-CA 120.25 -0.58 . . . . 0.0 111.435 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . 0.338 21.5 tptt 21.73 75.17 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.709 1 N-CA-C 122.055 4.094 . . . . 0.0 122.055 178.36 . . . . . . . . 3 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.434 ' HB3' ' NE2' ' A' ' 18' ' ' GLN . 16.8 t -90.5 102.44 5.07 Favored Pre-proline 0 N--CA 1.492 1.642 0 CA-C-N 112.09 -2.323 . . . . 0.0 106.355 179.122 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -14.72 -49.54 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.54 1 C-N-CA 125.976 4.451 . . . . 0.0 121.995 -146.116 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -139.12 92.67 2.61 Favored 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 123.215 0.606 . . . . 0.0 112.568 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.434 ' NE2' ' HB3' ' A' ' 15' ' ' SER . 98.6 mm-40 -91.91 73.85 5.65 Favored 'General case' 0 N--CA 1.507 2.403 0 CA-C-O 122.894 1.33 . . . . 0.0 112.116 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -107.9 -57.22 2.13 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 101.534 -3.506 . . . . 0.0 101.534 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -125.61 25.73 5.57 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 107.921 -2.072 . . . . 0.0 107.921 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.407 ' HB2' ' HA ' ' A' ' 18' ' ' GLN . 14.7 m-20 -110.64 16.47 21.43 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 119.323 -0.37 . . . . 0.0 111.091 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 55.4 m-20 12.21 74.92 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.648 0 O-C-N 125.055 1.472 . . . . 0.0 113.316 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.417 ' N ' ' OE1' ' A' ' 18' ' ' GLN . 41.6 t 16.79 91.72 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.045 0 O-C-N 125.377 1.673 . . . . 0.0 114.271 -179.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -90.53 25.58 2.25 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.496 ' HB ' ' SG ' ' A' ' 13' ' ' CYS . 5.4 t -127.94 -49.01 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 114.806 1.41 . . . . 0.0 114.806 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 16.2 p -117.95 -27.9 6.04 Favored 'General case' 0 N--CA 1.503 2.207 0 N-CA-C 115.754 1.761 . . . . 0.0 115.754 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.86 125.57 3.07 Favored Glycine 0 N--CA 1.496 2.695 0 CA-C-N 118.607 0.64 . . . . 0.0 111.996 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.505 2.283 0 O-C-N 124.559 0.799 . . . . 0.0 109.061 179.608 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.518 ' CE1' ' C ' ' A' ' 9' ' ' THR . 1.7 t80 . . . . . 0 C--O 1.219 -0.549 1 N-CA-C 100.157 -4.016 . . . . 0.0 100.157 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 26.3 t -102.44 114.95 43.41 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 CA-C-N 112.232 -2.258 . . . . 0.0 106.021 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 99.5 mttt 40.49 72.47 0.15 Allowed 'General case' 0 N--CA 1.499 1.988 0 CA-C-N 114.537 -1.21 . . . . 0.0 113.096 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 33.15 11.4 0.0 OUTLIER Glycine 0 N--CA 1.503 3.121 0 N-CA-C 122.134 3.614 . . . . 0.0 122.134 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.518 ' C ' ' CE1' ' A' ' 5' ' ' PHE . 67.4 m -162.43 151.66 15.5 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 119.851 1.825 . . . . 0.0 112.374 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.43 ' N ' ' CE1' ' A' ' 5' ' ' PHE . 44.7 t -50.65 96.39 0.11 Allowed Pre-proline 0 N--CA 1.502 2.146 0 N-CA-C 105.545 -2.02 . . . . 0.0 105.545 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -59.87 -13.66 23.64 Favored 'Trans proline' 0 CA--C 1.555 1.528 0 O-C-N 124.23 1.647 . . . . 0.0 109.834 -156.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.403 ' N ' ' O ' ' A' ' 10' ' ' CYS . 59.7 tttm -91.73 -47.87 7.12 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 114.491 -1.231 . . . . 0.0 111.237 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.638 ' SG ' ' HB ' ' A' ' 25' ' ' VAL . 14.3 p -117.05 34.21 5.23 Favored 'General case' 0 N--CA 1.509 2.513 0 CA-C-O 124.994 2.33 . . . . 0.0 114.925 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.463 ' HA ' HG22 ' A' ' 9' ' ' THR 0.372 1.6 tppp? -15.54 80.82 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.898 1 CA-C-N 106.656 -4.793 . . . . 0.0 114.785 178.225 . . . . . . . . 4 3 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 41.8 t -88.91 139.96 29.2 Favored Pre-proline 0 N--CA 1.504 2.227 0 CA-C-N 111.025 -2.807 . . . . 0.0 109.913 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_exo -31.74 -56.08 0.27 Allowed 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 124.307 3.338 . . . . 0.0 118.293 -150.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -138.0 83.06 1.95 Allowed 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.522 ' HA ' ' HB2' ' A' ' 21' ' ' ASP . 64.7 mm-40 -105.19 77.97 1.35 Allowed 'General case' 0 N--CA 1.514 2.738 0 C-N-CA 118.454 -1.298 . . . . 0.0 107.979 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -101.57 27.1 6.61 Favored 'General case' 0 N--CA 1.505 2.296 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 129.35 50.37 0.12 Allowed Glycine 0 N--CA 1.487 2.054 0 N-CA-C 105.668 -2.973 . . . . 0.0 105.668 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.522 ' HB2' ' HA ' ' A' ' 18' ' ' GLN . 1.2 m-20 -114.09 27.07 9.78 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 2.3 m120 22.16 62.16 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.364 0 O-C-N 125.438 1.711 . . . . 0.0 111.421 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 30.5 t 11.4 96.24 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.168 0 CA-C-N 112.813 -1.994 . . . . 0.0 115.991 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -93.41 46.82 1.21 Allowed 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.616 0.722 . . . . 0.0 110.893 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.638 ' HB ' ' SG ' ' A' ' 13' ' ' CYS . 13.4 t -126.69 -61.97 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 CA-C-N 114.496 -1.229 . . . . 0.0 111.126 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 27.3 p -116.14 -21.09 9.57 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.989 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.444 ' O ' ' CB ' ' A' ' 28' ' ' ALA . . . 139.89 -50.41 0.77 Allowed Glycine 0 N--CA 1.499 2.834 0 CA-C-O 118.537 -1.146 . . . . 0.0 112.023 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.444 ' CB ' ' O ' ' A' ' 27' ' ' GLY . . . . . . . . 0 N--CA 1.515 2.808 0 C-N-CA 126.064 1.746 . . . . 0.0 108.876 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.485 ' CE1' ' C ' ' A' ' 9' ' ' THR . 3.6 t80 . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 115.474 -2.203 . . . . 0.0 114.603 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.39 145.86 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 121.764 3.987 . . . . 0.0 121.764 179.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 41.8 mtmt 128.02 39.59 0.0 OUTLIER 'General case' 0 CA--C 1.567 1.628 4 CA-C-N 101.735 -7.029 . . . . 0.0 94.785 -178.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 40.36 31.53 0.37 Allowed Glycine 0 N--CA 1.475 1.26 0 C-N-CA 127.282 2.372 . . . . 0.0 115.854 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.485 ' C ' ' CE1' ' A' ' 5' ' ' PHE . 9.8 m -151.15 165.43 33.91 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-O 118.46 -0.781 . . . . 0.0 110.454 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.426 ' O ' ' N ' ' A' ' 12' ' ' LYS . 52.1 t -75.77 94.94 0.09 OUTLIER Pre-proline 0 N--CA 1.496 1.859 0 N-CA-C 104.062 -2.57 . . . . 0.0 104.062 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -53.71 -17.93 11.12 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 124.495 1.787 . . . . 0.0 113.428 -148.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.426 ' N ' ' O ' ' A' ' 10' ' ' CYS . 11.8 ttpp -96.32 -43.67 7.58 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 117.213 -1.375 . . . . 0.0 112.989 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.548 ' SG ' ' HB ' ' A' ' 25' ' ' VAL . 17.8 p -102.73 11.18 37.98 Favored 'General case' 0 N--CA 1.511 2.599 0 C-N-CA 117.809 -1.556 . . . . 0.0 112.116 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . 0.31 1.0 OUTLIER 2.04 83.97 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 109.911 -3.313 . . . . 0.0 119.611 178.104 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 30.3 t -90.2 95.78 0.77 Allowed Pre-proline 0 N--CA 1.491 1.61 0 CA-C-N 111.371 -2.65 . . . . 0.0 106.144 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -7.64 -56.36 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.514 2 C-N-CA 127.518 5.478 . . . . 0.0 123.405 -145.338 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -131.85 84.05 2.14 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.475 ' HB2' ' HA ' ' A' ' 9' ' ' THR . 38.8 mt-30 -98.78 98.09 9.24 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 123.157 1.456 . . . . 0.0 112.529 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -112.59 -54.21 2.64 Favored 'General case' 0 N--CA 1.499 1.983 1 N-CA-C 99.193 -4.373 . . . . 0.0 99.193 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -124.06 43.45 1.41 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 106.316 -2.714 . . . . 0.0 106.316 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.429 ' HB2' ' HA ' ' A' ' 18' ' ' GLN . 1.2 m-20 -116.34 20.39 14.25 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 117.74 -1.124 . . . . 0.0 111.44 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.427 ' C ' ' O ' ' A' ' 21' ' ' ASP . 63.4 m-80 8.15 67.73 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.931 0 O-C-N 125.131 1.519 . . . . 0.0 112.606 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.402 ' HA ' ' NE2' ' A' ' 18' ' ' GLN . 21.2 t 10.51 88.39 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 111.894 -2.412 . . . . 0.0 114.556 -179.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.64 44.05 1.18 Allowed 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.548 ' HB ' ' SG ' ' A' ' 13' ' ' CYS . 21.2 t -128.57 -53.58 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 CA-C-N 114.933 -1.031 . . . . 0.0 113.624 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 26.1 p -119.73 -52.97 2.21 Favored 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.75 63.39 0.15 Allowed Glycine 0 N--CA 1.498 2.803 0 N-CA-C 108.92 -1.672 . . . . 0.0 108.92 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.502 2.144 0 N-CA-C 115.738 1.755 . . . . 0.0 115.738 179.97 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.59 ' CZ ' ' HA ' ' A' ' 10' ' ' CYS . 2.0 t80 . . . . . 0 C--O 1.218 -0.569 1 N-CA-C 99.416 -4.29 . . . . 0.0 99.416 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.442 ' O ' ' CB ' ' A' ' 7' ' ' LYS 0.268 40.6 t -94.61 76.37 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.146 0 N-CA-C 103.209 -2.886 . . . . 0.0 103.209 179.581 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.442 ' CB ' ' O ' ' A' ' 6' ' ' VAL . 55.3 tttp 107.12 87.12 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 111.004 -2.816 . . . . 0.0 103.534 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 21.4 -58.04 0.0 OUTLIER Glycine 0 N--CA 1.507 3.371 0 C-N-CA 128.709 3.052 . . . . 0.0 120.027 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.451 HG22 ' H ' ' A' ' 10' ' ' CYS . 12.6 m -104.59 175.59 5.44 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 124.035 0.491 . . . . 0.0 110.573 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.59 ' HA ' ' CZ ' ' A' ' 5' ' ' PHE . 44.8 t -79.9 90.08 0.06 OUTLIER Pre-proline 0 N--CA 1.488 1.448 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.442 ' HD3' ' CD1' ' A' ' 5' ' ' PHE . 88.9 Cg_endo -65.41 -1.2 4.34 Favored 'Trans proline' 0 CA--C 1.559 1.739 0 O-C-N 123.787 1.414 . . . . 0.0 112.511 -144.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.429 ' N ' ' O ' ' A' ' 10' ' ' CYS . 4.0 tppt? -99.56 -41.56 7.3 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 118.53 -0.747 . . . . 0.0 109.151 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.556 ' SG ' ' HB ' ' A' ' 25' ' ' VAL . 17.6 p -111.34 9.48 21.57 Favored 'General case' 0 N--CA 1.512 2.642 0 CA-C-O 123.085 1.421 . . . . 0.0 112.377 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . 0.328 20.9 tttp -2.7 80.97 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 109.388 -3.551 . . . . 0.0 119.1 178.218 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 31.1 t -90.53 96.61 0.96 Allowed Pre-proline 0 C--N 1.301 -1.524 0 CA-C-N 109.566 -3.47 . . . . 0.0 105.253 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -33.86 -24.82 0.03 OUTLIER 'Trans proline' 0 N--CA 1.501 1.933 2 C-N-CA 126.419 4.746 . . . . 0.0 122.889 -125.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -147.52 94.33 2.36 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 119.575 1.08 . . . . 0.0 111.509 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.469 HE21 ' HA ' ' A' ' 23' ' ' CYS . 4.9 mm100 -95.89 71.39 2.96 Favored 'General case' 0 N--CA 1.504 2.254 0 CA-C-O 123.247 1.498 . . . . 0.0 110.333 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -103.92 -56.79 2.14 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 100.645 -3.835 . . . . 0.0 100.645 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -120.32 21.49 8.69 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 107.288 -2.325 . . . . 0.0 107.288 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -124.72 49.3 1.85 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 124.039 0.494 . . . . 0.0 110.605 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -29.7 94.12 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.645 0 O-C-N 124.366 1.041 . . . . 0.0 112.821 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.469 ' HA ' HE21 ' A' ' 18' ' ' GLN . 42.1 t -0.09 106.38 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 117.926 2.565 . . . . 0.0 117.926 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -106.87 29.06 7.36 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.556 ' HB ' ' SG ' ' A' ' 13' ' ' CYS . 12.4 t -117.46 -59.71 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -179.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 25.7 p -105.95 -41.69 5.33 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 114.59 1.329 . . . . 0.0 114.59 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 123.53 63.85 0.2 Allowed Glycine 0 N--CA 1.502 3.036 0 C-N-CA 120.373 -0.917 . . . . 0.0 111.776 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.507 2.388 0 N-CA-C 116.367 1.988 . . . . 0.0 116.367 -179.926 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.652 ' CE1' ' HA ' ' A' ' 10' ' ' CYS . 0.2 OUTLIER . . . . . 0 C--O 1.217 -0.633 0 N-CA-C 103.764 -2.68 . . . . 0.0 103.764 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 92.9 t -131.83 98.54 3.31 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 CA-C-N 112.009 -2.36 . . . . 0.0 108.233 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 69.04 53.13 0.48 Allowed 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 39.86 4.65 0.01 OUTLIER Glycine 0 N--CA 1.496 2.681 0 N-CA-C 120.463 2.945 . . . . 0.0 120.463 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.433 HG22 ' H ' ' A' ' 10' ' ' CYS . 16.6 m -137.84 -177.14 4.68 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.652 ' HA ' ' CE1' ' A' ' 5' ' ' PHE . 49.2 t -89.26 84.1 0.09 OUTLIER Pre-proline 0 N--CA 1.488 1.463 0 CA-C-N 118.388 0.54 . . . . 0.0 109.927 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -52.02 -26.84 26.63 Favored 'Trans proline' 0 CA--C 1.554 1.507 0 O-C-N 124.352 1.712 . . . . 0.0 114.209 -138.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -72.18 -42.78 65.46 Favored 'General case' 0 N--CA 1.501 2.125 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.024 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 31.6 p -97.94 -32.37 11.7 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 124.264 0.978 . . . . 0.0 109.927 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . 0.282 22.4 tttp 47.97 71.85 0.31 Allowed 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 121.39 3.848 . . . . 0.0 121.39 178.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.0 t -90.8 96.72 1.02 Allowed Pre-proline 0 N--CA 1.49 1.537 0 N-CA-C 104.107 -2.553 . . . . 0.0 104.107 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -16.82 -42.09 0.0 OUTLIER 'Trans proline' 0 CA--C 1.554 1.477 2 N-CA-C 124.629 4.819 . . . . 0.0 124.629 -139.219 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -138.89 92.18 2.59 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 118.729 0.695 . . . . 0.0 111.843 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.434 ' HA ' ' HB2' ' A' ' 21' ' ' ASP . 0.7 OUTLIER -102.97 85.1 2.46 Favored 'General case' 0 N--CA 1.511 2.607 0 CA-C-O 123.123 1.439 . . . . 0.0 112.704 179.931 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -112.67 -54.42 2.62 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 101.588 -3.486 . . . . 0.0 101.588 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -121.72 14.95 9.12 Favored Glycine 0 N--CA 1.487 2.063 0 CA-C-N 112.519 -2.128 . . . . 0.0 107.807 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.434 ' HB2' ' HA ' ' A' ' 18' ' ' GLN . 24.5 m-20 -112.25 41.4 1.99 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -19.51 89.05 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.525 0 O-C-N 125.893 1.995 . . . . 0.0 112.925 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 49.0 t -7.46 105.03 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 119.903 3.298 . . . . 0.0 119.903 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -110.95 44.7 1.25 Allowed 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 6.5 t -122.03 -59.46 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 CA-C-N 114.541 -1.209 . . . . 0.0 110.475 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 23.6 p -117.37 -47.28 2.66 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 124.661 1.226 . . . . 0.0 108.4 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 115.37 47.79 0.53 Allowed Glycine 0 N--CA 1.498 2.815 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.506 2.331 0 N-CA-C 115.939 1.829 . . . . 0.0 115.939 179.853 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.689 ' CE1' ' HA ' ' A' ' 10' ' ' CYS . 0.2 OUTLIER . . . . . 0 C--O 1.217 -0.617 1 N-CA-C 99.984 -4.08 . . . . 0.0 99.984 . . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . 0.312 70.3 t -122.82 130.92 74.16 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 1 N-CA-C 99.553 -4.24 . . . . 0.0 99.553 179.823 . . . . . . . . 3 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 9.9 pttm 25.94 68.27 0.05 Allowed 'General case' 0 N--CA 1.504 2.262 0 CA-C-O 123.249 1.5 . . . . 0.0 112.665 -179.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 40.13 -1.36 0.0 OUTLIER Glycine 0 N--CA 1.497 2.75 0 N-CA-C 121.765 3.466 . . . . 0.0 121.765 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.502 HG22 ' H ' ' A' ' 10' ' ' CYS . 8.8 m -140.71 -179.12 5.86 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 120.091 1.945 . . . . 0.0 109.654 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.689 ' HA ' ' CE1' ' A' ' 5' ' ' PHE . 45.7 t -78.84 91.0 0.06 OUTLIER Pre-proline 0 N--CA 1.484 1.24 0 N-CA-C 102.69 -3.078 . . . . 0.0 102.69 179.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -57.52 -21.89 48.34 Favored 'Trans proline' 0 CA--C 1.557 1.648 0 O-C-N 124.415 1.745 . . . . 0.0 111.114 -147.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 54.9 tptt -84.42 -46.21 11.92 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 113.892 -1.503 . . . . 0.0 111.58 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.567 ' SG ' ' HB ' ' A' ' 25' ' ' VAL . 3.9 p -116.65 25.1 10.81 Favored 'General case' 0 N--CA 1.51 2.526 0 CA-C-O 123.755 1.74 . . . . 0.0 115.69 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 9.7 ttpp -13.93 97.7 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 108.658 -3.883 . . . . 0.0 117.178 178.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.438 ' HB2' ' CG2' ' A' ' 25' ' ' VAL . 22.8 t -90.62 90.06 0.31 Allowed Pre-proline 0 C--N 1.292 -1.934 0 CA-C-N 109.89 -3.323 . . . . 0.0 105.669 179.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -20.68 -52.8 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.615 1 C-N-CA 126.0 4.467 . . . . 0.0 122.073 -123.997 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.3 p30 -133.8 94.85 3.34 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 123.531 0.732 . . . . 0.0 109.233 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.454 ' HG2' HG21 ' A' ' 9' ' ' THR . 10.7 mm-40 -100.29 74.33 1.74 Allowed 'General case' 0 N--CA 1.497 1.893 0 CA-C-N 114.541 -1.208 . . . . 0.0 107.908 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -96.03 -40.85 9.04 Favored 'General case' 0 N--CA 1.506 2.325 0 N-CA-C 104.805 -2.294 . . . . 0.0 104.805 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -100.01 8.68 59.47 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 106.783 -2.527 . . . . 0.0 106.783 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -124.28 172.84 8.78 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.478 0.656 . . . . 0.0 109.683 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.401 ' O ' ' CB ' ' A' ' 23' ' ' CYS . 9.3 m120 -118.0 -23.16 7.54 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 113.757 -1.565 . . . . 0.0 106.812 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.401 ' CB ' ' O ' ' A' ' 22' ' ' ASN . 38.2 t 127.35 126.82 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.347 0 C-N-CA 126.475 1.91 . . . . 0.0 111.775 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -120.63 38.06 4.12 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 124.164 0.915 . . . . 0.0 109.576 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.567 ' HB ' ' SG ' ' A' ' 13' ' ' CYS . 31.4 t -120.25 -50.66 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.169 -179.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 26.1 p -116.08 -48.74 2.72 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 124.183 0.927 . . . . 0.0 111.348 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 130.29 115.57 1.77 Allowed Glycine 0 N--CA 1.5 2.939 0 N-CA-C 110.879 -0.889 . . . . 0.0 110.879 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.946 0 O-C-N 124.169 0.57 . . . . 0.0 109.518 179.98 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.839 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.7 t -133.15 134.42 44.15 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 124.085 0.52 . . . . 0.0 110.415 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.406 ' O ' ' C ' ' A' ' 4' ' ' ARG . 10.4 p-10 -130.67 59.65 1.66 Allowed 'General case' 0 N--CA 1.504 2.236 0 O-C-N 123.988 0.805 . . . . 0.0 110.335 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.406 ' C ' ' O ' ' A' ' 3' ' ' ASP . 23.0 mtp180 -21.08 -64.13 0.03 OUTLIER 'General case' 0 N--CA 1.513 2.677 0 O-C-N 124.298 0.999 . . . . 0.0 112.812 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . 0.373 2.6 t80 -128.57 164.32 23.09 Favored 'General case' 0 N--CA 1.487 1.404 1 N-CA-C 93.958 -6.312 . . . . 0.0 93.958 179.69 . . . . . . . . 3 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.2 t -102.81 154.14 5.41 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 CA-C-N 113.083 -1.871 . . . . 0.0 106.883 179.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp 3.79 64.09 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.398 0 O-C-N 126.547 2.404 . . . . 0.0 113.076 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 37.61 28.52 0.04 OUTLIER Glycine 0 N--CA 1.494 2.509 0 N-CA-C 117.828 1.891 . . . . 0.0 117.828 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.5 ' HA ' ' HB2' ' A' ' 18' ' ' GLN . 9.0 m -157.74 164.67 36.86 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 53.3 t -89.08 85.85 0.14 Allowed Pre-proline 0 N--CA 1.493 1.705 0 CA-C-O 122.223 1.011 . . . . 0.0 111.484 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -54.08 -26.97 43.78 Favored 'Trans proline' 0 C--N 1.299 -2.032 0 C-N-CA 122.402 2.068 . . . . 0.0 116.735 -138.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 23.9 tptp -74.48 -36.0 63.28 Favored 'General case' 0 N--CA 1.504 2.249 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 27.4 p -100.31 -36.21 9.34 Favored 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . 0.318 29.1 tttt 49.82 76.09 0.15 Allowed 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 115.965 -2.294 . . . . 0.0 115.207 178.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.2 t -90.63 89.4 0.28 Allowed Pre-proline 0 C--N 1.304 -1.382 0 N-CA-C 103.304 -2.85 . . . . 0.0 103.304 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -21.96 -41.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.592 1 C-N-CA 126.112 4.542 . . . . 0.0 121.378 -129.368 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -130.07 84.81 2.23 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -179.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.5 ' HB2' ' HA ' ' A' ' 9' ' ' THR . 4.3 mm-40 -100.63 73.77 1.63 Allowed 'General case' 0 N--CA 1.504 2.274 0 CA-C-O 122.841 1.305 . . . . 0.0 108.972 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -97.64 -59.54 1.75 Allowed 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 100.838 -3.764 . . . . 0.0 100.838 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -131.69 29.4 3.42 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 105.754 -2.938 . . . . 0.0 105.754 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.483 ' HB2' ' HA ' ' A' ' 18' ' ' GLN . 14.4 m-20 -117.8 45.58 1.93 Allowed 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -8.99 99.06 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.434 0 N-CA-C 116.842 2.164 . . . . 0.0 116.842 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.477 ' HA ' HE21 ' A' ' 18' ' ' GLN . 32.1 t -26.18 107.71 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 116.422 2.008 . . . . 0.0 116.422 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.3 pm0 -110.61 36.68 3.01 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.114 0.483 . . . . 0.0 111.113 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.7 t -118.53 -58.42 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.258 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 31.4 p -114.35 -49.61 2.83 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 124.088 0.867 . . . . 0.0 109.192 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 119.03 59.24 0.26 Allowed Glycine 0 N--CA 1.498 2.804 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.817 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.504 2.266 0 N-CA-C 116.373 1.99 . . . . 0.0 116.373 179.887 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.515 0 CA-C-O 121.184 0.324 . . . . 0.0 112.326 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.0 m -112.9 68.25 0.67 Allowed 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -114.7 69.51 0.72 Allowed 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 113.304 -1.771 . . . . 0.0 109.272 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.64 -44.57 61.71 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.027 -0.988 . . . . 0.0 112.43 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . 0.256 3.4 t80 -128.14 -40.31 1.67 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 124.744 1.277 . . . . 0.0 109.773 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -82.17 68.77 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.371 1 N-CA-C 123.865 4.765 . . . . 0.0 123.865 -177.748 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.2 tptt -140.26 40.09 1.92 Allowed 'General case' 0 CA--C 1.587 2.396 3 N-CA-C 90.553 -7.573 . . . . 0.0 90.553 178.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 41.07 10.59 0.01 OUTLIER Glycine 0 N--CA 1.484 1.896 0 C-N-CA 130.48 3.895 . . . . 0.0 118.861 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.51 HG22 ' H ' ' A' ' 10' ' ' CYS . 6.6 m -154.14 -177.04 6.16 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.51 ' H ' HG22 ' A' ' 9' ' ' THR . 53.4 t -89.87 85.15 0.14 Allowed Pre-proline 0 C--N 1.306 -1.324 0 N-CA-C 105.268 -2.123 . . . . 0.0 105.268 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -70.92 3.11 3.54 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 124.458 3.439 . . . . 0.0 113.915 -133.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 53.4 tptt -97.77 -25.46 15.06 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 123.681 0.613 . . . . 0.0 109.747 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 27.7 p -114.47 -40.27 3.65 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.443 ' HA ' ' CG2' ' A' ' 9' ' ' THR 0.264 20.5 tttm 57.3 76.57 0.31 Allowed 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 121.298 3.814 . . . . 0.0 121.298 178.883 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 22.3 t -90.79 91.05 0.36 Allowed Pre-proline 0 N--CA 1.496 1.856 0 N-CA-C 105.493 -2.04 . . . . 0.0 105.493 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -27.44 -36.57 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.515 2 C-N-CA 126.167 4.578 . . . . 0.0 122.52 -126.854 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -132.03 79.75 1.88 Allowed 'General case' 0 N--CA 1.503 2.218 0 N-CA-C 116.166 1.913 . . . . 0.0 116.166 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -109.4 113.56 26.48 Favored 'General case' 0 N--CA 1.504 2.233 0 CA-C-O 122.067 0.937 . . . . 0.0 109.402 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -113.44 -60.83 1.83 Allowed 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 101.731 -3.433 . . . . 0.0 101.731 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -128.43 45.97 1.11 Allowed Glycine 0 N--CA 1.489 2.19 0 N-CA-C 103.617 -3.793 . . . . 0.0 103.617 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.411 ' O ' ' C ' ' A' ' 22' ' ' ASN . 7.3 m-20 -109.73 39.16 2.18 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 118.643 -0.694 . . . . 0.0 111.474 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.411 ' C ' ' O ' ' A' ' 21' ' ' ASP . 86.1 m-20 1.1 69.23 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.765 0 O-C-N 126.009 2.068 . . . . 0.0 112.949 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 53.1 t -1.84 127.73 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.328 0 N-CA-C 119.423 3.12 . . . . 0.0 119.423 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -116.52 35.82 4.39 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.154 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 10.7 t -124.28 -59.38 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 N-CA-C 114.757 1.392 . . . . 0.0 114.757 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 24.2 p -108.4 -46.08 3.77 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 114.563 1.32 . . . . 0.0 114.563 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 120.84 50.61 0.26 Allowed Glycine 0 N--CA 1.503 3.118 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.274 . . . . . . . 0 N--CA 1.496 1.839 1 N-CA-C 132.421 7.934 . . . . 0.0 132.421 -179.984 . . . . . . . . 2 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.299 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.3 m -117.79 157.27 26.87 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -135.06 175.44 9.58 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 124.31 2.005 . . . . 0.0 106.999 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.404 ' HE ' ' HA ' ' A' ' 4' ' ' ARG . 1.4 mmp_? 96.0 -58.29 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.263 1 CA-C-N 108.071 -4.15 . . . . 0.0 103.602 -179.833 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.401 ' CE1' ' HD3' ' A' ' 11' ' ' PRO . 2.0 t80 -130.67 177.49 7.35 Favored 'General case' 0 N--CA 1.488 1.464 1 N-CA-C 100.052 -4.055 . . . . 0.0 100.052 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.478 ' HB ' ' HB3' ' A' ' 11' ' ' PRO 0.257 3.6 t -105.19 121.81 57.67 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.99 0 CA-C-N 113.501 -1.681 . . . . 0.0 106.608 179.548 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 23.8 pttm 25.45 62.01 0.06 Allowed 'General case' 0 N--CA 1.509 2.483 0 CA-C-O 123.095 1.426 . . . . 0.0 111.602 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.405 ' HA3' ' CE1' ' A' ' 19' ' ' TYR . . . 30.31 38.18 0.02 OUTLIER Glycine 0 N--CA 1.499 2.892 0 CA-C-N 111.193 -2.73 . . . . 0.0 115.952 -179.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.527 ' HA ' ' HB2' ' A' ' 18' ' ' GLN . 35.3 m -152.4 157.64 41.53 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 115.142 1.534 . . . . 0.0 115.142 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.477 ' SG ' ' CG2' ' A' ' 25' ' ' VAL . 7.4 t -49.38 91.6 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.805 0 N-CA-C 103.384 -2.821 . . . . 0.0 103.384 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.478 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . 10.8 Cg_endo -41.09 -56.13 1.84 Allowed 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.572 2.182 . . . . 0.0 116.564 -150.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 21.8 ttmm -107.67 -1.17 21.34 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 124.671 1.232 . . . . 0.0 109.536 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -127.33 39.64 3.86 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 126.626 3.108 . . . . 0.0 109.6 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.412 ' N ' ' O ' ' A' ' 10' ' ' CYS 0.316 25.9 tttt -44.12 80.34 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.916 3 CA-C-N 104.198 -5.91 . . . . 0.0 119.411 179.657 . . . . . . . . 4 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.451 ' HG ' HG23 ' A' ' 25' ' ' VAL . 3.0 m -90.31 169.23 12.57 Favored Pre-proline 0 C--N 1.296 -1.718 1 CA-C-N 107.311 -4.495 . . . . 0.0 108.158 179.741 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -38.73 -58.42 0.75 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 123.666 2.911 . . . . 0.0 118.913 -167.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -150.13 86.8 1.44 Allowed 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.527 ' HB2' ' HA ' ' A' ' 9' ' ' THR . 18.6 mp0 -99.08 72.39 1.88 Allowed 'General case' 0 N--CA 1.501 2.104 0 CA-C-O 124.748 2.213 . . . . 0.0 112.488 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.405 ' CE1' ' HA3' ' A' ' 8' ' ' GLY . 79.0 m-85 -101.18 -48.81 4.28 Favored 'General case' 0 N--CA 1.49 1.572 1 N-CA-C 96.783 -5.266 . . . . 0.0 96.783 179.124 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -124.72 1.97 8.64 Favored Glycine 0 CA--C 1.552 2.374 0 CA-C-N 113.185 -1.825 . . . . 0.0 110.572 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.423 ' HB2' ' HA ' ' A' ' 18' ' ' GLN . 8.6 m-20 -92.31 39.76 1.03 Allowed 'General case' 0 N--CA 1.509 2.479 0 CA-C-N 118.699 1.249 . . . . 0.0 112.198 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.411 ' O ' ' C ' ' A' ' 23' ' ' CYS . 37.0 m-20 2.42 65.74 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.813 0 C-N-CA 125.854 1.662 . . . . 0.0 115.316 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.461 ' SG ' ' HD2' ' A' ' 11' ' ' PRO . 2.4 t 26.18 52.24 0.03 OUTLIER 'General case' 0 N--CA 1.521 3.107 0 O-C-N 124.651 1.219 . . . . 0.0 108.175 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.52 52.77 2.42 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-O 123.658 1.694 . . . . 0.0 113.923 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.477 ' CG2' ' SG ' ' A' ' 10' ' ' CYS . 44.6 t -123.57 -39.54 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 102.759 -3.052 . . . . 0.0 102.759 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.437 ' SG ' ' N ' ' A' ' 27' ' ' GLY . 20.6 p -123.77 -52.68 1.79 Allowed 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 110.977 -2.829 . . . . 0.0 109.555 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.437 ' N ' ' SG ' ' A' ' 26' ' ' CYS . . . 138.15 124.99 2.31 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 108.532 -1.827 . . . . 0.0 108.532 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.507 2.413 0 CA-C-O 117.405 -1.284 . . . . 0.0 111.598 -179.964 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.561 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.4 m -121.38 75.42 1.17 Allowed 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -120.89 53.01 1.15 Allowed 'General case' 0 N--CA 1.501 2.085 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.542 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 32.6 mmt-85 -36.73 -63.25 0.42 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 124.605 1.19 . . . . 0.0 108.873 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.496 ' CD1' ' HD3' ' A' ' 11' ' ' PRO . 1.5 t80 -140.12 -171.11 3.11 Favored 'General case' 0 CA--C 1.561 1.396 1 N-CA-C 98.295 -4.706 . . . . 0.0 98.295 179.781 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.447 ' H ' ' HD1' ' A' ' 5' ' ' PHE . 55.7 t -119.37 84.01 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 CA-C-N 112.267 -2.242 . . . . 0.0 107.494 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 71.5 tttt 98.03 71.5 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 112.003 -2.362 . . . . 0.0 105.117 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.411 ' HA3' ' CZ ' ' A' ' 19' ' ' TYR . . . 40.47 -58.08 0.0 OUTLIER Glycine 0 N--CA 1.495 2.611 0 C-N-CA 129.176 3.274 . . . . 0.0 118.866 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.433 ' HA ' ' H ' ' A' ' 18' ' ' GLN . 12.3 m -100.92 172.88 6.77 Favored 'General case' 0 C--N 1.295 -1.787 0 O-C-N 124.484 0.755 . . . . 0.0 109.163 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.459 ' HA ' ' CE1' ' A' ' 5' ' ' PHE . 49.5 t -74.08 94.45 0.06 OUTLIER Pre-proline 0 N--CA 1.487 1.38 0 N-CA-C 102.59 -3.115 . . . . 0.0 102.59 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.496 ' HD3' ' CD1' ' A' ' 5' ' ' PHE . 94.9 Cg_endo -62.61 -7.14 10.18 Favored 'Trans proline' 0 CA--C 1.556 1.576 0 O-C-N 124.077 1.567 . . . . 0.0 111.958 -147.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.426 ' N ' ' O ' ' A' ' 10' ' ' CYS . 1.3 ttmp? -95.1 -46.9 6.6 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 124.331 1.02 . . . . 0.0 109.87 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.552 ' SG ' ' HB ' ' A' ' 25' ' ' VAL . 19.3 p -102.11 6.76 41.07 Favored 'General case' 0 N--CA 1.511 2.579 0 C-N-CA 119.439 -0.904 . . . . 0.0 113.137 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . 0.343 25.1 tptt 6.52 77.19 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 118.907 2.929 . . . . 0.0 118.907 178.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 29.1 t -90.24 94.67 0.61 Allowed Pre-proline 0 C--N 1.3 -1.55 0 CA-C-N 111.155 -2.748 . . . . 0.0 104.119 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -15.45 -40.48 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.357 1 C-N-CA 127.495 5.463 . . . . 0.0 121.978 -136.588 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -142.23 96.5 2.97 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 123.383 0.673 . . . . 0.0 110.538 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.535 HE21 ' HA ' ' A' ' 23' ' ' CYS . 7.8 mm100 -100.94 65.96 1.13 Allowed 'General case' 0 N--CA 1.507 2.417 0 CA-C-O 123.365 1.555 . . . . 0.0 106.912 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.411 ' CZ ' ' HA3' ' A' ' 8' ' ' GLY . 0.5 OUTLIER -109.09 -56.29 2.3 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 103.516 -2.772 . . . . 0.0 103.516 179.831 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -117.0 19.97 11.74 Favored Glycine 0 N--CA 1.496 2.673 0 CA-C-N 113.642 -1.617 . . . . 0.0 110.104 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.427 ' HB2' ' HA ' ' A' ' 18' ' ' GLN . 12.7 m-20 -117.19 -49.78 2.58 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 106.214 -1.773 . . . . 0.0 106.214 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 59.6 m-20 64.94 124.64 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 O-C-N 125.997 2.061 . . . . 0.0 110.142 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.535 ' HA ' HE21 ' A' ' 18' ' ' GLN . 39.2 t -18.43 102.26 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 118.737 2.865 . . . . 0.0 118.737 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -112.01 15.9 20.48 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.528 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.552 ' HB ' ' SG ' ' A' ' 13' ' ' CYS . 16.6 t -112.2 -49.02 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 CA-C-O 118.903 -0.57 . . . . 0.0 112.349 -179.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 26.7 p -116.15 -37.83 3.74 Favored 'General case' 0 N--CA 1.502 2.128 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 124.32 89.99 0.87 Allowed Glycine 0 N--CA 1.501 3.021 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.539 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.261 . . . . . . . 0 N--CA 1.499 1.98 1 N-CA-C 132.072 7.805 . . . . 0.0 132.072 179.82 . . . . . . . . 2 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.378 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.8 m -105.66 170.25 8.0 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -130.24 -168.09 1.92 Allowed 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 123.868 1.794 . . . . 0.0 109.591 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 90.79 -63.22 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.15 0 CA-C-N 108.556 -3.929 . . . . 0.0 101.727 -179.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.482 ' CZ ' ' SG ' ' A' ' 10' ' ' CYS . 1.4 t80 -132.43 -149.15 0.37 Allowed 'General case' 0 C--N 1.306 -1.287 1 N-CA-C 98.574 -4.602 . . . . 0.0 98.574 -179.824 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.426 ' O ' ' HB2' ' A' ' 7' ' ' LYS . 73.9 t -124.12 78.15 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.033 0 N-CA-C 100.476 -3.898 . . . . 0.0 100.476 179.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.426 ' HB2' ' O ' ' A' ' 6' ' ' VAL . 1.0 OUTLIER 85.17 89.53 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 112.096 -2.32 . . . . 0.0 110.848 -179.948 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 33.69 -54.76 0.0 OUTLIER Glycine 0 N--CA 1.506 3.322 0 C-N-CA 129.879 3.609 . . . . 0.0 120.763 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.455 HG22 ' H ' ' A' ' 10' ' ' CYS . 19.9 m -103.34 -173.42 2.31 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.482 ' SG ' ' CZ ' ' A' ' 5' ' ' PHE . 46.5 t -85.9 81.75 0.03 OUTLIER Pre-proline 0 N--CA 1.484 1.267 0 CA-C-O 121.34 0.59 . . . . 0.0 110.383 -179.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -55.97 -20.11 28.56 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.545 2.163 . . . . 0.0 115.121 -132.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 15.5 ttmm -85.1 -34.25 22.24 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 27.4 p -105.04 -47.01 4.11 Favored 'General case' 0 N--CA 1.505 2.292 0 N-CA-C 102.208 -3.256 . . . . 0.0 102.208 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . 0.264 4.1 tttp 52.57 87.83 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.586 1 N-CA-C 122.44 4.237 . . . . 0.0 122.44 178.498 . . . . . . . . 3 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.417 ' HB3' ' NE2' ' A' ' 18' ' ' GLN . 12.6 t -90.62 118.31 68.6 Favored Pre-proline 0 N--CA 1.49 1.555 0 N-CA-C 101.239 -3.615 . . . . 0.0 101.239 178.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -10.05 -56.59 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.506 1 C-N-CA 125.988 4.459 . . . . 0.0 121.994 -153.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -138.62 94.33 2.83 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 123.335 0.654 . . . . 0.0 111.348 -179.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.515 HE21 ' HA ' ' A' ' 23' ' ' CYS . 3.8 mm100 -102.31 70.72 1.19 Allowed 'General case' 0 N--CA 1.507 2.375 0 CA-C-O 123.694 1.711 . . . . 0.0 111.103 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -102.62 -54.65 2.61 Favored 'General case' 0 N--CA 1.492 1.668 1 N-CA-C 99.848 -4.13 . . . . 0.0 99.848 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -124.77 22.46 6.45 Favored Glycine 0 N--CA 1.491 2.317 0 CA-C-N 113.183 -1.826 . . . . 0.0 109.137 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.411 ' HB2' ' HA ' ' A' ' 18' ' ' GLN . 2.2 m-20 -120.15 39.94 3.57 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -8.69 82.62 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.54 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.515 ' HA ' HE21 ' A' ' 18' ' ' GLN . 43.8 t -3.19 100.41 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 118.887 2.921 . . . . 0.0 118.887 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -101.46 41.06 1.23 Allowed 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 19.3 t -120.21 -58.17 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 CA-C-N 114.462 -1.244 . . . . 0.0 111.567 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 26.6 p -121.21 -39.03 2.72 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 124.184 0.927 . . . . 0.0 111.557 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 129.22 118.06 2.04 Favored Glycine 0 N--CA 1.496 2.669 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.383 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.916 0 CA-C-O 116.235 -1.841 . . . . 0.0 109.07 179.773 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.272 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.3 m -127.77 161.23 29.46 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -137.58 55.36 1.8 Allowed 'General case' 0 N--CA 1.502 2.135 0 CA-C-N 113.844 -1.525 . . . . 0.0 107.073 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 40.9 mtt-85 -25.96 -66.77 0.05 Allowed 'General case' 0 N--CA 1.506 2.34 0 O-C-N 124.888 1.368 . . . . 0.0 112.164 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.549 ' CZ ' ' HA ' ' A' ' 10' ' ' CYS . 1.1 t80 -144.03 149.12 36.18 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 101.243 -3.614 . . . . 0.0 101.243 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . 0.254 6.3 t -88.32 85.98 2.55 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 N-CA-C 102.043 -3.318 . . . . 0.0 102.043 179.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.481 ' O ' ' N ' ' A' ' 9' ' ' THR . 1.4 tmtp? 101.54 86.01 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 110.444 -3.071 . . . . 0.0 104.049 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 12.55 -52.41 0.0 OUTLIER Glycine 0 N--CA 1.51 3.627 0 N-CA-C 120.485 2.954 . . . . 0.0 120.485 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.481 ' N ' ' O ' ' A' ' 7' ' ' LYS . 30.9 m -95.88 175.27 6.56 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.549 ' HA ' ' CZ ' ' A' ' 5' ' ' PHE . 49.3 t -83.55 90.25 0.13 Allowed Pre-proline 0 C--N 1.305 -1.349 0 N-CA-C 104.386 -2.45 . . . . 0.0 104.386 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.454 ' CD ' ' CE1' ' A' ' 5' ' ' PHE . 98.2 Cg_endo -64.24 -7.88 15.06 Favored 'Trans proline' 0 CA--C 1.557 1.673 0 O-C-N 123.756 1.398 . . . . 0.0 111.825 -143.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.406 ' N ' ' O ' ' A' ' 10' ' ' CYS . 21.9 ttmm -86.18 -46.41 10.42 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.715 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.496 ' SG ' ' HB ' ' A' ' 25' ' ' VAL . 23.6 p -104.26 -2.97 24.88 Favored 'General case' 0 N--CA 1.508 2.458 0 C-N-CA 120.25 -0.58 . . . . 0.0 111.435 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . 0.338 21.5 tptt 21.73 75.17 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.709 1 N-CA-C 122.055 4.094 . . . . 0.0 122.055 178.36 . . . . . . . . 3 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.434 ' HB3' ' NE2' ' A' ' 18' ' ' GLN . 16.8 t -90.5 102.44 5.07 Favored Pre-proline 0 N--CA 1.492 1.642 0 CA-C-N 112.09 -2.323 . . . . 0.0 106.355 179.122 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -14.72 -49.54 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.54 1 C-N-CA 125.976 4.451 . . . . 0.0 121.995 -146.116 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -139.12 92.67 2.61 Favored 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 123.215 0.606 . . . . 0.0 112.568 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.434 ' NE2' ' HB3' ' A' ' 15' ' ' SER . 98.6 mm-40 -91.91 73.85 5.65 Favored 'General case' 0 N--CA 1.507 2.403 0 CA-C-O 122.894 1.33 . . . . 0.0 112.116 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -107.9 -57.22 2.13 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 101.534 -3.506 . . . . 0.0 101.534 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -125.61 25.73 5.57 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 107.921 -2.072 . . . . 0.0 107.921 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.407 ' HB2' ' HA ' ' A' ' 18' ' ' GLN . 14.7 m-20 -110.64 16.47 21.43 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 119.323 -0.37 . . . . 0.0 111.091 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 55.4 m-20 12.21 74.92 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.648 0 O-C-N 125.055 1.472 . . . . 0.0 113.316 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.417 ' N ' ' OE1' ' A' ' 18' ' ' GLN . 41.6 t 16.79 91.72 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.045 0 O-C-N 125.377 1.673 . . . . 0.0 114.271 -179.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -90.53 25.58 2.25 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.496 ' HB ' ' SG ' ' A' ' 13' ' ' CYS . 5.4 t -127.94 -49.01 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 114.806 1.41 . . . . 0.0 114.806 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 16.2 p -117.95 -27.9 6.04 Favored 'General case' 0 N--CA 1.503 2.207 0 N-CA-C 115.754 1.761 . . . . 0.0 115.754 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.86 125.57 3.07 Favored Glycine 0 N--CA 1.496 2.695 0 CA-C-N 118.607 0.64 . . . . 0.0 111.996 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.505 2.283 0 O-C-N 124.559 0.799 . . . . 0.0 109.061 179.608 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.437 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.4 m 69.33 162.93 0.23 Allowed 'General case' 0 N--CA 1.499 2.02 0 O-C-N 125.185 1.167 . . . . 0.0 113.974 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.404 ' O ' ' C ' ' A' ' 4' ' ' ARG . 0.9 OUTLIER -128.5 52.04 1.95 Allowed 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 112.496 -2.138 . . . . 0.0 107.008 179.885 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.404 ' C ' ' O ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -24.16 -60.79 0.05 Allowed 'General case' 0 N--CA 1.507 2.387 0 O-C-N 125.465 1.728 . . . . 0.0 111.405 -179.827 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.518 ' CE1' ' C ' ' A' ' 9' ' ' THR . 1.7 t80 -136.31 158.55 44.16 Favored 'General case' 0 C--N 1.313 -1.009 1 N-CA-C 100.157 -4.016 . . . . 0.0 100.157 179.895 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 26.3 t -102.44 114.95 43.41 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 CA-C-N 112.232 -2.258 . . . . 0.0 106.021 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 99.5 mttt 40.49 72.47 0.15 Allowed 'General case' 0 N--CA 1.499 1.988 0 CA-C-N 114.537 -1.21 . . . . 0.0 113.096 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 33.15 11.4 0.0 OUTLIER Glycine 0 N--CA 1.503 3.121 0 N-CA-C 122.134 3.614 . . . . 0.0 122.134 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.518 ' C ' ' CE1' ' A' ' 5' ' ' PHE . 67.4 m -162.43 151.66 15.5 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 119.851 1.825 . . . . 0.0 112.374 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.43 ' N ' ' CE1' ' A' ' 5' ' ' PHE . 44.7 t -50.65 96.39 0.11 Allowed Pre-proline 0 N--CA 1.502 2.146 0 N-CA-C 105.545 -2.02 . . . . 0.0 105.545 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -59.87 -13.66 23.64 Favored 'Trans proline' 0 CA--C 1.555 1.528 0 O-C-N 124.23 1.647 . . . . 0.0 109.834 -156.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.403 ' N ' ' O ' ' A' ' 10' ' ' CYS . 59.7 tttm -91.73 -47.87 7.12 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 114.491 -1.231 . . . . 0.0 111.237 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.638 ' SG ' ' HB ' ' A' ' 25' ' ' VAL . 14.3 p -117.05 34.21 5.23 Favored 'General case' 0 N--CA 1.509 2.513 0 CA-C-O 124.994 2.33 . . . . 0.0 114.925 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.463 ' HA ' HG22 ' A' ' 9' ' ' THR 0.372 1.6 tppp? -15.54 80.82 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.898 1 CA-C-N 106.656 -4.793 . . . . 0.0 114.785 178.225 . . . . . . . . 4 3 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 41.8 t -88.91 139.96 29.2 Favored Pre-proline 0 N--CA 1.504 2.227 0 CA-C-N 111.025 -2.807 . . . . 0.0 109.913 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_exo -31.74 -56.08 0.27 Allowed 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 124.307 3.338 . . . . 0.0 118.293 -150.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -138.0 83.06 1.95 Allowed 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.522 ' HA ' ' HB2' ' A' ' 21' ' ' ASP . 64.7 mm-40 -105.19 77.97 1.35 Allowed 'General case' 0 N--CA 1.514 2.738 0 C-N-CA 118.454 -1.298 . . . . 0.0 107.979 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -101.57 27.1 6.61 Favored 'General case' 0 N--CA 1.505 2.296 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 129.35 50.37 0.12 Allowed Glycine 0 N--CA 1.487 2.054 0 N-CA-C 105.668 -2.973 . . . . 0.0 105.668 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.522 ' HB2' ' HA ' ' A' ' 18' ' ' GLN . 1.2 m-20 -114.09 27.07 9.78 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 2.3 m120 22.16 62.16 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.364 0 O-C-N 125.438 1.711 . . . . 0.0 111.421 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 30.5 t 11.4 96.24 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.168 0 CA-C-N 112.813 -1.994 . . . . 0.0 115.991 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -93.41 46.82 1.21 Allowed 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.616 0.722 . . . . 0.0 110.893 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.638 ' HB ' ' SG ' ' A' ' 13' ' ' CYS . 13.4 t -126.69 -61.97 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 CA-C-N 114.496 -1.229 . . . . 0.0 111.126 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 27.3 p -116.14 -21.09 9.57 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.989 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.444 ' O ' ' CB ' ' A' ' 28' ' ' ALA . . . 139.89 -50.41 0.77 Allowed Glycine 0 N--CA 1.499 2.834 0 CA-C-O 118.537 -1.146 . . . . 0.0 112.023 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.444 ' CB ' ' O ' ' A' ' 27' ' ' GLY . . . . . . . . 0 N--CA 1.515 2.808 0 C-N-CA 126.064 1.746 . . . . 0.0 108.876 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.155 0 N-CA-C 110.341 -1.104 . . . . 0.0 110.341 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.6 t -111.99 55.06 0.68 Allowed 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 122.114 0.959 . . . . 0.0 111.368 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -123.82 65.38 1.04 Allowed 'General case' 0 N--CA 1.498 1.946 0 CA-C-N 113.613 -1.63 . . . . 0.0 107.462 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 31.5 mtm180 -85.06 -47.69 9.95 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 117.6 2.444 . . . . 0.0 117.6 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.485 ' CE1' ' C ' ' A' ' 9' ' ' THR . 3.6 t80 -113.84 73.45 0.82 Allowed 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 115.474 -2.203 . . . . 0.0 114.603 -178.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.39 145.86 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 121.764 3.987 . . . . 0.0 121.764 179.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 41.8 mtmt 128.02 39.59 0.0 OUTLIER 'General case' 0 CA--C 1.567 1.628 4 CA-C-N 101.735 -7.029 . . . . 0.0 94.785 -178.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 40.36 31.53 0.37 Allowed Glycine 0 N--CA 1.475 1.26 0 C-N-CA 127.282 2.372 . . . . 0.0 115.854 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.485 ' C ' ' CE1' ' A' ' 5' ' ' PHE . 9.8 m -151.15 165.43 33.91 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-O 118.46 -0.781 . . . . 0.0 110.454 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.426 ' O ' ' N ' ' A' ' 12' ' ' LYS . 52.1 t -75.77 94.94 0.09 OUTLIER Pre-proline 0 N--CA 1.496 1.859 0 N-CA-C 104.062 -2.57 . . . . 0.0 104.062 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -53.71 -17.93 11.12 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 124.495 1.787 . . . . 0.0 113.428 -148.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.426 ' N ' ' O ' ' A' ' 10' ' ' CYS . 11.8 ttpp -96.32 -43.67 7.58 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 117.213 -1.375 . . . . 0.0 112.989 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.548 ' SG ' ' HB ' ' A' ' 25' ' ' VAL . 17.8 p -102.73 11.18 37.98 Favored 'General case' 0 N--CA 1.511 2.599 0 C-N-CA 117.809 -1.556 . . . . 0.0 112.116 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . 0.31 1.0 OUTLIER 2.04 83.97 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 109.911 -3.313 . . . . 0.0 119.611 178.104 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 30.3 t -90.2 95.78 0.77 Allowed Pre-proline 0 N--CA 1.491 1.61 0 CA-C-N 111.371 -2.65 . . . . 0.0 106.144 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -7.64 -56.36 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.514 2 C-N-CA 127.518 5.478 . . . . 0.0 123.405 -145.338 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -131.85 84.05 2.14 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.475 ' HB2' ' HA ' ' A' ' 9' ' ' THR . 38.8 mt-30 -98.78 98.09 9.24 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 123.157 1.456 . . . . 0.0 112.529 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -112.59 -54.21 2.64 Favored 'General case' 0 N--CA 1.499 1.983 1 N-CA-C 99.193 -4.373 . . . . 0.0 99.193 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -124.06 43.45 1.41 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 106.316 -2.714 . . . . 0.0 106.316 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.429 ' HB2' ' HA ' ' A' ' 18' ' ' GLN . 1.2 m-20 -116.34 20.39 14.25 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 117.74 -1.124 . . . . 0.0 111.44 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.427 ' C ' ' O ' ' A' ' 21' ' ' ASP . 63.4 m-80 8.15 67.73 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.931 0 O-C-N 125.131 1.519 . . . . 0.0 112.606 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.402 ' HA ' ' NE2' ' A' ' 18' ' ' GLN . 21.2 t 10.51 88.39 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 111.894 -2.412 . . . . 0.0 114.556 -179.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.64 44.05 1.18 Allowed 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.548 ' HB ' ' SG ' ' A' ' 13' ' ' CYS . 21.2 t -128.57 -53.58 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 CA-C-N 114.933 -1.031 . . . . 0.0 113.624 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 26.1 p -119.73 -52.97 2.21 Favored 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.75 63.39 0.15 Allowed Glycine 0 N--CA 1.498 2.803 0 N-CA-C 108.92 -1.672 . . . . 0.0 108.92 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.502 2.144 0 N-CA-C 115.738 1.755 . . . . 0.0 115.738 179.97 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.431 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.423 ' HA ' HG22 ' A' ' 6' ' ' VAL . 64.8 m 106.1 69.3 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.391 0 O-C-N 126.715 2.068 . . . . 0.0 113.675 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.406 ' O ' ' C ' ' A' ' 4' ' ' ARG . 2.5 p30 -125.76 -154.43 0.62 Allowed 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 105.3 -2.111 . . . . 0.0 105.3 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.406 ' C ' ' O ' ' A' ' 3' ' ' ASP . 13.1 mmm180 -16.54 -60.82 0.01 OUTLIER 'General case' 0 N--CA 1.516 2.871 0 O-C-N 126.787 2.554 . . . . 0.0 109.007 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.59 ' CZ ' ' HA ' ' A' ' 10' ' ' CYS . 2.0 t80 -136.52 154.36 50.75 Favored 'General case' 0 C--N 1.31 -1.127 1 N-CA-C 99.416 -4.29 . . . . 0.0 99.416 179.589 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.442 ' O ' ' CB ' ' A' ' 7' ' ' LYS 0.268 40.6 t -94.61 76.37 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.146 0 N-CA-C 103.209 -2.886 . . . . 0.0 103.209 179.581 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.442 ' CB ' ' O ' ' A' ' 6' ' ' VAL . 55.3 tttp 107.12 87.12 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 111.004 -2.816 . . . . 0.0 103.534 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 21.4 -58.04 0.0 OUTLIER Glycine 0 N--CA 1.507 3.371 0 C-N-CA 128.709 3.052 . . . . 0.0 120.027 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.451 HG22 ' H ' ' A' ' 10' ' ' CYS . 12.6 m -104.59 175.59 5.44 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 124.035 0.491 . . . . 0.0 110.573 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.59 ' HA ' ' CZ ' ' A' ' 5' ' ' PHE . 44.8 t -79.9 90.08 0.06 OUTLIER Pre-proline 0 N--CA 1.488 1.448 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.442 ' HD3' ' CD1' ' A' ' 5' ' ' PHE . 88.9 Cg_endo -65.41 -1.2 4.34 Favored 'Trans proline' 0 CA--C 1.559 1.739 0 O-C-N 123.787 1.414 . . . . 0.0 112.511 -144.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.429 ' N ' ' O ' ' A' ' 10' ' ' CYS . 4.0 tppt? -99.56 -41.56 7.3 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 118.53 -0.747 . . . . 0.0 109.151 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.556 ' SG ' ' HB ' ' A' ' 25' ' ' VAL . 17.6 p -111.34 9.48 21.57 Favored 'General case' 0 N--CA 1.512 2.642 0 CA-C-O 123.085 1.421 . . . . 0.0 112.377 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . 0.328 20.9 tttp -2.7 80.97 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 109.388 -3.551 . . . . 0.0 119.1 178.218 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 31.1 t -90.53 96.61 0.96 Allowed Pre-proline 0 C--N 1.301 -1.524 0 CA-C-N 109.566 -3.47 . . . . 0.0 105.253 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -33.86 -24.82 0.03 OUTLIER 'Trans proline' 0 N--CA 1.501 1.933 2 C-N-CA 126.419 4.746 . . . . 0.0 122.889 -125.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -147.52 94.33 2.36 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 119.575 1.08 . . . . 0.0 111.509 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.469 HE21 ' HA ' ' A' ' 23' ' ' CYS . 4.9 mm100 -95.89 71.39 2.96 Favored 'General case' 0 N--CA 1.504 2.254 0 CA-C-O 123.247 1.498 . . . . 0.0 110.333 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -103.92 -56.79 2.14 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 100.645 -3.835 . . . . 0.0 100.645 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -120.32 21.49 8.69 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 107.288 -2.325 . . . . 0.0 107.288 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -124.72 49.3 1.85 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 124.039 0.494 . . . . 0.0 110.605 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -29.7 94.12 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.645 0 O-C-N 124.366 1.041 . . . . 0.0 112.821 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.469 ' HA ' HE21 ' A' ' 18' ' ' GLN . 42.1 t -0.09 106.38 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 117.926 2.565 . . . . 0.0 117.926 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -106.87 29.06 7.36 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.556 ' HB ' ' SG ' ' A' ' 13' ' ' CYS . 12.4 t -117.46 -59.71 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -179.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 25.7 p -105.95 -41.69 5.33 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 114.59 1.329 . . . . 0.0 114.59 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 123.53 63.85 0.2 Allowed Glycine 0 N--CA 1.502 3.036 0 C-N-CA 120.373 -0.917 . . . . 0.0 111.776 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.507 2.388 0 N-CA-C 116.367 1.988 . . . . 0.0 116.367 -179.926 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.656 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 43.4 m -121.11 168.6 11.38 Favored 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -130.81 62.68 1.6 Allowed 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 115.712 1.745 . . . . 0.0 115.712 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.23 -55.02 2.64 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 101.219 -3.623 . . . . 0.0 101.219 179.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.652 ' CE1' ' HA ' ' A' ' 10' ' ' CYS . 0.2 OUTLIER -136.37 -151.95 0.43 Allowed 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 110.891 -2.868 . . . . 0.0 103.764 -179.586 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 92.9 t -131.83 98.54 3.31 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 CA-C-N 112.009 -2.36 . . . . 0.0 108.233 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 69.04 53.13 0.48 Allowed 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 39.86 4.65 0.01 OUTLIER Glycine 0 N--CA 1.496 2.681 0 N-CA-C 120.463 2.945 . . . . 0.0 120.463 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.433 HG22 ' H ' ' A' ' 10' ' ' CYS . 16.6 m -137.84 -177.14 4.68 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.652 ' HA ' ' CE1' ' A' ' 5' ' ' PHE . 49.2 t -89.26 84.1 0.09 OUTLIER Pre-proline 0 N--CA 1.488 1.463 0 CA-C-N 118.388 0.54 . . . . 0.0 109.927 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -52.02 -26.84 26.63 Favored 'Trans proline' 0 CA--C 1.554 1.507 0 O-C-N 124.352 1.712 . . . . 0.0 114.209 -138.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -72.18 -42.78 65.46 Favored 'General case' 0 N--CA 1.501 2.125 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.024 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 31.6 p -97.94 -32.37 11.7 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 124.264 0.978 . . . . 0.0 109.927 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . 0.282 22.4 tttp 47.97 71.85 0.31 Allowed 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 121.39 3.848 . . . . 0.0 121.39 178.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.0 t -90.8 96.72 1.02 Allowed Pre-proline 0 N--CA 1.49 1.537 0 N-CA-C 104.107 -2.553 . . . . 0.0 104.107 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -16.82 -42.09 0.0 OUTLIER 'Trans proline' 0 CA--C 1.554 1.477 2 N-CA-C 124.629 4.819 . . . . 0.0 124.629 -139.219 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -138.89 92.18 2.59 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 118.729 0.695 . . . . 0.0 111.843 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.434 ' HA ' ' HB2' ' A' ' 21' ' ' ASP . 0.7 OUTLIER -102.97 85.1 2.46 Favored 'General case' 0 N--CA 1.511 2.607 0 CA-C-O 123.123 1.439 . . . . 0.0 112.704 179.931 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -112.67 -54.42 2.62 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 101.588 -3.486 . . . . 0.0 101.588 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -121.72 14.95 9.12 Favored Glycine 0 N--CA 1.487 2.063 0 CA-C-N 112.519 -2.128 . . . . 0.0 107.807 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.434 ' HB2' ' HA ' ' A' ' 18' ' ' GLN . 24.5 m-20 -112.25 41.4 1.99 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -19.51 89.05 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.525 0 O-C-N 125.893 1.995 . . . . 0.0 112.925 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 49.0 t -7.46 105.03 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 119.903 3.298 . . . . 0.0 119.903 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -110.95 44.7 1.25 Allowed 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 6.5 t -122.03 -59.46 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 CA-C-N 114.541 -1.209 . . . . 0.0 110.475 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 23.6 p -117.37 -47.28 2.66 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 124.661 1.226 . . . . 0.0 108.4 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 115.37 47.79 0.53 Allowed Glycine 0 N--CA 1.498 2.815 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.506 2.331 0 N-CA-C 115.939 1.829 . . . . 0.0 115.939 179.853 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 108.928 -1.669 . . . . 0.0 108.928 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 88.4 p -124.01 159.42 29.87 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -152.18 53.79 0.81 Allowed 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 113.612 -1.631 . . . . 0.0 111.272 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 25.2 mmt-85 -111.38 -53.37 2.71 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 100.912 -3.736 . . . . 0.0 100.912 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.689 ' CE1' ' HA ' ' A' ' 10' ' ' CYS . 0.2 OUTLIER -129.2 -154.7 0.65 Allowed 'General case' 0 C--N 1.301 -1.511 1 N-CA-C 99.984 -4.08 . . . . 0.0 99.984 -179.884 . . . . . . . . 4 4 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . 0.312 70.3 t -122.82 130.92 74.16 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 1 N-CA-C 99.553 -4.24 . . . . 0.0 99.553 179.823 . . . . . . . . 3 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 9.9 pttm 25.94 68.27 0.05 Allowed 'General case' 0 N--CA 1.504 2.262 0 CA-C-O 123.249 1.5 . . . . 0.0 112.665 -179.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 40.13 -1.36 0.0 OUTLIER Glycine 0 N--CA 1.497 2.75 0 N-CA-C 121.765 3.466 . . . . 0.0 121.765 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.502 HG22 ' H ' ' A' ' 10' ' ' CYS . 8.8 m -140.71 -179.12 5.86 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 120.091 1.945 . . . . 0.0 109.654 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.689 ' HA ' ' CE1' ' A' ' 5' ' ' PHE . 45.7 t -78.84 91.0 0.06 OUTLIER Pre-proline 0 N--CA 1.484 1.24 0 N-CA-C 102.69 -3.078 . . . . 0.0 102.69 179.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -57.52 -21.89 48.34 Favored 'Trans proline' 0 CA--C 1.557 1.648 0 O-C-N 124.415 1.745 . . . . 0.0 111.114 -147.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 54.9 tptt -84.42 -46.21 11.92 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 113.892 -1.503 . . . . 0.0 111.58 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.567 ' SG ' ' HB ' ' A' ' 25' ' ' VAL . 3.9 p -116.65 25.1 10.81 Favored 'General case' 0 N--CA 1.51 2.526 0 CA-C-O 123.755 1.74 . . . . 0.0 115.69 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 9.7 ttpp -13.93 97.7 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 108.658 -3.883 . . . . 0.0 117.178 178.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.438 ' HB2' ' CG2' ' A' ' 25' ' ' VAL . 22.8 t -90.62 90.06 0.31 Allowed Pre-proline 0 C--N 1.292 -1.934 0 CA-C-N 109.89 -3.323 . . . . 0.0 105.669 179.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -20.68 -52.8 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.615 1 C-N-CA 126.0 4.467 . . . . 0.0 122.073 -123.997 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.3 p30 -133.8 94.85 3.34 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 123.531 0.732 . . . . 0.0 109.233 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.454 ' HG2' HG21 ' A' ' 9' ' ' THR . 10.7 mm-40 -100.29 74.33 1.74 Allowed 'General case' 0 N--CA 1.497 1.893 0 CA-C-N 114.541 -1.208 . . . . 0.0 107.908 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -96.03 -40.85 9.04 Favored 'General case' 0 N--CA 1.506 2.325 0 N-CA-C 104.805 -2.294 . . . . 0.0 104.805 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -100.01 8.68 59.47 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 106.783 -2.527 . . . . 0.0 106.783 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -124.28 172.84 8.78 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.478 0.656 . . . . 0.0 109.683 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.401 ' O ' ' CB ' ' A' ' 23' ' ' CYS . 9.3 m120 -118.0 -23.16 7.54 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 113.757 -1.565 . . . . 0.0 106.812 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.401 ' CB ' ' O ' ' A' ' 22' ' ' ASN . 38.2 t 127.35 126.82 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.347 0 C-N-CA 126.475 1.91 . . . . 0.0 111.775 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -120.63 38.06 4.12 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 124.164 0.915 . . . . 0.0 109.576 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.567 ' HB ' ' SG ' ' A' ' 13' ' ' CYS . 31.4 t -120.25 -50.66 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.169 -179.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 26.1 p -116.08 -48.74 2.72 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 124.183 0.927 . . . . 0.0 111.348 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 130.29 115.57 1.77 Allowed Glycine 0 N--CA 1.5 2.939 0 N-CA-C 110.879 -0.889 . . . . 0.0 110.879 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.946 0 O-C-N 124.169 0.57 . . . . 0.0 109.518 179.98 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . 0.373 2.6 t80 . . . . . 0 N--CA 1.487 1.404 1 N-CA-C 93.958 -6.312 . . . . 0.0 93.958 . . . . . . . . . 2 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.453 HG11 ' HG3' ' A' ' 11' ' ' PRO . 2.2 t -102.81 154.14 5.41 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 CA-C-N 113.083 -1.871 . . . . 0.0 106.883 179.004 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp 3.79 64.09 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.398 0 O-C-N 126.547 2.404 . . . . 0.0 113.076 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.416 ' HA3' ' CE2' ' A' ' 19' ' ' TYR . . . 37.61 28.52 0.04 OUTLIER Glycine 0 N--CA 1.494 2.509 0 N-CA-C 117.828 1.891 . . . . 0.0 117.828 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.538 ' HA ' ' HB2' ' A' ' 18' ' ' GLN . 9.0 m -157.74 164.67 36.86 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 53.3 t -89.08 85.85 0.14 Allowed Pre-proline 0 N--CA 1.493 1.705 0 CA-C-O 122.223 1.011 . . . . 0.0 111.484 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.453 ' HG3' HG11 ' A' ' 6' ' ' VAL . 60.4 Cg_endo -54.08 -26.97 43.78 Favored 'Trans proline' 0 C--N 1.299 -2.032 0 C-N-CA 122.402 2.068 . . . . 0.0 116.735 -138.346 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 23.9 tptp -74.48 -36.0 63.28 Favored 'General case' 0 N--CA 1.504 2.249 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 27.4 p -100.31 -36.21 9.34 Favored 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.437 ' HA ' ' CG2' ' A' ' 9' ' ' THR 0.318 29.1 tttt 49.82 76.09 0.15 Allowed 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 115.965 -2.294 . . . . 0.0 115.207 178.938 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.448 ' HB2' HG21 ' A' ' 25' ' ' VAL . 13.2 t -90.63 89.4 0.28 Allowed Pre-proline 0 C--N 1.304 -1.382 0 N-CA-C 103.304 -2.85 . . . . 0.0 103.304 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -21.96 -41.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.592 1 C-N-CA 126.112 4.542 . . . . 0.0 121.378 -129.368 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -130.07 84.81 2.23 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -179.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.576 HE21 ' HA ' ' A' ' 23' ' ' CYS . 4.3 mm-40 -100.63 73.77 1.63 Allowed 'General case' 0 N--CA 1.504 2.274 0 CA-C-O 122.841 1.305 . . . . 0.0 108.972 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.416 ' CE2' ' HA3' ' A' ' 8' ' ' GLY . 51.3 m-85 -97.64 -59.54 1.75 Allowed 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 100.838 -3.764 . . . . 0.0 100.838 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -131.69 29.4 3.42 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 105.754 -2.938 . . . . 0.0 105.754 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.525 ' HB2' ' HA ' ' A' ' 18' ' ' GLN . 14.4 m-20 -117.8 45.58 1.93 Allowed 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -8.99 99.06 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.434 0 N-CA-C 116.842 2.164 . . . . 0.0 116.842 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.576 ' HA ' HE21 ' A' ' 18' ' ' GLN . 32.1 t -26.18 107.71 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 116.422 2.008 . . . . 0.0 116.422 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.3 pm0 -110.61 36.68 3.01 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.114 0.483 . . . . 0.0 111.113 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.448 HG21 ' HB2' ' A' ' 15' ' ' SER . 21.7 t -118.53 -58.42 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.258 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 31.4 p -114.35 -49.61 2.83 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 124.088 0.867 . . . . 0.0 109.192 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 119.03 59.24 0.26 Allowed Glycine 0 N--CA 1.498 2.804 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.817 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.504 2.266 0 N-CA-C 116.373 1.99 . . . . 0.0 116.373 179.887 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . 0.256 3.4 t80 . . . . . 0 N--CA 1.495 1.814 0 CA-C-O 122.742 1.258 . . . . 0.0 109.773 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -82.17 68.77 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.371 1 N-CA-C 123.865 4.765 . . . . 0.0 123.865 -177.748 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.2 tptt -140.26 40.09 1.92 Allowed 'General case' 0 CA--C 1.587 2.396 3 N-CA-C 90.553 -7.573 . . . . 0.0 90.553 178.074 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 41.07 10.59 0.01 OUTLIER Glycine 0 N--CA 1.484 1.896 0 C-N-CA 130.48 3.895 . . . . 0.0 118.861 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.602 HG22 ' H ' ' A' ' 10' ' ' CYS . 6.6 m -154.14 -177.04 6.16 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.602 ' H ' HG22 ' A' ' 9' ' ' THR . 53.4 t -89.87 85.15 0.14 Allowed Pre-proline 0 C--N 1.306 -1.324 0 N-CA-C 105.268 -2.123 . . . . 0.0 105.268 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -70.92 3.11 3.54 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 124.458 3.439 . . . . 0.0 113.915 -133.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 53.4 tptt -97.77 -25.46 15.06 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 123.681 0.613 . . . . 0.0 109.747 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 27.7 p -114.47 -40.27 3.65 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.568 ' HA ' ' CG2' ' A' ' 9' ' ' THR 0.264 20.5 tttm 57.3 76.57 0.31 Allowed 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 121.298 3.814 . . . . 0.0 121.298 178.883 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 22.3 t -90.79 91.05 0.36 Allowed Pre-proline 0 N--CA 1.496 1.856 0 N-CA-C 105.493 -2.04 . . . . 0.0 105.493 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -27.44 -36.57 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.515 2 C-N-CA 126.167 4.578 . . . . 0.0 122.52 -126.854 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -132.03 79.75 1.88 Allowed 'General case' 0 N--CA 1.503 2.218 0 N-CA-C 116.166 1.913 . . . . 0.0 116.166 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.401 ' H ' HG23 ' A' ' 9' ' ' THR . 25.8 mt-30 -109.4 113.56 26.48 Favored 'General case' 0 N--CA 1.504 2.233 0 CA-C-O 122.067 0.937 . . . . 0.0 109.402 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -113.44 -60.83 1.83 Allowed 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 101.731 -3.433 . . . . 0.0 101.731 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -128.43 45.97 1.11 Allowed Glycine 0 N--CA 1.489 2.19 0 N-CA-C 103.617 -3.793 . . . . 0.0 103.617 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.411 ' O ' ' C ' ' A' ' 22' ' ' ASN . 7.3 m-20 -109.73 39.16 2.18 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 118.643 -0.694 . . . . 0.0 111.474 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.411 ' C ' ' O ' ' A' ' 21' ' ' ASP . 86.1 m-20 1.1 69.23 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.765 0 O-C-N 126.009 2.068 . . . . 0.0 112.949 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 53.1 t -1.84 127.73 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.328 0 N-CA-C 119.423 3.12 . . . . 0.0 119.423 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -116.52 35.82 4.39 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.154 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 10.7 t -124.28 -59.38 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 N-CA-C 114.757 1.392 . . . . 0.0 114.757 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 24.2 p -108.4 -46.08 3.77 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 114.563 1.32 . . . . 0.0 114.563 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 120.84 50.61 0.26 Allowed Glycine 0 N--CA 1.503 3.118 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.274 . . . . . . . 0 N--CA 1.496 1.839 1 N-CA-C 132.421 7.934 . . . . 0.0 132.421 -179.984 . . . . . . . . 2 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.406 ' CE1' ' HD3' ' A' ' 11' ' ' PRO . 2.0 t80 . . . . . 0 N--CA 1.488 1.464 1 N-CA-C 100.052 -4.055 . . . . 0.0 100.052 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.613 ' HB ' ' HB3' ' A' ' 11' ' ' PRO 0.257 3.6 t -105.19 121.81 57.67 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.99 0 CA-C-N 113.501 -1.681 . . . . 0.0 106.608 179.548 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.409 ' HG2' HG12 ' A' ' 6' ' ' VAL . 23.8 pttm 25.45 62.01 0.06 Allowed 'General case' 0 N--CA 1.509 2.483 0 CA-C-O 123.095 1.426 . . . . 0.0 111.602 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.43 ' HA3' ' CE1' ' A' ' 19' ' ' TYR . . . 30.31 38.18 0.02 OUTLIER Glycine 0 N--CA 1.499 2.892 0 CA-C-N 111.193 -2.73 . . . . 0.0 115.952 -179.535 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.658 ' HA ' ' HB2' ' A' ' 18' ' ' GLN . 35.3 m -152.4 157.64 41.53 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 115.142 1.534 . . . . 0.0 115.142 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.531 ' N ' HG22 ' A' ' 9' ' ' THR . 7.4 t -49.38 91.6 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.805 0 N-CA-C 103.384 -2.821 . . . . 0.0 103.384 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.613 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . 10.8 Cg_endo -41.09 -56.13 1.84 Allowed 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.572 2.182 . . . . 0.0 116.564 -150.359 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 21.8 ttmm -107.67 -1.17 21.34 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 124.671 1.232 . . . . 0.0 109.536 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -127.33 39.64 3.86 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 126.626 3.108 . . . . 0.0 109.6 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.417 ' HA ' HG22 ' A' ' 9' ' ' THR 0.316 25.9 tttt -44.12 80.34 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.916 3 CA-C-N 104.198 -5.91 . . . . 0.0 119.411 179.657 . . . . . . . . 4 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.0 m -90.31 169.23 12.57 Favored Pre-proline 0 C--N 1.296 -1.718 1 CA-C-N 107.311 -4.495 . . . . 0.0 108.158 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -38.73 -58.42 0.75 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 123.666 2.911 . . . . 0.0 118.913 -167.123 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -150.13 86.8 1.44 Allowed 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.658 ' HB2' ' HA ' ' A' ' 9' ' ' THR . 18.6 mp0 -99.08 72.39 1.88 Allowed 'General case' 0 N--CA 1.501 2.104 0 CA-C-O 124.748 2.213 . . . . 0.0 112.488 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.43 ' CE1' ' HA3' ' A' ' 8' ' ' GLY . 79.0 m-85 -101.18 -48.81 4.28 Favored 'General case' 0 N--CA 1.49 1.572 1 N-CA-C 96.783 -5.266 . . . . 0.0 96.783 179.124 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -124.72 1.97 8.64 Favored Glycine 0 CA--C 1.552 2.374 0 CA-C-N 113.185 -1.825 . . . . 0.0 110.572 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.525 ' HB2' ' HA ' ' A' ' 18' ' ' GLN . 8.6 m-20 -92.31 39.76 1.03 Allowed 'General case' 0 N--CA 1.509 2.479 0 CA-C-N 118.699 1.249 . . . . 0.0 112.198 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.411 ' O ' ' C ' ' A' ' 23' ' ' CYS . 37.0 m-20 2.42 65.74 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.813 0 C-N-CA 125.854 1.662 . . . . 0.0 115.316 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.475 ' SG ' ' HD2' ' A' ' 11' ' ' PRO . 2.4 t 26.18 52.24 0.03 OUTLIER 'General case' 0 N--CA 1.521 3.107 0 O-C-N 124.651 1.219 . . . . 0.0 108.175 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.52 52.77 2.42 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-O 123.658 1.694 . . . . 0.0 113.923 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.477 ' CG2' ' SG ' ' A' ' 10' ' ' CYS . 44.6 t -123.57 -39.54 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 102.759 -3.052 . . . . 0.0 102.759 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.437 ' SG ' ' N ' ' A' ' 27' ' ' GLY . 20.6 p -123.77 -52.68 1.79 Allowed 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 110.977 -2.829 . . . . 0.0 109.555 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.437 ' N ' ' SG ' ' A' ' 26' ' ' CYS . . . 138.15 124.99 2.31 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 108.532 -1.827 . . . . 0.0 108.532 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.507 2.413 0 CA-C-O 117.405 -1.284 . . . . 0.0 111.598 -179.964 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.582 ' HD1' ' H ' ' A' ' 6' ' ' VAL . 1.5 t80 . . . . . 0 CA--C 1.561 1.396 1 N-CA-C 98.295 -4.706 . . . . 0.0 98.295 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.582 ' H ' ' HD1' ' A' ' 5' ' ' PHE . 55.7 t -119.37 84.01 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 CA-C-N 112.267 -2.242 . . . . 0.0 107.494 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 71.5 tttt 98.03 71.5 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 112.003 -2.362 . . . . 0.0 105.117 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.461 ' HA3' ' CZ ' ' A' ' 19' ' ' TYR . . . 40.47 -58.08 0.0 OUTLIER Glycine 0 N--CA 1.495 2.611 0 C-N-CA 129.176 3.274 . . . . 0.0 118.866 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.572 ' HA ' ' H ' ' A' ' 18' ' ' GLN . 12.3 m -100.92 172.88 6.77 Favored 'General case' 0 C--N 1.295 -1.787 0 O-C-N 124.484 0.755 . . . . 0.0 109.163 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.499 ' HA ' ' CE1' ' A' ' 5' ' ' PHE . 49.5 t -74.08 94.45 0.06 OUTLIER Pre-proline 0 N--CA 1.487 1.38 0 N-CA-C 102.59 -3.115 . . . . 0.0 102.59 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.486 ' HD2' ' CE1' ' A' ' 5' ' ' PHE . 94.9 Cg_endo -62.61 -7.14 10.18 Favored 'Trans proline' 0 CA--C 1.556 1.576 0 O-C-N 124.077 1.567 . . . . 0.0 111.958 -147.34 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.426 ' N ' ' O ' ' A' ' 10' ' ' CYS . 1.3 ttmp? -95.1 -46.9 6.6 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 124.331 1.02 . . . . 0.0 109.87 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.555 ' SG ' ' HB ' ' A' ' 25' ' ' VAL . 19.3 p -102.11 6.76 41.07 Favored 'General case' 0 N--CA 1.511 2.579 0 C-N-CA 119.439 -0.904 . . . . 0.0 113.137 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.49 ' HA ' ' CG2' ' A' ' 9' ' ' THR 0.343 25.1 tptt 6.52 77.19 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 118.907 2.929 . . . . 0.0 118.907 178.043 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 29.1 t -90.24 94.67 0.61 Allowed Pre-proline 0 C--N 1.3 -1.55 0 CA-C-N 111.155 -2.748 . . . . 0.0 104.119 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -15.45 -40.48 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.357 1 C-N-CA 127.495 5.463 . . . . 0.0 121.978 -136.588 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -142.23 96.5 2.97 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 123.383 0.673 . . . . 0.0 110.538 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.728 HE21 ' HA ' ' A' ' 23' ' ' CYS . 7.8 mm100 -100.94 65.96 1.13 Allowed 'General case' 0 N--CA 1.507 2.417 0 CA-C-O 123.365 1.555 . . . . 0.0 106.912 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.461 ' CZ ' ' HA3' ' A' ' 8' ' ' GLY . 0.5 OUTLIER -109.09 -56.29 2.3 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 103.516 -2.772 . . . . 0.0 103.516 179.831 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -117.0 19.97 11.74 Favored Glycine 0 N--CA 1.496 2.673 0 CA-C-N 113.642 -1.617 . . . . 0.0 110.104 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.463 ' HB2' ' HA ' ' A' ' 18' ' ' GLN . 12.7 m-20 -117.19 -49.78 2.58 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 106.214 -1.773 . . . . 0.0 106.214 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 59.6 m-20 64.94 124.64 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 O-C-N 125.997 2.061 . . . . 0.0 110.142 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.728 ' HA ' HE21 ' A' ' 18' ' ' GLN . 39.2 t -18.43 102.26 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 118.737 2.865 . . . . 0.0 118.737 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -112.01 15.9 20.48 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.528 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.555 ' HB ' ' SG ' ' A' ' 13' ' ' CYS . 16.6 t -112.2 -49.02 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 CA-C-O 118.903 -0.57 . . . . 0.0 112.349 -179.378 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 26.7 p -116.15 -37.83 3.74 Favored 'General case' 0 N--CA 1.502 2.128 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 124.32 89.99 0.87 Allowed Glycine 0 N--CA 1.501 3.021 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.539 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.261 . . . . . . . 0 N--CA 1.499 1.98 1 N-CA-C 132.072 7.805 . . . . 0.0 132.072 179.82 . . . . . . . . 2 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.482 ' CZ ' ' SG ' ' A' ' 10' ' ' CYS . 1.4 t80 . . . . . 0 C--O 1.218 -0.602 1 N-CA-C 98.574 -4.602 . . . . 0.0 98.574 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.519 ' O ' ' HB2' ' A' ' 7' ' ' LYS . 73.9 t -124.12 78.15 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.033 0 N-CA-C 100.476 -3.898 . . . . 0.0 100.476 179.364 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 6' ' ' VAL . 1.0 OUTLIER 85.17 89.53 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 112.096 -2.32 . . . . 0.0 110.848 -179.948 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 33.69 -54.76 0.0 OUTLIER Glycine 0 N--CA 1.506 3.322 0 C-N-CA 129.879 3.609 . . . . 0.0 120.763 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.503 HG22 ' HA ' ' A' ' 14' ' ' LYS . 19.9 m -103.34 -173.42 2.31 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.482 ' SG ' ' CZ ' ' A' ' 5' ' ' PHE . 46.5 t -85.9 81.75 0.03 OUTLIER Pre-proline 0 N--CA 1.484 1.267 0 CA-C-O 121.34 0.59 . . . . 0.0 110.383 -179.472 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.404 ' HD2' ' CE1' ' A' ' 5' ' ' PHE . 67.1 Cg_endo -55.97 -20.11 28.56 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.545 2.163 . . . . 0.0 115.121 -132.18 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 15.5 ttmm -85.1 -34.25 22.24 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 27.4 p -105.04 -47.01 4.11 Favored 'General case' 0 N--CA 1.505 2.292 0 N-CA-C 102.208 -3.256 . . . . 0.0 102.208 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.503 ' HA ' HG22 ' A' ' 9' ' ' THR 0.264 4.1 tttp 52.57 87.83 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.586 1 N-CA-C 122.44 4.237 . . . . 0.0 122.44 178.498 . . . . . . . . 4 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.429 ' HB3' ' NE2' ' A' ' 18' ' ' GLN . 12.6 t -90.62 118.31 68.6 Favored Pre-proline 0 N--CA 1.49 1.555 0 N-CA-C 101.239 -3.615 . . . . 0.0 101.239 178.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -10.05 -56.59 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.506 1 C-N-CA 125.988 4.459 . . . . 0.0 121.994 -153.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -138.62 94.33 2.83 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 123.335 0.654 . . . . 0.0 111.348 -179.308 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.665 HE21 ' HA ' ' A' ' 23' ' ' CYS . 3.8 mm100 -102.31 70.72 1.19 Allowed 'General case' 0 N--CA 1.507 2.375 0 CA-C-O 123.694 1.711 . . . . 0.0 111.103 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -102.62 -54.65 2.61 Favored 'General case' 0 N--CA 1.492 1.668 1 N-CA-C 99.848 -4.13 . . . . 0.0 99.848 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -124.77 22.46 6.45 Favored Glycine 0 N--CA 1.491 2.317 0 CA-C-N 113.183 -1.826 . . . . 0.0 109.137 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.447 ' HB2' ' HA ' ' A' ' 18' ' ' GLN . 2.2 m-20 -120.15 39.94 3.57 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 22.9 m-20 -8.69 82.62 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.54 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.665 ' HA ' HE21 ' A' ' 18' ' ' GLN . 43.8 t -3.19 100.41 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 118.887 2.921 . . . . 0.0 118.887 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -101.46 41.06 1.23 Allowed 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 19.3 t -120.21 -58.17 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 CA-C-N 114.462 -1.244 . . . . 0.0 111.567 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 26.6 p -121.21 -39.03 2.72 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 124.184 0.927 . . . . 0.0 111.557 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 129.22 118.06 2.04 Favored Glycine 0 N--CA 1.496 2.669 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.383 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.916 0 CA-C-O 116.235 -1.841 . . . . 0.0 109.07 179.773 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.609 ' CZ ' ' HA ' ' A' ' 10' ' ' CYS . 1.1 t80 . . . . . 0 C--O 1.219 -0.543 0 N-CA-C 101.243 -3.614 . . . . 0.0 101.243 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . 0.254 6.3 t -88.32 85.98 2.55 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 N-CA-C 102.043 -3.318 . . . . 0.0 102.043 179.154 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.481 ' O ' ' N ' ' A' ' 9' ' ' THR . 1.4 tmtp? 101.54 86.01 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 110.444 -3.071 . . . . 0.0 104.049 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 12.55 -52.41 0.0 OUTLIER Glycine 0 N--CA 1.51 3.627 0 N-CA-C 120.485 2.954 . . . . 0.0 120.485 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.491 ' CG2' ' HA ' ' A' ' 14' ' ' LYS . 30.9 m -95.88 175.27 6.56 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.609 ' HA ' ' CZ ' ' A' ' 5' ' ' PHE . 49.3 t -83.55 90.25 0.13 Allowed Pre-proline 0 C--N 1.305 -1.349 0 N-CA-C 104.386 -2.45 . . . . 0.0 104.386 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.48 ' HD2' ' CE1' ' A' ' 5' ' ' PHE . 98.2 Cg_endo -64.24 -7.88 15.06 Favored 'Trans proline' 0 CA--C 1.557 1.673 0 O-C-N 123.756 1.398 . . . . 0.0 111.825 -143.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.406 ' N ' ' O ' ' A' ' 10' ' ' CYS . 21.9 ttmm -86.18 -46.41 10.42 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.715 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.509 ' SG ' ' HB ' ' A' ' 25' ' ' VAL . 23.6 p -104.26 -2.97 24.88 Favored 'General case' 0 N--CA 1.508 2.458 0 C-N-CA 120.25 -0.58 . . . . 0.0 111.435 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.491 ' HA ' ' CG2' ' A' ' 9' ' ' THR 0.338 21.5 tptt 21.73 75.17 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.709 1 N-CA-C 122.055 4.094 . . . . 0.0 122.055 178.36 . . . . . . . . 4 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.453 ' HB3' ' NE2' ' A' ' 18' ' ' GLN . 16.8 t -90.5 102.44 5.07 Favored Pre-proline 0 N--CA 1.492 1.642 0 CA-C-N 112.09 -2.323 . . . . 0.0 106.355 179.122 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -14.72 -49.54 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.54 1 C-N-CA 125.976 4.451 . . . . 0.0 121.995 -146.116 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -139.12 92.67 2.61 Favored 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 123.215 0.606 . . . . 0.0 112.568 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.462 ' HA ' ' HB2' ' A' ' 21' ' ' ASP . 98.6 mm-40 -91.91 73.85 5.65 Favored 'General case' 0 N--CA 1.507 2.403 0 CA-C-O 122.894 1.33 . . . . 0.0 112.116 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -107.9 -57.22 2.13 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 101.534 -3.506 . . . . 0.0 101.534 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -125.61 25.73 5.57 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 107.921 -2.072 . . . . 0.0 107.921 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.462 ' HB2' ' HA ' ' A' ' 18' ' ' GLN . 14.7 m-20 -110.64 16.47 21.43 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 119.323 -0.37 . . . . 0.0 111.091 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 55.4 m-20 12.21 74.92 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.648 0 O-C-N 125.055 1.472 . . . . 0.0 113.316 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.459 ' HB3' ' HB2' ' A' ' 28' ' ' ALA . 41.6 t 16.79 91.72 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.045 0 O-C-N 125.377 1.673 . . . . 0.0 114.271 -179.421 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -90.53 25.58 2.25 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.509 ' HB ' ' SG ' ' A' ' 13' ' ' CYS . 5.4 t -127.94 -49.01 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 114.806 1.41 . . . . 0.0 114.806 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 16.2 p -117.95 -27.9 6.04 Favored 'General case' 0 N--CA 1.503 2.207 0 N-CA-C 115.754 1.761 . . . . 0.0 115.754 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.86 125.57 3.07 Favored Glycine 0 N--CA 1.496 2.695 0 CA-C-N 118.607 0.64 . . . . 0.0 111.996 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.459 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . . . . . . . . 0 N--CA 1.505 2.283 0 O-C-N 124.559 0.799 . . . . 0.0 109.061 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.518 ' CE1' ' C ' ' A' ' 9' ' ' THR . 1.7 t80 . . . . . 0 C--O 1.219 -0.549 1 N-CA-C 100.157 -4.016 . . . . 0.0 100.157 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.44 ' H ' ' HD1' ' A' ' 5' ' ' PHE . 26.3 t -102.44 114.95 43.41 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 CA-C-N 112.232 -2.258 . . . . 0.0 106.021 179.261 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 99.5 mttt 40.49 72.47 0.15 Allowed 'General case' 0 N--CA 1.499 1.988 0 CA-C-N 114.537 -1.21 . . . . 0.0 113.096 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 33.15 11.4 0.0 OUTLIER Glycine 0 N--CA 1.503 3.121 0 N-CA-C 122.134 3.614 . . . . 0.0 122.134 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.585 ' HA ' ' HB2' ' A' ' 18' ' ' GLN . 67.4 m -162.43 151.66 15.5 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 119.851 1.825 . . . . 0.0 112.374 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.457 ' HA ' ' HE1' ' A' ' 5' ' ' PHE . 44.7 t -50.65 96.39 0.11 Allowed Pre-proline 0 N--CA 1.502 2.146 0 N-CA-C 105.545 -2.02 . . . . 0.0 105.545 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -59.87 -13.66 23.64 Favored 'Trans proline' 0 CA--C 1.555 1.528 0 O-C-N 124.23 1.647 . . . . 0.0 109.834 -156.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.403 ' N ' ' O ' ' A' ' 10' ' ' CYS . 59.7 tttm -91.73 -47.87 7.12 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 114.491 -1.231 . . . . 0.0 111.237 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.657 ' SG ' ' HB ' ' A' ' 25' ' ' VAL . 14.3 p -117.05 34.21 5.23 Favored 'General case' 0 N--CA 1.509 2.513 0 CA-C-O 124.994 2.33 . . . . 0.0 114.925 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.535 ' HA ' ' CG2' ' A' ' 9' ' ' THR 0.372 1.6 tppp? -15.54 80.82 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.898 1 CA-C-N 106.656 -4.793 . . . . 0.0 114.785 178.225 . . . . . . . . 4 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.419 ' HB2' HG21 ' A' ' 25' ' ' VAL . 41.8 t -88.91 139.96 29.2 Favored Pre-proline 0 N--CA 1.504 2.227 0 CA-C-N 111.025 -2.807 . . . . 0.0 109.913 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_exo -31.74 -56.08 0.27 Allowed 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 124.307 3.338 . . . . 0.0 118.293 -150.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -138.0 83.06 1.95 Allowed 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.585 ' HB2' ' HA ' ' A' ' 9' ' ' THR . 64.7 mm-40 -105.19 77.97 1.35 Allowed 'General case' 0 N--CA 1.514 2.738 0 C-N-CA 118.454 -1.298 . . . . 0.0 107.979 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -101.57 27.1 6.61 Favored 'General case' 0 N--CA 1.505 2.296 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 129.35 50.37 0.12 Allowed Glycine 0 N--CA 1.487 2.054 0 N-CA-C 105.668 -2.973 . . . . 0.0 105.668 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.576 ' HB2' ' HA ' ' A' ' 18' ' ' GLN . 1.2 m-20 -114.09 27.07 9.78 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 18.9 m-20 22.16 62.16 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.364 0 O-C-N 125.438 1.711 . . . . 0.0 111.421 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.428 ' HA ' ' OE1' ' A' ' 18' ' ' GLN . 30.5 t 11.4 96.24 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.168 0 CA-C-N 112.813 -1.994 . . . . 0.0 115.991 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -93.41 46.82 1.21 Allowed 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.616 0.722 . . . . 0.0 110.893 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.657 ' HB ' ' SG ' ' A' ' 13' ' ' CYS . 13.4 t -126.69 -61.97 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 CA-C-N 114.496 -1.229 . . . . 0.0 111.126 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 27.3 p -116.14 -21.09 9.57 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.989 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.444 ' O ' ' CB ' ' A' ' 28' ' ' ALA . . . 139.89 -50.41 0.77 Allowed Glycine 0 N--CA 1.499 2.834 0 CA-C-O 118.537 -1.146 . . . . 0.0 112.023 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.444 ' CB ' ' O ' ' A' ' 27' ' ' GLY . . . . . . . . 0 N--CA 1.515 2.808 0 C-N-CA 126.064 1.746 . . . . 0.0 108.876 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.485 ' CE1' ' C ' ' A' ' 9' ' ' THR . 3.6 t80 . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 115.474 -2.203 . . . . 0.0 114.603 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.442 HG12 ' H ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -138.39 145.86 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 121.764 3.987 . . . . 0.0 121.764 179.188 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.442 ' H ' HG12 ' A' ' 6' ' ' VAL . 41.8 mtmt 128.02 39.59 0.0 OUTLIER 'General case' 0 CA--C 1.567 1.628 4 CA-C-N 101.735 -7.029 . . . . 0.0 94.785 -178.491 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 40.36 31.53 0.37 Allowed Glycine 0 N--CA 1.475 1.26 0 C-N-CA 127.282 2.372 . . . . 0.0 115.854 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.493 HG22 ' HA ' ' A' ' 14' ' ' LYS . 9.8 m -151.15 165.43 33.91 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-O 118.46 -0.781 . . . . 0.0 110.454 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.426 ' O ' ' N ' ' A' ' 12' ' ' LYS . 52.1 t -75.77 94.94 0.09 OUTLIER Pre-proline 0 N--CA 1.496 1.859 0 N-CA-C 104.062 -2.57 . . . . 0.0 104.062 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -53.71 -17.93 11.12 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 124.495 1.787 . . . . 0.0 113.428 -148.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.426 ' N ' ' O ' ' A' ' 10' ' ' CYS . 11.8 ttpp -96.32 -43.67 7.58 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 117.213 -1.375 . . . . 0.0 112.989 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.578 ' SG ' ' HB ' ' A' ' 25' ' ' VAL . 17.8 p -102.73 11.18 37.98 Favored 'General case' 0 N--CA 1.511 2.599 0 C-N-CA 117.809 -1.556 . . . . 0.0 112.116 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.493 ' HA ' HG22 ' A' ' 9' ' ' THR 0.31 1.0 OUTLIER 2.04 83.97 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 109.911 -3.313 . . . . 0.0 119.611 178.104 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 30.3 t -90.2 95.78 0.77 Allowed Pre-proline 0 N--CA 1.491 1.61 0 CA-C-N 111.371 -2.65 . . . . 0.0 106.144 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -7.64 -56.36 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.514 2 C-N-CA 127.518 5.478 . . . . 0.0 123.405 -145.338 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -131.85 84.05 2.14 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.483 ' HB2' ' HA ' ' A' ' 9' ' ' THR . 38.8 mt-30 -98.78 98.09 9.24 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 123.157 1.456 . . . . 0.0 112.529 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -112.59 -54.21 2.64 Favored 'General case' 0 N--CA 1.499 1.983 1 N-CA-C 99.193 -4.373 . . . . 0.0 99.193 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -124.06 43.45 1.41 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 106.316 -2.714 . . . . 0.0 106.316 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.435 ' HB2' ' HA ' ' A' ' 18' ' ' GLN . 1.2 m-20 -116.34 20.39 14.25 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 117.74 -1.124 . . . . 0.0 111.44 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.427 ' C ' ' O ' ' A' ' 21' ' ' ASP . 63.4 m-80 8.15 67.73 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.931 0 O-C-N 125.131 1.519 . . . . 0.0 112.606 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.443 ' HA ' ' NE2' ' A' ' 18' ' ' GLN . 21.2 t 10.51 88.39 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 111.894 -2.412 . . . . 0.0 114.556 -179.328 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.64 44.05 1.18 Allowed 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.578 ' HB ' ' SG ' ' A' ' 13' ' ' CYS . 21.2 t -128.57 -53.58 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 CA-C-N 114.933 -1.031 . . . . 0.0 113.624 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 26.1 p -119.73 -52.97 2.21 Favored 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.75 63.39 0.15 Allowed Glycine 0 N--CA 1.498 2.803 0 N-CA-C 108.92 -1.672 . . . . 0.0 108.92 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.502 2.144 0 N-CA-C 115.738 1.755 . . . . 0.0 115.738 179.97 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.653 ' CZ ' ' HA ' ' A' ' 10' ' ' CYS . 2.0 t80 . . . . . 0 C--O 1.218 -0.569 1 N-CA-C 99.416 -4.29 . . . . 0.0 99.416 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.442 ' O ' ' CB ' ' A' ' 7' ' ' LYS 0.268 40.6 t -94.61 76.37 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.146 0 N-CA-C 103.209 -2.886 . . . . 0.0 103.209 179.581 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.442 ' CB ' ' O ' ' A' ' 6' ' ' VAL . 55.3 tttp 107.12 87.12 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 111.004 -2.816 . . . . 0.0 103.534 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 21.4 -58.04 0.0 OUTLIER Glycine 0 N--CA 1.507 3.371 0 C-N-CA 128.709 3.052 . . . . 0.0 120.027 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.51 ' HA ' ' H ' ' A' ' 18' ' ' GLN . 12.6 m -104.59 175.59 5.44 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 124.035 0.491 . . . . 0.0 110.573 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.653 ' HA ' ' CZ ' ' A' ' 5' ' ' PHE . 44.8 t -79.9 90.08 0.06 OUTLIER Pre-proline 0 N--CA 1.488 1.448 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.417 ' CD ' ' CE1' ' A' ' 5' ' ' PHE . 88.9 Cg_endo -65.41 -1.2 4.34 Favored 'Trans proline' 0 CA--C 1.559 1.739 0 O-C-N 123.787 1.414 . . . . 0.0 112.511 -144.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.429 ' N ' ' O ' ' A' ' 10' ' ' CYS . 4.0 tppt? -99.56 -41.56 7.3 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 118.53 -0.747 . . . . 0.0 109.151 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.571 ' SG ' ' HB ' ' A' ' 25' ' ' VAL . 17.6 p -111.34 9.48 21.57 Favored 'General case' 0 N--CA 1.512 2.642 0 CA-C-O 123.085 1.421 . . . . 0.0 112.377 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.414 ' HA ' HG22 ' A' ' 9' ' ' THR 0.328 20.9 tttp -2.7 80.97 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 109.388 -3.551 . . . . 0.0 119.1 178.218 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 31.1 t -90.53 96.61 0.96 Allowed Pre-proline 0 C--N 1.301 -1.524 0 CA-C-N 109.566 -3.47 . . . . 0.0 105.253 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -33.86 -24.82 0.03 OUTLIER 'Trans proline' 0 N--CA 1.501 1.933 2 C-N-CA 126.419 4.746 . . . . 0.0 122.889 -125.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -147.52 94.33 2.36 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 119.575 1.08 . . . . 0.0 111.509 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.52 HE21 ' HA ' ' A' ' 23' ' ' CYS . 4.9 mm100 -95.89 71.39 2.96 Favored 'General case' 0 N--CA 1.504 2.254 0 CA-C-O 123.247 1.498 . . . . 0.0 110.333 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -103.92 -56.79 2.14 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 100.645 -3.835 . . . . 0.0 100.645 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -120.32 21.49 8.69 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 107.288 -2.325 . . . . 0.0 107.288 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.425 ' HB2' ' HA ' ' A' ' 18' ' ' GLN . 54.2 m-20 -124.72 49.3 1.85 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 124.039 0.494 . . . . 0.0 110.605 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -29.7 94.12 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.645 0 O-C-N 124.366 1.041 . . . . 0.0 112.821 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.52 ' HA ' HE21 ' A' ' 18' ' ' GLN . 42.1 t -0.09 106.38 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 117.926 2.565 . . . . 0.0 117.926 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -106.87 29.06 7.36 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.571 ' HB ' ' SG ' ' A' ' 13' ' ' CYS . 12.4 t -117.46 -59.71 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -179.503 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 25.7 p -105.95 -41.69 5.33 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 114.59 1.329 . . . . 0.0 114.59 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 123.53 63.85 0.2 Allowed Glycine 0 N--CA 1.502 3.036 0 C-N-CA 120.373 -0.917 . . . . 0.0 111.776 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.507 2.388 0 N-CA-C 116.367 1.988 . . . . 0.0 116.367 -179.926 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.679 ' CE1' ' HA ' ' A' ' 10' ' ' CYS . 0.2 OUTLIER . . . . . 0 C--O 1.217 -0.633 0 N-CA-C 103.764 -2.68 . . . . 0.0 103.764 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 92.9 t -131.83 98.54 3.31 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 CA-C-N 112.009 -2.36 . . . . 0.0 108.233 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 69.04 53.13 0.48 Allowed 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 39.86 4.65 0.01 OUTLIER Glycine 0 N--CA 1.496 2.681 0 N-CA-C 120.463 2.945 . . . . 0.0 120.463 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.47 ' CG2' ' HA ' ' A' ' 14' ' ' LYS . 16.6 m -137.84 -177.14 4.68 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.679 ' HA ' ' CE1' ' A' ' 5' ' ' PHE . 49.2 t -89.26 84.1 0.09 OUTLIER Pre-proline 0 N--CA 1.488 1.463 0 CA-C-N 118.388 0.54 . . . . 0.0 109.927 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -52.02 -26.84 26.63 Favored 'Trans proline' 0 CA--C 1.554 1.507 0 O-C-N 124.352 1.712 . . . . 0.0 114.209 -138.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -72.18 -42.78 65.46 Favored 'General case' 0 N--CA 1.501 2.125 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.024 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 31.6 p -97.94 -32.37 11.7 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 124.264 0.978 . . . . 0.0 109.927 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.47 ' HA ' ' CG2' ' A' ' 9' ' ' THR 0.282 22.4 tttp 47.97 71.85 0.31 Allowed 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 121.39 3.848 . . . . 0.0 121.39 178.795 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.409 ' HB2' HG21 ' A' ' 25' ' ' VAL . 19.0 t -90.8 96.72 1.02 Allowed Pre-proline 0 N--CA 1.49 1.537 0 N-CA-C 104.107 -2.553 . . . . 0.0 104.107 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -16.82 -42.09 0.0 OUTLIER 'Trans proline' 0 CA--C 1.554 1.477 2 N-CA-C 124.629 4.819 . . . . 0.0 124.629 -139.219 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -138.89 92.18 2.59 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 118.729 0.695 . . . . 0.0 111.843 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.501 ' HA ' ' HB2' ' A' ' 21' ' ' ASP . 0.7 OUTLIER -102.97 85.1 2.46 Favored 'General case' 0 N--CA 1.511 2.607 0 CA-C-O 123.123 1.439 . . . . 0.0 112.704 179.931 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -112.67 -54.42 2.62 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 101.588 -3.486 . . . . 0.0 101.588 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -121.72 14.95 9.12 Favored Glycine 0 N--CA 1.487 2.063 0 CA-C-N 112.519 -2.128 . . . . 0.0 107.807 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.501 ' HB2' ' HA ' ' A' ' 18' ' ' GLN . 24.5 m-20 -112.25 41.4 1.99 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -19.51 89.05 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.525 0 O-C-N 125.893 1.995 . . . . 0.0 112.925 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.429 ' HA ' HE22 ' A' ' 18' ' ' GLN . 49.0 t -7.46 105.03 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 119.903 3.298 . . . . 0.0 119.903 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -110.95 44.7 1.25 Allowed 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.409 HG21 ' HB2' ' A' ' 15' ' ' SER . 6.5 t -122.03 -59.46 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 CA-C-N 114.541 -1.209 . . . . 0.0 110.475 -179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 23.6 p -117.37 -47.28 2.66 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 124.661 1.226 . . . . 0.0 108.4 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 115.37 47.79 0.53 Allowed Glycine 0 N--CA 1.498 2.815 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.506 2.331 0 N-CA-C 115.939 1.829 . . . . 0.0 115.939 179.853 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.722 ' CE1' ' HA ' ' A' ' 10' ' ' CYS . 0.2 OUTLIER . . . . . 0 C--O 1.217 -0.617 1 N-CA-C 99.984 -4.08 . . . . 0.0 99.984 . . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . 0.312 70.3 t -122.82 130.92 74.16 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 1 N-CA-C 99.553 -4.24 . . . . 0.0 99.553 179.823 . . . . . . . . 3 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 9.9 pttm 25.94 68.27 0.05 Allowed 'General case' 0 N--CA 1.504 2.262 0 CA-C-O 123.249 1.5 . . . . 0.0 112.665 -179.008 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 40.13 -1.36 0.0 OUTLIER Glycine 0 N--CA 1.497 2.75 0 N-CA-C 121.765 3.466 . . . . 0.0 121.765 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.555 HG22 ' H ' ' A' ' 10' ' ' CYS . 8.8 m -140.71 -179.12 5.86 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 120.091 1.945 . . . . 0.0 109.654 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.722 ' HA ' ' CE1' ' A' ' 5' ' ' PHE . 45.7 t -78.84 91.0 0.06 OUTLIER Pre-proline 0 N--CA 1.484 1.24 0 N-CA-C 102.69 -3.078 . . . . 0.0 102.69 179.352 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -57.52 -21.89 48.34 Favored 'Trans proline' 0 CA--C 1.557 1.648 0 O-C-N 124.415 1.745 . . . . 0.0 111.114 -147.333 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 54.9 tptt -84.42 -46.21 11.92 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 113.892 -1.503 . . . . 0.0 111.58 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.583 ' SG ' ' HB ' ' A' ' 25' ' ' VAL . 3.9 p -116.65 25.1 10.81 Favored 'General case' 0 N--CA 1.51 2.526 0 CA-C-O 123.755 1.74 . . . . 0.0 115.69 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.413 ' HA ' HG22 ' A' ' 9' ' ' THR . 9.7 ttpp -13.93 97.7 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 108.658 -3.883 . . . . 0.0 117.178 178.513 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.451 ' HB2' ' CG2' ' A' ' 25' ' ' VAL . 22.8 t -90.62 90.06 0.31 Allowed Pre-proline 0 C--N 1.292 -1.934 0 CA-C-N 109.89 -3.323 . . . . 0.0 105.669 179.224 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -20.68 -52.8 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.615 1 C-N-CA 126.0 4.467 . . . . 0.0 122.073 -123.997 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.3 p30 -133.8 94.85 3.34 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 123.531 0.732 . . . . 0.0 109.233 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.495 ' HG2' HG23 ' A' ' 9' ' ' THR . 10.7 mm-40 -100.29 74.33 1.74 Allowed 'General case' 0 N--CA 1.497 1.893 0 CA-C-N 114.541 -1.208 . . . . 0.0 107.908 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -96.03 -40.85 9.04 Favored 'General case' 0 N--CA 1.506 2.325 0 N-CA-C 104.805 -2.294 . . . . 0.0 104.805 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -100.01 8.68 59.47 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 106.783 -2.527 . . . . 0.0 106.783 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -124.28 172.84 8.78 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.478 0.656 . . . . 0.0 109.683 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.401 ' O ' ' CB ' ' A' ' 23' ' ' CYS . 99.0 m-20 -118.0 -23.16 7.54 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 113.757 -1.565 . . . . 0.0 106.812 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.401 ' CB ' ' O ' ' A' ' 22' ' ' ASN . 38.2 t 127.35 126.82 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.347 0 C-N-CA 126.475 1.91 . . . . 0.0 111.775 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -120.63 38.06 4.12 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 124.164 0.915 . . . . 0.0 109.576 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.583 ' HB ' ' SG ' ' A' ' 13' ' ' CYS . 31.4 t -120.25 -50.66 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.169 -179.722 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 26.1 p -116.08 -48.74 2.72 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 124.183 0.927 . . . . 0.0 111.348 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 130.29 115.57 1.77 Allowed Glycine 0 N--CA 1.5 2.939 0 N-CA-C 110.879 -0.889 . . . . 0.0 110.879 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.946 0 O-C-N 124.169 0.57 . . . . 0.0 109.518 179.98 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.839 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.7 t -133.15 134.42 44.15 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 124.085 0.52 . . . . 0.0 110.415 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.406 ' O ' ' C ' ' A' ' 4' ' ' ARG . 10.4 p-10 -130.67 59.65 1.66 Allowed 'General case' 0 N--CA 1.504 2.236 0 O-C-N 123.988 0.805 . . . . 0.0 110.335 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.406 ' C ' ' O ' ' A' ' 3' ' ' ASP . 23.0 mtp180 -21.08 -64.13 0.03 OUTLIER 'General case' 0 N--CA 1.513 2.677 0 O-C-N 124.298 0.999 . . . . 0.0 112.812 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . 0.373 2.6 t80 -128.57 164.32 23.09 Favored 'General case' 0 N--CA 1.487 1.404 1 N-CA-C 93.958 -6.312 . . . . 0.0 93.958 179.69 . . . . . . . . 3 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.453 HG11 ' HG3' ' A' ' 11' ' ' PRO . 2.2 t -102.81 154.14 5.41 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 CA-C-N 113.083 -1.871 . . . . 0.0 106.883 179.004 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp 3.79 64.09 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.398 0 O-C-N 126.547 2.404 . . . . 0.0 113.076 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.416 ' HA3' ' CE2' ' A' ' 19' ' ' TYR . . . 37.61 28.52 0.04 OUTLIER Glycine 0 N--CA 1.494 2.509 0 N-CA-C 117.828 1.891 . . . . 0.0 117.828 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.538 ' HA ' ' HB2' ' A' ' 18' ' ' GLN . 9.0 m -157.74 164.67 36.86 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 53.3 t -89.08 85.85 0.14 Allowed Pre-proline 0 N--CA 1.493 1.705 0 CA-C-O 122.223 1.011 . . . . 0.0 111.484 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.453 ' HG3' HG11 ' A' ' 6' ' ' VAL . 60.4 Cg_endo -54.08 -26.97 43.78 Favored 'Trans proline' 0 C--N 1.299 -2.032 0 C-N-CA 122.402 2.068 . . . . 0.0 116.735 -138.346 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 23.9 tptp -74.48 -36.0 63.28 Favored 'General case' 0 N--CA 1.504 2.249 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 27.4 p -100.31 -36.21 9.34 Favored 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.437 ' HA ' ' CG2' ' A' ' 9' ' ' THR 0.318 29.1 tttt 49.82 76.09 0.15 Allowed 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 115.965 -2.294 . . . . 0.0 115.207 178.938 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.448 ' HB2' HG21 ' A' ' 25' ' ' VAL . 13.2 t -90.63 89.4 0.28 Allowed Pre-proline 0 C--N 1.304 -1.382 0 N-CA-C 103.304 -2.85 . . . . 0.0 103.304 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -21.96 -41.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.592 1 C-N-CA 126.112 4.542 . . . . 0.0 121.378 -129.368 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -130.07 84.81 2.23 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -179.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.576 HE21 ' HA ' ' A' ' 23' ' ' CYS . 4.3 mm-40 -100.63 73.77 1.63 Allowed 'General case' 0 N--CA 1.504 2.274 0 CA-C-O 122.841 1.305 . . . . 0.0 108.972 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.416 ' CE2' ' HA3' ' A' ' 8' ' ' GLY . 51.3 m-85 -97.64 -59.54 1.75 Allowed 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 100.838 -3.764 . . . . 0.0 100.838 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -131.69 29.4 3.42 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 105.754 -2.938 . . . . 0.0 105.754 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.525 ' HB2' ' HA ' ' A' ' 18' ' ' GLN . 14.4 m-20 -117.8 45.58 1.93 Allowed 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -8.99 99.06 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.434 0 N-CA-C 116.842 2.164 . . . . 0.0 116.842 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.576 ' HA ' HE21 ' A' ' 18' ' ' GLN . 32.1 t -26.18 107.71 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 116.422 2.008 . . . . 0.0 116.422 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.3 pm0 -110.61 36.68 3.01 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.114 0.483 . . . . 0.0 111.113 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.448 HG21 ' HB2' ' A' ' 15' ' ' SER . 21.7 t -118.53 -58.42 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.258 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 31.4 p -114.35 -49.61 2.83 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 124.088 0.867 . . . . 0.0 109.192 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 119.03 59.24 0.26 Allowed Glycine 0 N--CA 1.498 2.804 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.817 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.504 2.266 0 N-CA-C 116.373 1.99 . . . . 0.0 116.373 179.887 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.515 0 CA-C-O 121.184 0.324 . . . . 0.0 112.326 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.0 m -112.9 68.25 0.67 Allowed 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -114.7 69.51 0.72 Allowed 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 113.304 -1.771 . . . . 0.0 109.272 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.41 ' H ' ' HD3' ' A' ' 4' ' ' ARG . 0.0 OUTLIER -72.64 -44.57 61.71 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.027 -0.988 . . . . 0.0 112.43 -179.897 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . 0.256 3.4 t80 -128.14 -40.31 1.67 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 124.744 1.277 . . . . 0.0 109.773 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -82.17 68.77 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.371 1 N-CA-C 123.865 4.765 . . . . 0.0 123.865 -177.748 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.2 tptt -140.26 40.09 1.92 Allowed 'General case' 0 CA--C 1.587 2.396 3 N-CA-C 90.553 -7.573 . . . . 0.0 90.553 178.074 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 41.07 10.59 0.01 OUTLIER Glycine 0 N--CA 1.484 1.896 0 C-N-CA 130.48 3.895 . . . . 0.0 118.861 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.602 HG22 ' H ' ' A' ' 10' ' ' CYS . 6.6 m -154.14 -177.04 6.16 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.602 ' H ' HG22 ' A' ' 9' ' ' THR . 53.4 t -89.87 85.15 0.14 Allowed Pre-proline 0 C--N 1.306 -1.324 0 N-CA-C 105.268 -2.123 . . . . 0.0 105.268 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -70.92 3.11 3.54 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 124.458 3.439 . . . . 0.0 113.915 -133.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 53.4 tptt -97.77 -25.46 15.06 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 123.681 0.613 . . . . 0.0 109.747 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 27.7 p -114.47 -40.27 3.65 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.568 ' HA ' ' CG2' ' A' ' 9' ' ' THR 0.264 20.5 tttm 57.3 76.57 0.31 Allowed 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 121.298 3.814 . . . . 0.0 121.298 178.883 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 22.3 t -90.79 91.05 0.36 Allowed Pre-proline 0 N--CA 1.496 1.856 0 N-CA-C 105.493 -2.04 . . . . 0.0 105.493 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -27.44 -36.57 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.515 2 C-N-CA 126.167 4.578 . . . . 0.0 122.52 -126.854 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -132.03 79.75 1.88 Allowed 'General case' 0 N--CA 1.503 2.218 0 N-CA-C 116.166 1.913 . . . . 0.0 116.166 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.401 ' H ' HG23 ' A' ' 9' ' ' THR . 25.8 mt-30 -109.4 113.56 26.48 Favored 'General case' 0 N--CA 1.504 2.233 0 CA-C-O 122.067 0.937 . . . . 0.0 109.402 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -113.44 -60.83 1.83 Allowed 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 101.731 -3.433 . . . . 0.0 101.731 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -128.43 45.97 1.11 Allowed Glycine 0 N--CA 1.489 2.19 0 N-CA-C 103.617 -3.793 . . . . 0.0 103.617 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.411 ' O ' ' C ' ' A' ' 22' ' ' ASN . 7.3 m-20 -109.73 39.16 2.18 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 118.643 -0.694 . . . . 0.0 111.474 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.411 ' C ' ' O ' ' A' ' 21' ' ' ASP . 86.1 m-20 1.1 69.23 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.765 0 O-C-N 126.009 2.068 . . . . 0.0 112.949 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 53.1 t -1.84 127.73 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.328 0 N-CA-C 119.423 3.12 . . . . 0.0 119.423 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -116.52 35.82 4.39 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.154 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 10.7 t -124.28 -59.38 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 N-CA-C 114.757 1.392 . . . . 0.0 114.757 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 24.2 p -108.4 -46.08 3.77 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 114.563 1.32 . . . . 0.0 114.563 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 120.84 50.61 0.26 Allowed Glycine 0 N--CA 1.503 3.118 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.274 . . . . . . . 0 N--CA 1.496 1.839 1 N-CA-C 132.421 7.934 . . . . 0.0 132.421 -179.984 . . . . . . . . 2 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.299 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.3 m -117.79 157.27 26.87 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -135.06 175.44 9.58 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 124.31 2.005 . . . . 0.0 106.999 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.537 ' HA ' ' HE ' ' A' ' 4' ' ' ARG . 1.4 mmp_? 96.0 -58.29 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.263 1 CA-C-N 108.071 -4.15 . . . . 0.0 103.602 -179.833 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.406 ' CE1' ' HD3' ' A' ' 11' ' ' PRO . 2.0 t80 -130.67 177.49 7.35 Favored 'General case' 0 N--CA 1.488 1.464 1 N-CA-C 100.052 -4.055 . . . . 0.0 100.052 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.613 ' HB ' ' HB3' ' A' ' 11' ' ' PRO 0.257 3.6 t -105.19 121.81 57.67 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.99 0 CA-C-N 113.501 -1.681 . . . . 0.0 106.608 179.548 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.409 ' HG2' HG12 ' A' ' 6' ' ' VAL . 23.8 pttm 25.45 62.01 0.06 Allowed 'General case' 0 N--CA 1.509 2.483 0 CA-C-O 123.095 1.426 . . . . 0.0 111.602 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.43 ' HA3' ' CE1' ' A' ' 19' ' ' TYR . . . 30.31 38.18 0.02 OUTLIER Glycine 0 N--CA 1.499 2.892 0 CA-C-N 111.193 -2.73 . . . . 0.0 115.952 -179.535 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.658 ' HA ' ' HB2' ' A' ' 18' ' ' GLN . 35.3 m -152.4 157.64 41.53 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 115.142 1.534 . . . . 0.0 115.142 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.531 ' N ' HG22 ' A' ' 9' ' ' THR . 7.4 t -49.38 91.6 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.805 0 N-CA-C 103.384 -2.821 . . . . 0.0 103.384 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.613 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . 10.8 Cg_endo -41.09 -56.13 1.84 Allowed 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.572 2.182 . . . . 0.0 116.564 -150.359 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 21.8 ttmm -107.67 -1.17 21.34 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 124.671 1.232 . . . . 0.0 109.536 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -127.33 39.64 3.86 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 126.626 3.108 . . . . 0.0 109.6 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.417 ' HA ' HG22 ' A' ' 9' ' ' THR 0.316 25.9 tttt -44.12 80.34 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.916 3 CA-C-N 104.198 -5.91 . . . . 0.0 119.411 179.657 . . . . . . . . 4 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.0 m -90.31 169.23 12.57 Favored Pre-proline 0 C--N 1.296 -1.718 1 CA-C-N 107.311 -4.495 . . . . 0.0 108.158 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -38.73 -58.42 0.75 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 123.666 2.911 . . . . 0.0 118.913 -167.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -150.13 86.8 1.44 Allowed 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.658 ' HB2' ' HA ' ' A' ' 9' ' ' THR . 18.6 mp0 -99.08 72.39 1.88 Allowed 'General case' 0 N--CA 1.501 2.104 0 CA-C-O 124.748 2.213 . . . . 0.0 112.488 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.43 ' CE1' ' HA3' ' A' ' 8' ' ' GLY . 79.0 m-85 -101.18 -48.81 4.28 Favored 'General case' 0 N--CA 1.49 1.572 1 N-CA-C 96.783 -5.266 . . . . 0.0 96.783 179.124 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -124.72 1.97 8.64 Favored Glycine 0 CA--C 1.552 2.374 0 CA-C-N 113.185 -1.825 . . . . 0.0 110.572 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.525 ' HB2' ' HA ' ' A' ' 18' ' ' GLN . 8.6 m-20 -92.31 39.76 1.03 Allowed 'General case' 0 N--CA 1.509 2.479 0 CA-C-N 118.699 1.249 . . . . 0.0 112.198 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.411 ' O ' ' C ' ' A' ' 23' ' ' CYS . 37.0 m-20 2.42 65.74 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.813 0 C-N-CA 125.854 1.662 . . . . 0.0 115.316 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.475 ' SG ' ' HD2' ' A' ' 11' ' ' PRO . 2.4 t 26.18 52.24 0.03 OUTLIER 'General case' 0 N--CA 1.521 3.107 0 O-C-N 124.651 1.219 . . . . 0.0 108.175 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.52 52.77 2.42 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-O 123.658 1.694 . . . . 0.0 113.923 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.477 ' CG2' ' SG ' ' A' ' 10' ' ' CYS . 44.6 t -123.57 -39.54 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 102.759 -3.052 . . . . 0.0 102.759 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.437 ' SG ' ' N ' ' A' ' 27' ' ' GLY . 20.6 p -123.77 -52.68 1.79 Allowed 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 110.977 -2.829 . . . . 0.0 109.555 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.437 ' N ' ' SG ' ' A' ' 26' ' ' CYS . . . 138.15 124.99 2.31 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 108.532 -1.827 . . . . 0.0 108.532 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.507 2.413 0 CA-C-O 117.405 -1.284 . . . . 0.0 111.598 -179.964 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.561 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.4 m -121.38 75.42 1.17 Allowed 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -120.89 53.01 1.15 Allowed 'General case' 0 N--CA 1.501 2.085 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.542 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 32.6 mmt-85 -36.73 -63.25 0.42 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 124.605 1.19 . . . . 0.0 108.873 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.582 ' HD1' ' H ' ' A' ' 6' ' ' VAL . 1.5 t80 -140.12 -171.11 3.11 Favored 'General case' 0 CA--C 1.561 1.396 1 N-CA-C 98.295 -4.706 . . . . 0.0 98.295 179.781 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.582 ' H ' ' HD1' ' A' ' 5' ' ' PHE . 55.7 t -119.37 84.01 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 CA-C-N 112.267 -2.242 . . . . 0.0 107.494 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 71.5 tttt 98.03 71.5 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 112.003 -2.362 . . . . 0.0 105.117 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.461 ' HA3' ' CZ ' ' A' ' 19' ' ' TYR . . . 40.47 -58.08 0.0 OUTLIER Glycine 0 N--CA 1.495 2.611 0 C-N-CA 129.176 3.274 . . . . 0.0 118.866 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.572 ' HA ' ' H ' ' A' ' 18' ' ' GLN . 12.3 m -100.92 172.88 6.77 Favored 'General case' 0 C--N 1.295 -1.787 0 O-C-N 124.484 0.755 . . . . 0.0 109.163 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.499 ' HA ' ' CE1' ' A' ' 5' ' ' PHE . 49.5 t -74.08 94.45 0.06 OUTLIER Pre-proline 0 N--CA 1.487 1.38 0 N-CA-C 102.59 -3.115 . . . . 0.0 102.59 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.486 ' HD2' ' CE1' ' A' ' 5' ' ' PHE . 94.9 Cg_endo -62.61 -7.14 10.18 Favored 'Trans proline' 0 CA--C 1.556 1.576 0 O-C-N 124.077 1.567 . . . . 0.0 111.958 -147.34 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.426 ' N ' ' O ' ' A' ' 10' ' ' CYS . 1.3 ttmp? -95.1 -46.9 6.6 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 124.331 1.02 . . . . 0.0 109.87 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.555 ' SG ' ' HB ' ' A' ' 25' ' ' VAL . 19.3 p -102.11 6.76 41.07 Favored 'General case' 0 N--CA 1.511 2.579 0 C-N-CA 119.439 -0.904 . . . . 0.0 113.137 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.49 ' HA ' ' CG2' ' A' ' 9' ' ' THR 0.343 25.1 tptt 6.52 77.19 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 118.907 2.929 . . . . 0.0 118.907 178.043 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 29.1 t -90.24 94.67 0.61 Allowed Pre-proline 0 C--N 1.3 -1.55 0 CA-C-N 111.155 -2.748 . . . . 0.0 104.119 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -15.45 -40.48 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.357 1 C-N-CA 127.495 5.463 . . . . 0.0 121.978 -136.588 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -142.23 96.5 2.97 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 123.383 0.673 . . . . 0.0 110.538 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.728 HE21 ' HA ' ' A' ' 23' ' ' CYS . 7.8 mm100 -100.94 65.96 1.13 Allowed 'General case' 0 N--CA 1.507 2.417 0 CA-C-O 123.365 1.555 . . . . 0.0 106.912 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.461 ' CZ ' ' HA3' ' A' ' 8' ' ' GLY . 0.5 OUTLIER -109.09 -56.29 2.3 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 103.516 -2.772 . . . . 0.0 103.516 179.831 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -117.0 19.97 11.74 Favored Glycine 0 N--CA 1.496 2.673 0 CA-C-N 113.642 -1.617 . . . . 0.0 110.104 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.463 ' HB2' ' HA ' ' A' ' 18' ' ' GLN . 12.7 m-20 -117.19 -49.78 2.58 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 106.214 -1.773 . . . . 0.0 106.214 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 59.6 m-20 64.94 124.64 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 O-C-N 125.997 2.061 . . . . 0.0 110.142 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.728 ' HA ' HE21 ' A' ' 18' ' ' GLN . 39.2 t -18.43 102.26 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 118.737 2.865 . . . . 0.0 118.737 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -112.01 15.9 20.48 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.528 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.555 ' HB ' ' SG ' ' A' ' 13' ' ' CYS . 16.6 t -112.2 -49.02 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 CA-C-O 118.903 -0.57 . . . . 0.0 112.349 -179.378 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 26.7 p -116.15 -37.83 3.74 Favored 'General case' 0 N--CA 1.502 2.128 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 124.32 89.99 0.87 Allowed Glycine 0 N--CA 1.501 3.021 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.539 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.261 . . . . . . . 0 N--CA 1.499 1.98 1 N-CA-C 132.072 7.805 . . . . 0.0 132.072 179.82 . . . . . . . . 2 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.378 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.8 m -105.66 170.25 8.0 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -130.24 -168.09 1.92 Allowed 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 123.868 1.794 . . . . 0.0 109.591 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 90.79 -63.22 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.15 0 CA-C-N 108.556 -3.929 . . . . 0.0 101.727 -179.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.482 ' CZ ' ' SG ' ' A' ' 10' ' ' CYS . 1.4 t80 -132.43 -149.15 0.37 Allowed 'General case' 0 C--N 1.306 -1.287 1 N-CA-C 98.574 -4.602 . . . . 0.0 98.574 -179.824 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.519 ' O ' ' HB2' ' A' ' 7' ' ' LYS . 73.9 t -124.12 78.15 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.033 0 N-CA-C 100.476 -3.898 . . . . 0.0 100.476 179.364 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 6' ' ' VAL . 1.0 OUTLIER 85.17 89.53 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 112.096 -2.32 . . . . 0.0 110.848 -179.948 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 33.69 -54.76 0.0 OUTLIER Glycine 0 N--CA 1.506 3.322 0 C-N-CA 129.879 3.609 . . . . 0.0 120.763 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.503 HG22 ' HA ' ' A' ' 14' ' ' LYS . 19.9 m -103.34 -173.42 2.31 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.482 ' SG ' ' CZ ' ' A' ' 5' ' ' PHE . 46.5 t -85.9 81.75 0.03 OUTLIER Pre-proline 0 N--CA 1.484 1.267 0 CA-C-O 121.34 0.59 . . . . 0.0 110.383 -179.472 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.404 ' HD2' ' CE1' ' A' ' 5' ' ' PHE . 67.1 Cg_endo -55.97 -20.11 28.56 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.545 2.163 . . . . 0.0 115.121 -132.18 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 15.5 ttmm -85.1 -34.25 22.24 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 27.4 p -105.04 -47.01 4.11 Favored 'General case' 0 N--CA 1.505 2.292 0 N-CA-C 102.208 -3.256 . . . . 0.0 102.208 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.503 ' HA ' HG22 ' A' ' 9' ' ' THR 0.264 4.1 tttp 52.57 87.83 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.586 1 N-CA-C 122.44 4.237 . . . . 0.0 122.44 178.498 . . . . . . . . 4 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.429 ' HB3' ' NE2' ' A' ' 18' ' ' GLN . 12.6 t -90.62 118.31 68.6 Favored Pre-proline 0 N--CA 1.49 1.555 0 N-CA-C 101.239 -3.615 . . . . 0.0 101.239 178.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -10.05 -56.59 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.506 1 C-N-CA 125.988 4.459 . . . . 0.0 121.994 -153.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -138.62 94.33 2.83 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 123.335 0.654 . . . . 0.0 111.348 -179.308 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.665 HE21 ' HA ' ' A' ' 23' ' ' CYS . 3.8 mm100 -102.31 70.72 1.19 Allowed 'General case' 0 N--CA 1.507 2.375 0 CA-C-O 123.694 1.711 . . . . 0.0 111.103 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -102.62 -54.65 2.61 Favored 'General case' 0 N--CA 1.492 1.668 1 N-CA-C 99.848 -4.13 . . . . 0.0 99.848 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -124.77 22.46 6.45 Favored Glycine 0 N--CA 1.491 2.317 0 CA-C-N 113.183 -1.826 . . . . 0.0 109.137 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.447 ' HB2' ' HA ' ' A' ' 18' ' ' GLN . 2.2 m-20 -120.15 39.94 3.57 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 22.9 m-20 -8.69 82.62 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.54 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.665 ' HA ' HE21 ' A' ' 18' ' ' GLN . 43.8 t -3.19 100.41 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 118.887 2.921 . . . . 0.0 118.887 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -101.46 41.06 1.23 Allowed 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 19.3 t -120.21 -58.17 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 CA-C-N 114.462 -1.244 . . . . 0.0 111.567 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 26.6 p -121.21 -39.03 2.72 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 124.184 0.927 . . . . 0.0 111.557 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 129.22 118.06 2.04 Favored Glycine 0 N--CA 1.496 2.669 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.383 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.916 0 CA-C-O 116.235 -1.841 . . . . 0.0 109.07 179.773 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.272 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.3 m -127.77 161.23 29.46 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -137.58 55.36 1.8 Allowed 'General case' 0 N--CA 1.502 2.135 0 CA-C-N 113.844 -1.525 . . . . 0.0 107.073 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 40.9 mtt-85 -25.96 -66.77 0.05 Allowed 'General case' 0 N--CA 1.506 2.34 0 O-C-N 124.888 1.368 . . . . 0.0 112.164 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.609 ' CZ ' ' HA ' ' A' ' 10' ' ' CYS . 1.1 t80 -144.03 149.12 36.18 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 101.243 -3.614 . . . . 0.0 101.243 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . 0.254 6.3 t -88.32 85.98 2.55 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 N-CA-C 102.043 -3.318 . . . . 0.0 102.043 179.154 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.481 ' O ' ' N ' ' A' ' 9' ' ' THR . 1.4 tmtp? 101.54 86.01 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 110.444 -3.071 . . . . 0.0 104.049 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 12.55 -52.41 0.0 OUTLIER Glycine 0 N--CA 1.51 3.627 0 N-CA-C 120.485 2.954 . . . . 0.0 120.485 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.491 ' CG2' ' HA ' ' A' ' 14' ' ' LYS . 30.9 m -95.88 175.27 6.56 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.609 ' HA ' ' CZ ' ' A' ' 5' ' ' PHE . 49.3 t -83.55 90.25 0.13 Allowed Pre-proline 0 C--N 1.305 -1.349 0 N-CA-C 104.386 -2.45 . . . . 0.0 104.386 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.48 ' HD2' ' CE1' ' A' ' 5' ' ' PHE . 98.2 Cg_endo -64.24 -7.88 15.06 Favored 'Trans proline' 0 CA--C 1.557 1.673 0 O-C-N 123.756 1.398 . . . . 0.0 111.825 -143.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.406 ' N ' ' O ' ' A' ' 10' ' ' CYS . 21.9 ttmm -86.18 -46.41 10.42 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.715 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.509 ' SG ' ' HB ' ' A' ' 25' ' ' VAL . 23.6 p -104.26 -2.97 24.88 Favored 'General case' 0 N--CA 1.508 2.458 0 C-N-CA 120.25 -0.58 . . . . 0.0 111.435 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.491 ' HA ' ' CG2' ' A' ' 9' ' ' THR 0.338 21.5 tptt 21.73 75.17 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.709 1 N-CA-C 122.055 4.094 . . . . 0.0 122.055 178.36 . . . . . . . . 4 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.453 ' HB3' ' NE2' ' A' ' 18' ' ' GLN . 16.8 t -90.5 102.44 5.07 Favored Pre-proline 0 N--CA 1.492 1.642 0 CA-C-N 112.09 -2.323 . . . . 0.0 106.355 179.122 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -14.72 -49.54 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.54 1 C-N-CA 125.976 4.451 . . . . 0.0 121.995 -146.116 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -139.12 92.67 2.61 Favored 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 123.215 0.606 . . . . 0.0 112.568 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.462 ' HA ' ' HB2' ' A' ' 21' ' ' ASP . 98.6 mm-40 -91.91 73.85 5.65 Favored 'General case' 0 N--CA 1.507 2.403 0 CA-C-O 122.894 1.33 . . . . 0.0 112.116 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -107.9 -57.22 2.13 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 101.534 -3.506 . . . . 0.0 101.534 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -125.61 25.73 5.57 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 107.921 -2.072 . . . . 0.0 107.921 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.462 ' HB2' ' HA ' ' A' ' 18' ' ' GLN . 14.7 m-20 -110.64 16.47 21.43 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 119.323 -0.37 . . . . 0.0 111.091 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 55.4 m-20 12.21 74.92 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.648 0 O-C-N 125.055 1.472 . . . . 0.0 113.316 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.459 ' HB3' ' HB2' ' A' ' 28' ' ' ALA . 41.6 t 16.79 91.72 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.045 0 O-C-N 125.377 1.673 . . . . 0.0 114.271 -179.421 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -90.53 25.58 2.25 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.509 ' HB ' ' SG ' ' A' ' 13' ' ' CYS . 5.4 t -127.94 -49.01 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 114.806 1.41 . . . . 0.0 114.806 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 16.2 p -117.95 -27.9 6.04 Favored 'General case' 0 N--CA 1.503 2.207 0 N-CA-C 115.754 1.761 . . . . 0.0 115.754 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.86 125.57 3.07 Favored Glycine 0 N--CA 1.496 2.695 0 CA-C-N 118.607 0.64 . . . . 0.0 111.996 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.459 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . . . . . . . . 0 N--CA 1.505 2.283 0 O-C-N 124.559 0.799 . . . . 0.0 109.061 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.437 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.4 m 69.33 162.93 0.23 Allowed 'General case' 0 N--CA 1.499 2.02 0 O-C-N 125.185 1.167 . . . . 0.0 113.974 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.404 ' O ' ' C ' ' A' ' 4' ' ' ARG . 0.9 OUTLIER -128.5 52.04 1.95 Allowed 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 112.496 -2.138 . . . . 0.0 107.008 179.885 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.416 ' HB3' ' NH1' ' A' ' 4' ' ' ARG . 0.0 OUTLIER -24.16 -60.79 0.05 Allowed 'General case' 0 N--CA 1.507 2.387 0 O-C-N 125.465 1.728 . . . . 0.0 111.405 -179.827 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.518 ' CE1' ' C ' ' A' ' 9' ' ' THR . 1.7 t80 -136.31 158.55 44.16 Favored 'General case' 0 C--N 1.313 -1.009 1 N-CA-C 100.157 -4.016 . . . . 0.0 100.157 179.895 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.44 ' H ' ' HD1' ' A' ' 5' ' ' PHE . 26.3 t -102.44 114.95 43.41 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 CA-C-N 112.232 -2.258 . . . . 0.0 106.021 179.261 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 99.5 mttt 40.49 72.47 0.15 Allowed 'General case' 0 N--CA 1.499 1.988 0 CA-C-N 114.537 -1.21 . . . . 0.0 113.096 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 33.15 11.4 0.0 OUTLIER Glycine 0 N--CA 1.503 3.121 0 N-CA-C 122.134 3.614 . . . . 0.0 122.134 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.585 ' HA ' ' HB2' ' A' ' 18' ' ' GLN . 67.4 m -162.43 151.66 15.5 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 119.851 1.825 . . . . 0.0 112.374 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.457 ' HA ' ' HE1' ' A' ' 5' ' ' PHE . 44.7 t -50.65 96.39 0.11 Allowed Pre-proline 0 N--CA 1.502 2.146 0 N-CA-C 105.545 -2.02 . . . . 0.0 105.545 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -59.87 -13.66 23.64 Favored 'Trans proline' 0 CA--C 1.555 1.528 0 O-C-N 124.23 1.647 . . . . 0.0 109.834 -156.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.403 ' N ' ' O ' ' A' ' 10' ' ' CYS . 59.7 tttm -91.73 -47.87 7.12 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 114.491 -1.231 . . . . 0.0 111.237 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.657 ' SG ' ' HB ' ' A' ' 25' ' ' VAL . 14.3 p -117.05 34.21 5.23 Favored 'General case' 0 N--CA 1.509 2.513 0 CA-C-O 124.994 2.33 . . . . 0.0 114.925 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.535 ' HA ' ' CG2' ' A' ' 9' ' ' THR 0.372 1.6 tppp? -15.54 80.82 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.898 1 CA-C-N 106.656 -4.793 . . . . 0.0 114.785 178.225 . . . . . . . . 4 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.419 ' HB2' HG21 ' A' ' 25' ' ' VAL . 41.8 t -88.91 139.96 29.2 Favored Pre-proline 0 N--CA 1.504 2.227 0 CA-C-N 111.025 -2.807 . . . . 0.0 109.913 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_exo -31.74 -56.08 0.27 Allowed 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 124.307 3.338 . . . . 0.0 118.293 -150.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -138.0 83.06 1.95 Allowed 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.585 ' HB2' ' HA ' ' A' ' 9' ' ' THR . 64.7 mm-40 -105.19 77.97 1.35 Allowed 'General case' 0 N--CA 1.514 2.738 0 C-N-CA 118.454 -1.298 . . . . 0.0 107.979 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -101.57 27.1 6.61 Favored 'General case' 0 N--CA 1.505 2.296 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 129.35 50.37 0.12 Allowed Glycine 0 N--CA 1.487 2.054 0 N-CA-C 105.668 -2.973 . . . . 0.0 105.668 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.576 ' HB2' ' HA ' ' A' ' 18' ' ' GLN . 1.2 m-20 -114.09 27.07 9.78 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 18.9 m-20 22.16 62.16 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.364 0 O-C-N 125.438 1.711 . . . . 0.0 111.421 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.428 ' HA ' ' OE1' ' A' ' 18' ' ' GLN . 30.5 t 11.4 96.24 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.168 0 CA-C-N 112.813 -1.994 . . . . 0.0 115.991 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -93.41 46.82 1.21 Allowed 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.616 0.722 . . . . 0.0 110.893 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.657 ' HB ' ' SG ' ' A' ' 13' ' ' CYS . 13.4 t -126.69 -61.97 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 CA-C-N 114.496 -1.229 . . . . 0.0 111.126 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 27.3 p -116.14 -21.09 9.57 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.989 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.444 ' O ' ' CB ' ' A' ' 28' ' ' ALA . . . 139.89 -50.41 0.77 Allowed Glycine 0 N--CA 1.499 2.834 0 CA-C-O 118.537 -1.146 . . . . 0.0 112.023 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.444 ' CB ' ' O ' ' A' ' 27' ' ' GLY . . . . . . . . 0 N--CA 1.515 2.808 0 C-N-CA 126.064 1.746 . . . . 0.0 108.876 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.155 0 N-CA-C 110.341 -1.104 . . . . 0.0 110.341 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.6 t -111.99 55.06 0.68 Allowed 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 122.114 0.959 . . . . 0.0 111.368 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -123.82 65.38 1.04 Allowed 'General case' 0 N--CA 1.498 1.946 0 CA-C-N 113.613 -1.63 . . . . 0.0 107.462 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 31.5 mtm180 -85.06 -47.69 9.95 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 117.6 2.444 . . . . 0.0 117.6 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.485 ' CE1' ' C ' ' A' ' 9' ' ' THR . 3.6 t80 -113.84 73.45 0.82 Allowed 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 115.474 -2.203 . . . . 0.0 114.603 -178.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.442 HG12 ' H ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -138.39 145.86 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 121.764 3.987 . . . . 0.0 121.764 179.188 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.442 ' H ' HG12 ' A' ' 6' ' ' VAL . 41.8 mtmt 128.02 39.59 0.0 OUTLIER 'General case' 0 CA--C 1.567 1.628 4 CA-C-N 101.735 -7.029 . . . . 0.0 94.785 -178.491 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 40.36 31.53 0.37 Allowed Glycine 0 N--CA 1.475 1.26 0 C-N-CA 127.282 2.372 . . . . 0.0 115.854 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.493 HG22 ' HA ' ' A' ' 14' ' ' LYS . 9.8 m -151.15 165.43 33.91 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-O 118.46 -0.781 . . . . 0.0 110.454 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.426 ' O ' ' N ' ' A' ' 12' ' ' LYS . 52.1 t -75.77 94.94 0.09 OUTLIER Pre-proline 0 N--CA 1.496 1.859 0 N-CA-C 104.062 -2.57 . . . . 0.0 104.062 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -53.71 -17.93 11.12 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 124.495 1.787 . . . . 0.0 113.428 -148.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.426 ' N ' ' O ' ' A' ' 10' ' ' CYS . 11.8 ttpp -96.32 -43.67 7.58 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 117.213 -1.375 . . . . 0.0 112.989 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.578 ' SG ' ' HB ' ' A' ' 25' ' ' VAL . 17.8 p -102.73 11.18 37.98 Favored 'General case' 0 N--CA 1.511 2.599 0 C-N-CA 117.809 -1.556 . . . . 0.0 112.116 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.493 ' HA ' HG22 ' A' ' 9' ' ' THR 0.31 1.0 OUTLIER 2.04 83.97 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 109.911 -3.313 . . . . 0.0 119.611 178.104 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 30.3 t -90.2 95.78 0.77 Allowed Pre-proline 0 N--CA 1.491 1.61 0 CA-C-N 111.371 -2.65 . . . . 0.0 106.144 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -7.64 -56.36 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.514 2 C-N-CA 127.518 5.478 . . . . 0.0 123.405 -145.338 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -131.85 84.05 2.14 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.483 ' HB2' ' HA ' ' A' ' 9' ' ' THR . 38.8 mt-30 -98.78 98.09 9.24 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 123.157 1.456 . . . . 0.0 112.529 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -112.59 -54.21 2.64 Favored 'General case' 0 N--CA 1.499 1.983 1 N-CA-C 99.193 -4.373 . . . . 0.0 99.193 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -124.06 43.45 1.41 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 106.316 -2.714 . . . . 0.0 106.316 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.435 ' HB2' ' HA ' ' A' ' 18' ' ' GLN . 1.2 m-20 -116.34 20.39 14.25 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 117.74 -1.124 . . . . 0.0 111.44 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.427 ' C ' ' O ' ' A' ' 21' ' ' ASP . 63.4 m-80 8.15 67.73 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.931 0 O-C-N 125.131 1.519 . . . . 0.0 112.606 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.443 ' HA ' ' NE2' ' A' ' 18' ' ' GLN . 21.2 t 10.51 88.39 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 111.894 -2.412 . . . . 0.0 114.556 -179.328 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.64 44.05 1.18 Allowed 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.578 ' HB ' ' SG ' ' A' ' 13' ' ' CYS . 21.2 t -128.57 -53.58 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 CA-C-N 114.933 -1.031 . . . . 0.0 113.624 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 26.1 p -119.73 -52.97 2.21 Favored 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.75 63.39 0.15 Allowed Glycine 0 N--CA 1.498 2.803 0 N-CA-C 108.92 -1.672 . . . . 0.0 108.92 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.502 2.144 0 N-CA-C 115.738 1.755 . . . . 0.0 115.738 179.97 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.431 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.437 ' HA ' HG22 ' A' ' 6' ' ' VAL . 64.8 m 106.1 69.3 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.391 0 O-C-N 126.715 2.068 . . . . 0.0 113.675 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.406 ' O ' ' C ' ' A' ' 4' ' ' ARG . 2.5 p30 -125.76 -154.43 0.62 Allowed 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 105.3 -2.111 . . . . 0.0 105.3 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.406 ' C ' ' O ' ' A' ' 3' ' ' ASP . 13.1 mmm180 -16.54 -60.82 0.01 OUTLIER 'General case' 0 N--CA 1.516 2.871 0 O-C-N 126.787 2.554 . . . . 0.0 109.007 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.653 ' CZ ' ' HA ' ' A' ' 10' ' ' CYS . 2.0 t80 -136.52 154.36 50.75 Favored 'General case' 0 C--N 1.31 -1.127 1 N-CA-C 99.416 -4.29 . . . . 0.0 99.416 179.589 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.442 ' O ' ' CB ' ' A' ' 7' ' ' LYS 0.268 40.6 t -94.61 76.37 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.146 0 N-CA-C 103.209 -2.886 . . . . 0.0 103.209 179.581 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.442 ' CB ' ' O ' ' A' ' 6' ' ' VAL . 55.3 tttp 107.12 87.12 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 111.004 -2.816 . . . . 0.0 103.534 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 21.4 -58.04 0.0 OUTLIER Glycine 0 N--CA 1.507 3.371 0 C-N-CA 128.709 3.052 . . . . 0.0 120.027 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.51 ' HA ' ' H ' ' A' ' 18' ' ' GLN . 12.6 m -104.59 175.59 5.44 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 124.035 0.491 . . . . 0.0 110.573 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.653 ' HA ' ' CZ ' ' A' ' 5' ' ' PHE . 44.8 t -79.9 90.08 0.06 OUTLIER Pre-proline 0 N--CA 1.488 1.448 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.417 ' CD ' ' CE1' ' A' ' 5' ' ' PHE . 88.9 Cg_endo -65.41 -1.2 4.34 Favored 'Trans proline' 0 CA--C 1.559 1.739 0 O-C-N 123.787 1.414 . . . . 0.0 112.511 -144.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.429 ' N ' ' O ' ' A' ' 10' ' ' CYS . 4.0 tppt? -99.56 -41.56 7.3 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 118.53 -0.747 . . . . 0.0 109.151 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.571 ' SG ' ' HB ' ' A' ' 25' ' ' VAL . 17.6 p -111.34 9.48 21.57 Favored 'General case' 0 N--CA 1.512 2.642 0 CA-C-O 123.085 1.421 . . . . 0.0 112.377 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.414 ' HA ' HG22 ' A' ' 9' ' ' THR 0.328 20.9 tttp -2.7 80.97 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 109.388 -3.551 . . . . 0.0 119.1 178.218 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 31.1 t -90.53 96.61 0.96 Allowed Pre-proline 0 C--N 1.301 -1.524 0 CA-C-N 109.566 -3.47 . . . . 0.0 105.253 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -33.86 -24.82 0.03 OUTLIER 'Trans proline' 0 N--CA 1.501 1.933 2 C-N-CA 126.419 4.746 . . . . 0.0 122.889 -125.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -147.52 94.33 2.36 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 119.575 1.08 . . . . 0.0 111.509 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.52 HE21 ' HA ' ' A' ' 23' ' ' CYS . 4.9 mm100 -95.89 71.39 2.96 Favored 'General case' 0 N--CA 1.504 2.254 0 CA-C-O 123.247 1.498 . . . . 0.0 110.333 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -103.92 -56.79 2.14 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 100.645 -3.835 . . . . 0.0 100.645 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -120.32 21.49 8.69 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 107.288 -2.325 . . . . 0.0 107.288 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.425 ' HB2' ' HA ' ' A' ' 18' ' ' GLN . 54.2 m-20 -124.72 49.3 1.85 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 124.039 0.494 . . . . 0.0 110.605 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -29.7 94.12 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.645 0 O-C-N 124.366 1.041 . . . . 0.0 112.821 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.52 ' HA ' HE21 ' A' ' 18' ' ' GLN . 42.1 t -0.09 106.38 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 117.926 2.565 . . . . 0.0 117.926 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -106.87 29.06 7.36 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.571 ' HB ' ' SG ' ' A' ' 13' ' ' CYS . 12.4 t -117.46 -59.71 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -179.503 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 25.7 p -105.95 -41.69 5.33 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 114.59 1.329 . . . . 0.0 114.59 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 123.53 63.85 0.2 Allowed Glycine 0 N--CA 1.502 3.036 0 C-N-CA 120.373 -0.917 . . . . 0.0 111.776 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.507 2.388 0 N-CA-C 116.367 1.988 . . . . 0.0 116.367 -179.926 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.656 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 43.4 m -121.11 168.6 11.38 Favored 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -130.81 62.68 1.6 Allowed 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 115.712 1.745 . . . . 0.0 115.712 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.401 ' N ' ' HD2' ' A' ' 4' ' ' ARG . 0.0 OUTLIER -101.23 -55.02 2.64 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 101.219 -3.623 . . . . 0.0 101.219 179.344 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.679 ' CE1' ' HA ' ' A' ' 10' ' ' CYS . 0.2 OUTLIER -136.37 -151.95 0.43 Allowed 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 110.891 -2.868 . . . . 0.0 103.764 -179.586 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 92.9 t -131.83 98.54 3.31 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 CA-C-N 112.009 -2.36 . . . . 0.0 108.233 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 69.04 53.13 0.48 Allowed 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 39.86 4.65 0.01 OUTLIER Glycine 0 N--CA 1.496 2.681 0 N-CA-C 120.463 2.945 . . . . 0.0 120.463 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.47 ' CG2' ' HA ' ' A' ' 14' ' ' LYS . 16.6 m -137.84 -177.14 4.68 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.679 ' HA ' ' CE1' ' A' ' 5' ' ' PHE . 49.2 t -89.26 84.1 0.09 OUTLIER Pre-proline 0 N--CA 1.488 1.463 0 CA-C-N 118.388 0.54 . . . . 0.0 109.927 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -52.02 -26.84 26.63 Favored 'Trans proline' 0 CA--C 1.554 1.507 0 O-C-N 124.352 1.712 . . . . 0.0 114.209 -138.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -72.18 -42.78 65.46 Favored 'General case' 0 N--CA 1.501 2.125 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.024 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 31.6 p -97.94 -32.37 11.7 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 124.264 0.978 . . . . 0.0 109.927 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.47 ' HA ' ' CG2' ' A' ' 9' ' ' THR 0.282 22.4 tttp 47.97 71.85 0.31 Allowed 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 121.39 3.848 . . . . 0.0 121.39 178.795 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.409 ' HB2' HG21 ' A' ' 25' ' ' VAL . 19.0 t -90.8 96.72 1.02 Allowed Pre-proline 0 N--CA 1.49 1.537 0 N-CA-C 104.107 -2.553 . . . . 0.0 104.107 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -16.82 -42.09 0.0 OUTLIER 'Trans proline' 0 CA--C 1.554 1.477 2 N-CA-C 124.629 4.819 . . . . 0.0 124.629 -139.219 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -138.89 92.18 2.59 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 118.729 0.695 . . . . 0.0 111.843 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.501 ' HA ' ' HB2' ' A' ' 21' ' ' ASP . 0.7 OUTLIER -102.97 85.1 2.46 Favored 'General case' 0 N--CA 1.511 2.607 0 CA-C-O 123.123 1.439 . . . . 0.0 112.704 179.931 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -112.67 -54.42 2.62 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 101.588 -3.486 . . . . 0.0 101.588 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -121.72 14.95 9.12 Favored Glycine 0 N--CA 1.487 2.063 0 CA-C-N 112.519 -2.128 . . . . 0.0 107.807 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.501 ' HB2' ' HA ' ' A' ' 18' ' ' GLN . 24.5 m-20 -112.25 41.4 1.99 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -19.51 89.05 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.525 0 O-C-N 125.893 1.995 . . . . 0.0 112.925 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.429 ' HA ' HE22 ' A' ' 18' ' ' GLN . 49.0 t -7.46 105.03 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 119.903 3.298 . . . . 0.0 119.903 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -110.95 44.7 1.25 Allowed 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.409 HG21 ' HB2' ' A' ' 15' ' ' SER . 6.5 t -122.03 -59.46 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 CA-C-N 114.541 -1.209 . . . . 0.0 110.475 -179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 23.6 p -117.37 -47.28 2.66 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 124.661 1.226 . . . . 0.0 108.4 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 115.37 47.79 0.53 Allowed Glycine 0 N--CA 1.498 2.815 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.506 2.331 0 N-CA-C 115.939 1.829 . . . . 0.0 115.939 179.853 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 108.928 -1.669 . . . . 0.0 108.928 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 88.4 p -124.01 159.42 29.87 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -152.18 53.79 0.81 Allowed 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 113.612 -1.631 . . . . 0.0 111.272 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 25.2 mmt-85 -111.38 -53.37 2.71 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 100.912 -3.736 . . . . 0.0 100.912 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.722 ' CE1' ' HA ' ' A' ' 10' ' ' CYS . 0.2 OUTLIER -129.2 -154.7 0.65 Allowed 'General case' 0 C--N 1.301 -1.511 1 N-CA-C 99.984 -4.08 . . . . 0.0 99.984 -179.884 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . 0.312 70.3 t -122.82 130.92 74.16 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 1 N-CA-C 99.553 -4.24 . . . . 0.0 99.553 179.823 . . . . . . . . 3 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 9.9 pttm 25.94 68.27 0.05 Allowed 'General case' 0 N--CA 1.504 2.262 0 CA-C-O 123.249 1.5 . . . . 0.0 112.665 -179.008 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 40.13 -1.36 0.0 OUTLIER Glycine 0 N--CA 1.497 2.75 0 N-CA-C 121.765 3.466 . . . . 0.0 121.765 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.555 HG22 ' H ' ' A' ' 10' ' ' CYS . 8.8 m -140.71 -179.12 5.86 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 120.091 1.945 . . . . 0.0 109.654 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.722 ' HA ' ' CE1' ' A' ' 5' ' ' PHE . 45.7 t -78.84 91.0 0.06 OUTLIER Pre-proline 0 N--CA 1.484 1.24 0 N-CA-C 102.69 -3.078 . . . . 0.0 102.69 179.352 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -57.52 -21.89 48.34 Favored 'Trans proline' 0 CA--C 1.557 1.648 0 O-C-N 124.415 1.745 . . . . 0.0 111.114 -147.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 54.9 tptt -84.42 -46.21 11.92 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 113.892 -1.503 . . . . 0.0 111.58 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.583 ' SG ' ' HB ' ' A' ' 25' ' ' VAL . 3.9 p -116.65 25.1 10.81 Favored 'General case' 0 N--CA 1.51 2.526 0 CA-C-O 123.755 1.74 . . . . 0.0 115.69 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.413 ' HA ' HG22 ' A' ' 9' ' ' THR . 9.7 ttpp -13.93 97.7 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 108.658 -3.883 . . . . 0.0 117.178 178.513 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.451 ' HB2' ' CG2' ' A' ' 25' ' ' VAL . 22.8 t -90.62 90.06 0.31 Allowed Pre-proline 0 C--N 1.292 -1.934 0 CA-C-N 109.89 -3.323 . . . . 0.0 105.669 179.224 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -20.68 -52.8 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.615 1 C-N-CA 126.0 4.467 . . . . 0.0 122.073 -123.997 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.3 p30 -133.8 94.85 3.34 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 123.531 0.732 . . . . 0.0 109.233 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.495 ' HG2' HG23 ' A' ' 9' ' ' THR . 10.7 mm-40 -100.29 74.33 1.74 Allowed 'General case' 0 N--CA 1.497 1.893 0 CA-C-N 114.541 -1.208 . . . . 0.0 107.908 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -96.03 -40.85 9.04 Favored 'General case' 0 N--CA 1.506 2.325 0 N-CA-C 104.805 -2.294 . . . . 0.0 104.805 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -100.01 8.68 59.47 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 106.783 -2.527 . . . . 0.0 106.783 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -124.28 172.84 8.78 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.478 0.656 . . . . 0.0 109.683 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.401 ' O ' ' CB ' ' A' ' 23' ' ' CYS . 99.0 m-20 -118.0 -23.16 7.54 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 113.757 -1.565 . . . . 0.0 106.812 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.401 ' CB ' ' O ' ' A' ' 22' ' ' ASN . 38.2 t 127.35 126.82 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.347 0 C-N-CA 126.475 1.91 . . . . 0.0 111.775 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -120.63 38.06 4.12 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 124.164 0.915 . . . . 0.0 109.576 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.583 ' HB ' ' SG ' ' A' ' 13' ' ' CYS . 31.4 t -120.25 -50.66 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.169 -179.722 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 26.1 p -116.08 -48.74 2.72 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 124.183 0.927 . . . . 0.0 111.348 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 130.29 115.57 1.77 Allowed Glycine 0 N--CA 1.5 2.939 0 N-CA-C 110.879 -0.889 . . . . 0.0 110.879 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.946 0 O-C-N 124.169 0.57 . . . . 0.0 109.518 179.98 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . 0.373 2.6 t80 . . . . . 0 N--CA 1.487 1.404 1 N-CA-C 93.958 -6.312 . . . . 0.0 93.958 . . . . . . . . . 2 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.453 HG11 ' HG3' ' A' ' 11' ' ' PRO . 2.2 t -102.81 154.14 5.41 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 CA-C-N 113.083 -1.871 . . . . 0.0 106.883 179.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp 3.79 64.09 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.398 0 O-C-N 126.547 2.404 . . . . 0.0 113.076 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.416 ' HA3' ' CE2' ' A' ' 19' ' ' TYR . . . 37.61 28.52 0.04 OUTLIER Glycine 0 N--CA 1.494 2.509 0 N-CA-C 117.828 1.891 . . . . 0.0 117.828 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.538 ' HA ' ' HB2' ' A' ' 18' ' ' GLN . 9.0 m -157.74 164.67 36.86 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 53.3 t -89.08 85.85 0.14 Allowed Pre-proline 0 N--CA 1.493 1.705 0 CA-C-O 122.223 1.011 . . . . 0.0 111.484 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.453 ' HG3' HG11 ' A' ' 6' ' ' VAL . 60.4 Cg_endo -54.08 -26.97 43.78 Favored 'Trans proline' 0 C--N 1.299 -2.032 0 C-N-CA 122.402 2.068 . . . . 0.0 116.735 -138.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 23.9 tptp -74.48 -36.0 63.28 Favored 'General case' 0 N--CA 1.504 2.249 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 27.4 p -100.31 -36.21 9.34 Favored 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.437 ' HA ' ' CG2' ' A' ' 9' ' ' THR 0.318 29.1 tttt 49.82 76.09 0.15 Allowed 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 115.965 -2.294 . . . . 0.0 115.207 178.938 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.448 ' HB2' HG21 ' A' ' 25' ' ' VAL . 13.2 t -90.63 89.4 0.28 Allowed Pre-proline 0 C--N 1.304 -1.382 0 N-CA-C 103.304 -2.85 . . . . 0.0 103.304 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -21.96 -41.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.592 1 C-N-CA 126.112 4.542 . . . . 0.0 121.378 -129.368 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -130.07 84.81 2.23 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -179.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.576 HE21 ' HA ' ' A' ' 23' ' ' CYS . 4.3 mm-40 -100.63 73.77 1.63 Allowed 'General case' 0 N--CA 1.504 2.274 0 CA-C-O 122.841 1.305 . . . . 0.0 108.972 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.416 ' CE2' ' HA3' ' A' ' 8' ' ' GLY . 51.3 m-85 -97.64 -59.54 1.75 Allowed 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 100.838 -3.764 . . . . 0.0 100.838 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -131.69 29.4 3.42 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 105.754 -2.938 . . . . 0.0 105.754 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.525 ' HB2' ' HA ' ' A' ' 18' ' ' GLN . 14.4 m-20 -117.8 45.58 1.93 Allowed 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -8.99 99.06 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.434 0 N-CA-C 116.842 2.164 . . . . 0.0 116.842 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.576 ' HA ' HE21 ' A' ' 18' ' ' GLN . 32.1 t -26.18 107.71 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 116.422 2.008 . . . . 0.0 116.422 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.3 pm0 -110.61 36.68 3.01 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.114 0.483 . . . . 0.0 111.113 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.448 HG21 ' HB2' ' A' ' 15' ' ' SER . 21.7 t -118.53 -58.42 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.258 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 31.4 p -114.35 -49.61 2.83 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 124.088 0.867 . . . . 0.0 109.192 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 119.03 59.24 0.26 Allowed Glycine 0 N--CA 1.498 2.804 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.817 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.504 2.266 0 N-CA-C 116.373 1.99 . . . . 0.0 116.373 179.887 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . 0.256 3.4 t80 . . . . . 0 N--CA 1.495 1.814 0 CA-C-O 122.742 1.258 . . . . 0.0 109.773 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -82.17 68.77 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.371 1 N-CA-C 123.865 4.765 . . . . 0.0 123.865 -177.748 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.2 tptt -140.26 40.09 1.92 Allowed 'General case' 0 CA--C 1.587 2.396 3 N-CA-C 90.553 -7.573 . . . . 0.0 90.553 178.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 41.07 10.59 0.01 OUTLIER Glycine 0 N--CA 1.484 1.896 0 C-N-CA 130.48 3.895 . . . . 0.0 118.861 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.602 HG22 ' H ' ' A' ' 10' ' ' CYS . 6.6 m -154.14 -177.04 6.16 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.602 ' H ' HG22 ' A' ' 9' ' ' THR . 53.4 t -89.87 85.15 0.14 Allowed Pre-proline 0 C--N 1.306 -1.324 0 N-CA-C 105.268 -2.123 . . . . 0.0 105.268 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -70.92 3.11 3.54 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 124.458 3.439 . . . . 0.0 113.915 -133.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 53.4 tptt -97.77 -25.46 15.06 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 123.681 0.613 . . . . 0.0 109.747 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 27.7 p -114.47 -40.27 3.65 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.568 ' HA ' ' CG2' ' A' ' 9' ' ' THR 0.264 20.5 tttm 57.3 76.57 0.31 Allowed 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 121.298 3.814 . . . . 0.0 121.298 178.883 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 22.3 t -90.79 91.05 0.36 Allowed Pre-proline 0 N--CA 1.496 1.856 0 N-CA-C 105.493 -2.04 . . . . 0.0 105.493 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -27.44 -36.57 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.515 2 C-N-CA 126.167 4.578 . . . . 0.0 122.52 -126.854 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -132.03 79.75 1.88 Allowed 'General case' 0 N--CA 1.503 2.218 0 N-CA-C 116.166 1.913 . . . . 0.0 116.166 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.401 ' H ' HG23 ' A' ' 9' ' ' THR . 72.1 mt-30 -109.4 113.56 26.48 Favored 'General case' 0 N--CA 1.504 2.233 0 CA-C-O 122.067 0.937 . . . . 0.0 109.402 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -113.44 -60.83 1.83 Allowed 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 101.731 -3.433 . . . . 0.0 101.731 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -128.43 45.97 1.11 Allowed Glycine 0 N--CA 1.489 2.19 0 N-CA-C 103.617 -3.793 . . . . 0.0 103.617 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.411 ' O ' ' C ' ' A' ' 22' ' ' ASN . 7.3 m-20 -109.73 39.16 2.18 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 118.643 -0.694 . . . . 0.0 111.474 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.411 ' C ' ' O ' ' A' ' 21' ' ' ASP . 86.1 m-20 1.1 69.23 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.765 0 O-C-N 126.009 2.068 . . . . 0.0 112.949 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 53.1 t -1.84 127.73 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.328 0 N-CA-C 119.423 3.12 . . . . 0.0 119.423 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -116.52 35.82 4.39 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.154 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 10.7 t -124.28 -59.38 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 N-CA-C 114.757 1.392 . . . . 0.0 114.757 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 24.2 p -108.4 -46.08 3.77 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 114.563 1.32 . . . . 0.0 114.563 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 120.84 50.61 0.26 Allowed Glycine 0 N--CA 1.503 3.118 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.274 . . . . . . . 0 N--CA 1.496 1.839 1 N-CA-C 132.421 7.934 . . . . 0.0 132.421 -179.984 . . . . . . . . 2 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.406 ' CE1' ' HD3' ' A' ' 11' ' ' PRO . 2.0 t80 . . . . . 0 N--CA 1.488 1.464 1 N-CA-C 100.052 -4.055 . . . . 0.0 100.052 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.613 ' HB ' ' HB3' ' A' ' 11' ' ' PRO 0.257 3.6 t -105.19 121.81 57.67 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.99 0 CA-C-N 113.501 -1.681 . . . . 0.0 106.608 179.548 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.409 ' HG2' HG12 ' A' ' 6' ' ' VAL . 23.8 pttm 25.45 62.01 0.06 Allowed 'General case' 0 N--CA 1.509 2.483 0 CA-C-O 123.095 1.426 . . . . 0.0 111.602 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.43 ' HA3' ' CE1' ' A' ' 19' ' ' TYR . . . 30.31 38.18 0.02 OUTLIER Glycine 0 N--CA 1.499 2.892 0 CA-C-N 111.193 -2.73 . . . . 0.0 115.952 -179.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.658 ' HA ' ' HB2' ' A' ' 18' ' ' GLN . 35.3 m -152.4 157.64 41.53 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 115.142 1.534 . . . . 0.0 115.142 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.531 ' N ' HG22 ' A' ' 9' ' ' THR . 7.4 t -49.38 91.6 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.805 0 N-CA-C 103.384 -2.821 . . . . 0.0 103.384 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.613 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . 10.8 Cg_endo -41.09 -56.13 1.84 Allowed 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.572 2.182 . . . . 0.0 116.564 -150.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 21.8 ttmm -107.67 -1.17 21.34 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 124.671 1.232 . . . . 0.0 109.536 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -127.33 39.64 3.86 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 126.626 3.108 . . . . 0.0 109.6 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.417 ' HA ' HG22 ' A' ' 9' ' ' THR 0.316 25.9 tttt -44.12 80.34 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.916 3 CA-C-N 104.198 -5.91 . . . . 0.0 119.411 179.657 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.0 m -90.31 169.23 12.57 Favored Pre-proline 0 C--N 1.296 -1.718 1 CA-C-N 107.311 -4.495 . . . . 0.0 108.158 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -38.73 -58.42 0.75 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 123.666 2.911 . . . . 0.0 118.913 -167.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -150.13 86.8 1.44 Allowed 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.658 ' HB2' ' HA ' ' A' ' 9' ' ' THR . 18.6 mp0 -99.08 72.39 1.88 Allowed 'General case' 0 N--CA 1.501 2.104 0 CA-C-O 124.748 2.213 . . . . 0.0 112.488 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.43 ' CE1' ' HA3' ' A' ' 8' ' ' GLY . 79.0 m-85 -101.18 -48.81 4.28 Favored 'General case' 0 N--CA 1.49 1.572 1 N-CA-C 96.783 -5.266 . . . . 0.0 96.783 179.124 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -124.72 1.97 8.64 Favored Glycine 0 CA--C 1.552 2.374 0 CA-C-N 113.185 -1.825 . . . . 0.0 110.572 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.525 ' HB2' ' HA ' ' A' ' 18' ' ' GLN . 8.6 m-20 -92.31 39.76 1.03 Allowed 'General case' 0 N--CA 1.509 2.479 0 CA-C-N 118.699 1.249 . . . . 0.0 112.198 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.411 ' O ' ' C ' ' A' ' 23' ' ' CYS . 37.0 m-20 2.42 65.74 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.813 0 C-N-CA 125.854 1.662 . . . . 0.0 115.316 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.475 ' SG ' ' HD2' ' A' ' 11' ' ' PRO . 2.4 t 26.18 52.24 0.03 OUTLIER 'General case' 0 N--CA 1.521 3.107 0 O-C-N 124.651 1.219 . . . . 0.0 108.175 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.52 52.77 2.42 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-O 123.658 1.694 . . . . 0.0 113.923 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.477 ' CG2' ' SG ' ' A' ' 10' ' ' CYS . 44.6 t -123.57 -39.54 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 102.759 -3.052 . . . . 0.0 102.759 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.437 ' SG ' ' N ' ' A' ' 27' ' ' GLY . 20.6 p -123.77 -52.68 1.79 Allowed 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 110.977 -2.829 . . . . 0.0 109.555 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.437 ' N ' ' SG ' ' A' ' 26' ' ' CYS . . . 138.15 124.99 2.31 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 108.532 -1.827 . . . . 0.0 108.532 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.507 2.413 0 CA-C-O 117.405 -1.284 . . . . 0.0 111.598 -179.964 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.582 ' HD1' ' H ' ' A' ' 6' ' ' VAL . 1.5 t80 . . . . . 0 CA--C 1.561 1.396 1 N-CA-C 98.295 -4.706 . . . . 0.0 98.295 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.582 ' H ' ' HD1' ' A' ' 5' ' ' PHE . 55.7 t -119.37 84.01 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 CA-C-N 112.267 -2.242 . . . . 0.0 107.494 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 71.5 tttt 98.03 71.5 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 112.003 -2.362 . . . . 0.0 105.117 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.461 ' HA3' ' CZ ' ' A' ' 19' ' ' TYR . . . 40.47 -58.08 0.0 OUTLIER Glycine 0 N--CA 1.495 2.611 0 C-N-CA 129.176 3.274 . . . . 0.0 118.866 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.572 ' HA ' ' H ' ' A' ' 18' ' ' GLN . 12.3 m -100.92 172.88 6.77 Favored 'General case' 0 C--N 1.295 -1.787 0 O-C-N 124.484 0.755 . . . . 0.0 109.163 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.499 ' HA ' ' CE1' ' A' ' 5' ' ' PHE . 49.5 t -74.08 94.45 0.06 OUTLIER Pre-proline 0 N--CA 1.487 1.38 0 N-CA-C 102.59 -3.115 . . . . 0.0 102.59 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.486 ' HD2' ' CE1' ' A' ' 5' ' ' PHE . 94.9 Cg_endo -62.61 -7.14 10.18 Favored 'Trans proline' 0 CA--C 1.556 1.576 0 O-C-N 124.077 1.567 . . . . 0.0 111.958 -147.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.426 ' N ' ' O ' ' A' ' 10' ' ' CYS . 1.3 ttmp? -95.1 -46.9 6.6 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 124.331 1.02 . . . . 0.0 109.87 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.555 ' SG ' ' HB ' ' A' ' 25' ' ' VAL . 19.3 p -102.11 6.76 41.07 Favored 'General case' 0 N--CA 1.511 2.579 0 C-N-CA 119.439 -0.904 . . . . 0.0 113.137 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.49 ' HA ' ' CG2' ' A' ' 9' ' ' THR 0.343 25.1 tptt 6.52 77.19 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 118.907 2.929 . . . . 0.0 118.907 178.043 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 29.1 t -90.24 94.67 0.61 Allowed Pre-proline 0 C--N 1.3 -1.55 0 CA-C-N 111.155 -2.748 . . . . 0.0 104.119 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -15.45 -40.48 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.357 1 C-N-CA 127.495 5.463 . . . . 0.0 121.978 -136.588 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -142.23 96.5 2.97 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 123.383 0.673 . . . . 0.0 110.538 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.728 HE21 ' HA ' ' A' ' 23' ' ' CYS . 7.8 mm100 -100.94 65.96 1.13 Allowed 'General case' 0 N--CA 1.507 2.417 0 CA-C-O 123.365 1.555 . . . . 0.0 106.912 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.461 ' CZ ' ' HA3' ' A' ' 8' ' ' GLY . 0.5 OUTLIER -109.09 -56.29 2.3 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 103.516 -2.772 . . . . 0.0 103.516 179.831 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -117.0 19.97 11.74 Favored Glycine 0 N--CA 1.496 2.673 0 CA-C-N 113.642 -1.617 . . . . 0.0 110.104 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.463 ' HB2' ' HA ' ' A' ' 18' ' ' GLN . 12.7 m-20 -117.19 -49.78 2.58 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 106.214 -1.773 . . . . 0.0 106.214 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 59.6 m-20 64.94 124.64 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 O-C-N 125.997 2.061 . . . . 0.0 110.142 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.728 ' HA ' HE21 ' A' ' 18' ' ' GLN . 39.2 t -18.43 102.26 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 118.737 2.865 . . . . 0.0 118.737 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -112.01 15.9 20.48 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.528 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.555 ' HB ' ' SG ' ' A' ' 13' ' ' CYS . 16.6 t -112.2 -49.02 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 CA-C-O 118.903 -0.57 . . . . 0.0 112.349 -179.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 26.7 p -116.15 -37.83 3.74 Favored 'General case' 0 N--CA 1.502 2.128 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 124.32 89.99 0.87 Allowed Glycine 0 N--CA 1.501 3.021 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.539 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.261 . . . . . . . 0 N--CA 1.499 1.98 1 N-CA-C 132.072 7.805 . . . . 0.0 132.072 179.82 . . . . . . . . 2 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.482 ' CZ ' ' SG ' ' A' ' 10' ' ' CYS . 1.4 t80 . . . . . 0 C--O 1.218 -0.602 1 N-CA-C 98.574 -4.602 . . . . 0.0 98.574 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.519 ' O ' ' HB2' ' A' ' 7' ' ' LYS . 73.9 t -124.12 78.15 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.033 0 N-CA-C 100.476 -3.898 . . . . 0.0 100.476 179.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 6' ' ' VAL . 1.0 OUTLIER 85.17 89.53 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 112.096 -2.32 . . . . 0.0 110.848 -179.948 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 33.69 -54.76 0.0 OUTLIER Glycine 0 N--CA 1.506 3.322 0 C-N-CA 129.879 3.609 . . . . 0.0 120.763 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.503 HG22 ' HA ' ' A' ' 14' ' ' LYS . 19.9 m -103.34 -173.42 2.31 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.482 ' SG ' ' CZ ' ' A' ' 5' ' ' PHE . 46.5 t -85.9 81.75 0.03 OUTLIER Pre-proline 0 N--CA 1.484 1.267 0 CA-C-O 121.34 0.59 . . . . 0.0 110.383 -179.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.404 ' HD2' ' CE1' ' A' ' 5' ' ' PHE . 67.1 Cg_endo -55.97 -20.11 28.56 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.545 2.163 . . . . 0.0 115.121 -132.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 15.5 ttmm -85.1 -34.25 22.24 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 27.4 p -105.04 -47.01 4.11 Favored 'General case' 0 N--CA 1.505 2.292 0 N-CA-C 102.208 -3.256 . . . . 0.0 102.208 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.503 ' HA ' HG22 ' A' ' 9' ' ' THR 0.264 4.1 tttp 52.57 87.83 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.586 1 N-CA-C 122.44 4.237 . . . . 0.0 122.44 178.498 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.429 ' HB3' ' NE2' ' A' ' 18' ' ' GLN . 12.6 t -90.62 118.31 68.6 Favored Pre-proline 0 N--CA 1.49 1.555 0 N-CA-C 101.239 -3.615 . . . . 0.0 101.239 178.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -10.05 -56.59 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.506 1 C-N-CA 125.988 4.459 . . . . 0.0 121.994 -153.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -138.62 94.33 2.83 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 123.335 0.654 . . . . 0.0 111.348 -179.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.665 HE21 ' HA ' ' A' ' 23' ' ' CYS . 3.8 mm100 -102.31 70.72 1.19 Allowed 'General case' 0 N--CA 1.507 2.375 0 CA-C-O 123.694 1.711 . . . . 0.0 111.103 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -102.62 -54.65 2.61 Favored 'General case' 0 N--CA 1.492 1.668 1 N-CA-C 99.848 -4.13 . . . . 0.0 99.848 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -124.77 22.46 6.45 Favored Glycine 0 N--CA 1.491 2.317 0 CA-C-N 113.183 -1.826 . . . . 0.0 109.137 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.447 ' HB2' ' HA ' ' A' ' 18' ' ' GLN . 2.2 m-20 -120.15 39.94 3.57 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.428 HD22 ' H ' ' A' ' 22' ' ' ASN . 2.1 m120 -8.69 82.62 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.54 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.665 ' HA ' HE21 ' A' ' 18' ' ' GLN . 43.8 t -3.19 100.41 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 118.887 2.921 . . . . 0.0 118.887 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -101.46 41.06 1.23 Allowed 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 19.3 t -120.21 -58.17 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 CA-C-N 114.462 -1.244 . . . . 0.0 111.567 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 26.6 p -121.21 -39.03 2.72 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 124.184 0.927 . . . . 0.0 111.557 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 129.22 118.06 2.04 Favored Glycine 0 N--CA 1.496 2.669 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.383 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.916 0 CA-C-O 116.235 -1.841 . . . . 0.0 109.07 179.773 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.609 ' CZ ' ' HA ' ' A' ' 10' ' ' CYS . 1.1 t80 . . . . . 0 C--O 1.219 -0.543 0 N-CA-C 101.243 -3.614 . . . . 0.0 101.243 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . 0.254 6.3 t -88.32 85.98 2.55 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 N-CA-C 102.043 -3.318 . . . . 0.0 102.043 179.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.481 ' O ' ' N ' ' A' ' 9' ' ' THR . 1.4 tmtp? 101.54 86.01 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 110.444 -3.071 . . . . 0.0 104.049 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 12.55 -52.41 0.0 OUTLIER Glycine 0 N--CA 1.51 3.627 0 N-CA-C 120.485 2.954 . . . . 0.0 120.485 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.491 ' CG2' ' HA ' ' A' ' 14' ' ' LYS . 30.9 m -95.88 175.27 6.56 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.609 ' HA ' ' CZ ' ' A' ' 5' ' ' PHE . 49.3 t -83.55 90.25 0.13 Allowed Pre-proline 0 C--N 1.305 -1.349 0 N-CA-C 104.386 -2.45 . . . . 0.0 104.386 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.48 ' HD2' ' CE1' ' A' ' 5' ' ' PHE . 98.2 Cg_endo -64.24 -7.88 15.06 Favored 'Trans proline' 0 CA--C 1.557 1.673 0 O-C-N 123.756 1.398 . . . . 0.0 111.825 -143.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.406 ' N ' ' O ' ' A' ' 10' ' ' CYS . 21.9 ttmm -86.18 -46.41 10.42 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.715 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.509 ' SG ' ' HB ' ' A' ' 25' ' ' VAL . 23.6 p -104.26 -2.97 24.88 Favored 'General case' 0 N--CA 1.508 2.458 0 C-N-CA 120.25 -0.58 . . . . 0.0 111.435 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.491 ' HA ' ' CG2' ' A' ' 9' ' ' THR 0.338 21.5 tptt 21.73 75.17 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.709 1 N-CA-C 122.055 4.094 . . . . 0.0 122.055 178.36 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.453 ' HB3' ' NE2' ' A' ' 18' ' ' GLN . 16.8 t -90.5 102.44 5.07 Favored Pre-proline 0 N--CA 1.492 1.642 0 CA-C-N 112.09 -2.323 . . . . 0.0 106.355 179.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -14.72 -49.54 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.54 1 C-N-CA 125.976 4.451 . . . . 0.0 121.995 -146.116 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -139.12 92.67 2.61 Favored 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 123.215 0.606 . . . . 0.0 112.568 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.462 ' HA ' ' HB2' ' A' ' 21' ' ' ASP . 98.6 mm-40 -91.91 73.85 5.65 Favored 'General case' 0 N--CA 1.507 2.403 0 CA-C-O 122.894 1.33 . . . . 0.0 112.116 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -107.9 -57.22 2.13 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 101.534 -3.506 . . . . 0.0 101.534 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -125.61 25.73 5.57 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 107.921 -2.072 . . . . 0.0 107.921 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.462 ' HB2' ' HA ' ' A' ' 18' ' ' GLN . 14.7 m-20 -110.64 16.47 21.43 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 119.323 -0.37 . . . . 0.0 111.091 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 55.4 m-20 12.21 74.92 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.648 0 O-C-N 125.055 1.472 . . . . 0.0 113.316 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.459 ' HB3' ' HB2' ' A' ' 28' ' ' ALA . 41.6 t 16.79 91.72 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.045 0 O-C-N 125.377 1.673 . . . . 0.0 114.271 -179.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -90.53 25.58 2.25 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.509 ' HB ' ' SG ' ' A' ' 13' ' ' CYS . 5.4 t -127.94 -49.01 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 114.806 1.41 . . . . 0.0 114.806 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 16.2 p -117.95 -27.9 6.04 Favored 'General case' 0 N--CA 1.503 2.207 0 N-CA-C 115.754 1.761 . . . . 0.0 115.754 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.86 125.57 3.07 Favored Glycine 0 N--CA 1.496 2.695 0 CA-C-N 118.607 0.64 . . . . 0.0 111.996 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.459 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . . . . . . . . 0 N--CA 1.505 2.283 0 O-C-N 124.559 0.799 . . . . 0.0 109.061 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.518 ' CE1' ' C ' ' A' ' 9' ' ' THR . 1.7 t80 . . . . . 0 C--O 1.219 -0.549 1 N-CA-C 100.157 -4.016 . . . . 0.0 100.157 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.44 ' H ' ' HD1' ' A' ' 5' ' ' PHE . 26.3 t -102.44 114.95 43.41 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 CA-C-N 112.232 -2.258 . . . . 0.0 106.021 179.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 99.5 mttt 40.49 72.47 0.15 Allowed 'General case' 0 N--CA 1.499 1.988 0 CA-C-N 114.537 -1.21 . . . . 0.0 113.096 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 33.15 11.4 0.0 OUTLIER Glycine 0 N--CA 1.503 3.121 0 N-CA-C 122.134 3.614 . . . . 0.0 122.134 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.585 ' HA ' ' HB2' ' A' ' 18' ' ' GLN . 67.4 m -162.43 151.66 15.5 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 119.851 1.825 . . . . 0.0 112.374 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.457 ' HA ' ' HE1' ' A' ' 5' ' ' PHE . 44.7 t -50.65 96.39 0.11 Allowed Pre-proline 0 N--CA 1.502 2.146 0 N-CA-C 105.545 -2.02 . . . . 0.0 105.545 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -59.87 -13.66 23.64 Favored 'Trans proline' 0 CA--C 1.555 1.528 0 O-C-N 124.23 1.647 . . . . 0.0 109.834 -156.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.403 ' N ' ' O ' ' A' ' 10' ' ' CYS . 59.7 tttm -91.73 -47.87 7.12 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 114.491 -1.231 . . . . 0.0 111.237 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.657 ' SG ' ' HB ' ' A' ' 25' ' ' VAL . 14.3 p -117.05 34.21 5.23 Favored 'General case' 0 N--CA 1.509 2.513 0 CA-C-O 124.994 2.33 . . . . 0.0 114.925 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.535 ' HA ' ' CG2' ' A' ' 9' ' ' THR 0.372 1.6 tppp? -15.54 80.82 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.898 1 CA-C-N 106.656 -4.793 . . . . 0.0 114.785 178.225 . . . . . . . . 4 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.419 ' HB2' HG21 ' A' ' 25' ' ' VAL . 41.8 t -88.91 139.96 29.2 Favored Pre-proline 0 N--CA 1.504 2.227 0 CA-C-N 111.025 -2.807 . . . . 0.0 109.913 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_exo -31.74 -56.08 0.27 Allowed 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 124.307 3.338 . . . . 0.0 118.293 -150.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -138.0 83.06 1.95 Allowed 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.585 ' HB2' ' HA ' ' A' ' 9' ' ' THR . 64.7 mm-40 -105.19 77.97 1.35 Allowed 'General case' 0 N--CA 1.514 2.738 0 C-N-CA 118.454 -1.298 . . . . 0.0 107.979 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -101.57 27.1 6.61 Favored 'General case' 0 N--CA 1.505 2.296 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 129.35 50.37 0.12 Allowed Glycine 0 N--CA 1.487 2.054 0 N-CA-C 105.668 -2.973 . . . . 0.0 105.668 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.576 ' HB2' ' HA ' ' A' ' 18' ' ' GLN . 1.2 m-20 -114.09 27.07 9.78 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.489 HD22 ' H ' ' A' ' 22' ' ' ASN . 2.3 m120 22.16 62.16 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.364 0 O-C-N 125.438 1.711 . . . . 0.0 111.421 -179.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.428 ' HA ' ' OE1' ' A' ' 18' ' ' GLN . 30.5 t 11.4 96.24 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.168 0 CA-C-N 112.813 -1.994 . . . . 0.0 115.991 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -93.41 46.82 1.21 Allowed 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.616 0.722 . . . . 0.0 110.893 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.657 ' HB ' ' SG ' ' A' ' 13' ' ' CYS . 13.4 t -126.69 -61.97 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 CA-C-N 114.496 -1.229 . . . . 0.0 111.126 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 27.3 p -116.14 -21.09 9.57 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.989 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.444 ' O ' ' CB ' ' A' ' 28' ' ' ALA . . . 139.89 -50.41 0.77 Allowed Glycine 0 N--CA 1.499 2.834 0 CA-C-O 118.537 -1.146 . . . . 0.0 112.023 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.444 ' CB ' ' O ' ' A' ' 27' ' ' GLY . . . . . . . . 0 N--CA 1.515 2.808 0 C-N-CA 126.064 1.746 . . . . 0.0 108.876 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.485 ' CE1' ' C ' ' A' ' 9' ' ' THR . 3.6 t80 . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 115.474 -2.203 . . . . 0.0 114.603 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.442 HG12 ' H ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -138.39 145.86 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 121.764 3.987 . . . . 0.0 121.764 179.188 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.442 ' H ' HG12 ' A' ' 6' ' ' VAL . 41.8 mtmt 128.02 39.59 0.0 OUTLIER 'General case' 0 CA--C 1.567 1.628 4 CA-C-N 101.735 -7.029 . . . . 0.0 94.785 -178.491 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 40.36 31.53 0.37 Allowed Glycine 0 N--CA 1.475 1.26 0 C-N-CA 127.282 2.372 . . . . 0.0 115.854 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.493 HG22 ' HA ' ' A' ' 14' ' ' LYS . 9.8 m -151.15 165.43 33.91 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-O 118.46 -0.781 . . . . 0.0 110.454 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.426 ' O ' ' N ' ' A' ' 12' ' ' LYS . 52.1 t -75.77 94.94 0.09 OUTLIER Pre-proline 0 N--CA 1.496 1.859 0 N-CA-C 104.062 -2.57 . . . . 0.0 104.062 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -53.71 -17.93 11.12 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 124.495 1.787 . . . . 0.0 113.428 -148.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.426 ' N ' ' O ' ' A' ' 10' ' ' CYS . 11.8 ttpp -96.32 -43.67 7.58 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 117.213 -1.375 . . . . 0.0 112.989 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.578 ' SG ' ' HB ' ' A' ' 25' ' ' VAL . 17.8 p -102.73 11.18 37.98 Favored 'General case' 0 N--CA 1.511 2.599 0 C-N-CA 117.809 -1.556 . . . . 0.0 112.116 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.493 ' HA ' HG22 ' A' ' 9' ' ' THR 0.31 1.0 OUTLIER 2.04 83.97 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 109.911 -3.313 . . . . 0.0 119.611 178.104 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 30.3 t -90.2 95.78 0.77 Allowed Pre-proline 0 N--CA 1.491 1.61 0 CA-C-N 111.371 -2.65 . . . . 0.0 106.144 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -7.64 -56.36 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.514 2 C-N-CA 127.518 5.478 . . . . 0.0 123.405 -145.338 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -131.85 84.05 2.14 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.483 ' HB2' ' HA ' ' A' ' 9' ' ' THR . 38.8 mt-30 -98.78 98.09 9.24 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 123.157 1.456 . . . . 0.0 112.529 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -112.59 -54.21 2.64 Favored 'General case' 0 N--CA 1.499 1.983 1 N-CA-C 99.193 -4.373 . . . . 0.0 99.193 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -124.06 43.45 1.41 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 106.316 -2.714 . . . . 0.0 106.316 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.435 ' HB2' ' HA ' ' A' ' 18' ' ' GLN . 1.2 m-20 -116.34 20.39 14.25 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 117.74 -1.124 . . . . 0.0 111.44 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.427 ' C ' ' O ' ' A' ' 21' ' ' ASP . 63.4 m-80 8.15 67.73 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.931 0 O-C-N 125.131 1.519 . . . . 0.0 112.606 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.443 ' HA ' ' NE2' ' A' ' 18' ' ' GLN . 21.2 t 10.51 88.39 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 111.894 -2.412 . . . . 0.0 114.556 -179.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.64 44.05 1.18 Allowed 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.578 ' HB ' ' SG ' ' A' ' 13' ' ' CYS . 21.2 t -128.57 -53.58 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 CA-C-N 114.933 -1.031 . . . . 0.0 113.624 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 26.1 p -119.73 -52.97 2.21 Favored 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.75 63.39 0.15 Allowed Glycine 0 N--CA 1.498 2.803 0 N-CA-C 108.92 -1.672 . . . . 0.0 108.92 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.502 2.144 0 N-CA-C 115.738 1.755 . . . . 0.0 115.738 179.97 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.653 ' CZ ' ' HA ' ' A' ' 10' ' ' CYS . 2.0 t80 . . . . . 0 C--O 1.218 -0.569 1 N-CA-C 99.416 -4.29 . . . . 0.0 99.416 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.442 ' O ' ' CB ' ' A' ' 7' ' ' LYS 0.268 40.6 t -94.61 76.37 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.146 0 N-CA-C 103.209 -2.886 . . . . 0.0 103.209 179.581 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.442 ' CB ' ' O ' ' A' ' 6' ' ' VAL . 55.3 tttp 107.12 87.12 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 111.004 -2.816 . . . . 0.0 103.534 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 21.4 -58.04 0.0 OUTLIER Glycine 0 N--CA 1.507 3.371 0 C-N-CA 128.709 3.052 . . . . 0.0 120.027 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.51 ' HA ' ' H ' ' A' ' 18' ' ' GLN . 12.6 m -104.59 175.59 5.44 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 124.035 0.491 . . . . 0.0 110.573 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.653 ' HA ' ' CZ ' ' A' ' 5' ' ' PHE . 44.8 t -79.9 90.08 0.06 OUTLIER Pre-proline 0 N--CA 1.488 1.448 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.417 ' CD ' ' CE1' ' A' ' 5' ' ' PHE . 88.9 Cg_endo -65.41 -1.2 4.34 Favored 'Trans proline' 0 CA--C 1.559 1.739 0 O-C-N 123.787 1.414 . . . . 0.0 112.511 -144.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.429 ' N ' ' O ' ' A' ' 10' ' ' CYS . 4.0 tppt? -99.56 -41.56 7.3 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 118.53 -0.747 . . . . 0.0 109.151 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.571 ' SG ' ' HB ' ' A' ' 25' ' ' VAL . 17.6 p -111.34 9.48 21.57 Favored 'General case' 0 N--CA 1.512 2.642 0 CA-C-O 123.085 1.421 . . . . 0.0 112.377 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.414 ' HA ' HG22 ' A' ' 9' ' ' THR 0.328 20.9 tttp -2.7 80.97 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 109.388 -3.551 . . . . 0.0 119.1 178.218 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 31.1 t -90.53 96.61 0.96 Allowed Pre-proline 0 C--N 1.301 -1.524 0 CA-C-N 109.566 -3.47 . . . . 0.0 105.253 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -33.86 -24.82 0.03 OUTLIER 'Trans proline' 0 N--CA 1.501 1.933 2 C-N-CA 126.419 4.746 . . . . 0.0 122.889 -125.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -147.52 94.33 2.36 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 119.575 1.08 . . . . 0.0 111.509 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.52 HE21 ' HA ' ' A' ' 23' ' ' CYS . 4.9 mm100 -95.89 71.39 2.96 Favored 'General case' 0 N--CA 1.504 2.254 0 CA-C-O 123.247 1.498 . . . . 0.0 110.333 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -103.92 -56.79 2.14 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 100.645 -3.835 . . . . 0.0 100.645 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -120.32 21.49 8.69 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 107.288 -2.325 . . . . 0.0 107.288 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.425 ' HB2' ' HA ' ' A' ' 18' ' ' GLN . 54.2 m-20 -124.72 49.3 1.85 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 124.039 0.494 . . . . 0.0 110.605 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -29.7 94.12 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.645 0 O-C-N 124.366 1.041 . . . . 0.0 112.821 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.52 ' HA ' HE21 ' A' ' 18' ' ' GLN . 42.1 t -0.09 106.38 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 117.926 2.565 . . . . 0.0 117.926 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -106.87 29.06 7.36 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.571 ' HB ' ' SG ' ' A' ' 13' ' ' CYS . 12.4 t -117.46 -59.71 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -179.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 25.7 p -105.95 -41.69 5.33 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 114.59 1.329 . . . . 0.0 114.59 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 123.53 63.85 0.2 Allowed Glycine 0 N--CA 1.502 3.036 0 C-N-CA 120.373 -0.917 . . . . 0.0 111.776 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.507 2.388 0 N-CA-C 116.367 1.988 . . . . 0.0 116.367 -179.926 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.679 ' CE1' ' HA ' ' A' ' 10' ' ' CYS . 0.2 OUTLIER . . . . . 0 C--O 1.217 -0.633 0 N-CA-C 103.764 -2.68 . . . . 0.0 103.764 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 92.9 t -131.83 98.54 3.31 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 CA-C-N 112.009 -2.36 . . . . 0.0 108.233 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 69.04 53.13 0.48 Allowed 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 39.86 4.65 0.01 OUTLIER Glycine 0 N--CA 1.496 2.681 0 N-CA-C 120.463 2.945 . . . . 0.0 120.463 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.47 ' CG2' ' HA ' ' A' ' 14' ' ' LYS . 16.6 m -137.84 -177.14 4.68 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.679 ' HA ' ' CE1' ' A' ' 5' ' ' PHE . 49.2 t -89.26 84.1 0.09 OUTLIER Pre-proline 0 N--CA 1.488 1.463 0 CA-C-N 118.388 0.54 . . . . 0.0 109.927 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -52.02 -26.84 26.63 Favored 'Trans proline' 0 CA--C 1.554 1.507 0 O-C-N 124.352 1.712 . . . . 0.0 114.209 -138.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -72.18 -42.78 65.46 Favored 'General case' 0 N--CA 1.501 2.125 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.024 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 31.6 p -97.94 -32.37 11.7 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 124.264 0.978 . . . . 0.0 109.927 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.47 ' HA ' ' CG2' ' A' ' 9' ' ' THR 0.282 22.4 tttp 47.97 71.85 0.31 Allowed 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 121.39 3.848 . . . . 0.0 121.39 178.795 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.409 ' HB2' HG21 ' A' ' 25' ' ' VAL . 19.0 t -90.8 96.72 1.02 Allowed Pre-proline 0 N--CA 1.49 1.537 0 N-CA-C 104.107 -2.553 . . . . 0.0 104.107 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -16.82 -42.09 0.0 OUTLIER 'Trans proline' 0 CA--C 1.554 1.477 2 N-CA-C 124.629 4.819 . . . . 0.0 124.629 -139.219 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -138.89 92.18 2.59 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 118.729 0.695 . . . . 0.0 111.843 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.501 ' HA ' ' HB2' ' A' ' 21' ' ' ASP . 0.7 OUTLIER -102.97 85.1 2.46 Favored 'General case' 0 N--CA 1.511 2.607 0 CA-C-O 123.123 1.439 . . . . 0.0 112.704 179.931 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -112.67 -54.42 2.62 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 101.588 -3.486 . . . . 0.0 101.588 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -121.72 14.95 9.12 Favored Glycine 0 N--CA 1.487 2.063 0 CA-C-N 112.519 -2.128 . . . . 0.0 107.807 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.501 ' HB2' ' HA ' ' A' ' 18' ' ' GLN . 24.5 m-20 -112.25 41.4 1.99 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -19.51 89.05 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.525 0 O-C-N 125.893 1.995 . . . . 0.0 112.925 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.429 ' HA ' HE22 ' A' ' 18' ' ' GLN . 49.0 t -7.46 105.03 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 119.903 3.298 . . . . 0.0 119.903 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -110.95 44.7 1.25 Allowed 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.409 HG21 ' HB2' ' A' ' 15' ' ' SER . 6.5 t -122.03 -59.46 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 CA-C-N 114.541 -1.209 . . . . 0.0 110.475 -179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 23.6 p -117.37 -47.28 2.66 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 124.661 1.226 . . . . 0.0 108.4 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 115.37 47.79 0.53 Allowed Glycine 0 N--CA 1.498 2.815 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.506 2.331 0 N-CA-C 115.939 1.829 . . . . 0.0 115.939 179.853 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.722 ' CE1' ' HA ' ' A' ' 10' ' ' CYS . 0.2 OUTLIER . . . . . 0 C--O 1.217 -0.617 1 N-CA-C 99.984 -4.08 . . . . 0.0 99.984 . . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . 0.312 70.3 t -122.82 130.92 74.16 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 1 N-CA-C 99.553 -4.24 . . . . 0.0 99.553 179.823 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 9.9 pttm 25.94 68.27 0.05 Allowed 'General case' 0 N--CA 1.504 2.262 0 CA-C-O 123.249 1.5 . . . . 0.0 112.665 -179.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 40.13 -1.36 0.0 OUTLIER Glycine 0 N--CA 1.497 2.75 0 N-CA-C 121.765 3.466 . . . . 0.0 121.765 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.555 HG22 ' H ' ' A' ' 10' ' ' CYS . 8.8 m -140.71 -179.12 5.86 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 120.091 1.945 . . . . 0.0 109.654 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.722 ' HA ' ' CE1' ' A' ' 5' ' ' PHE . 45.7 t -78.84 91.0 0.06 OUTLIER Pre-proline 0 N--CA 1.484 1.24 0 N-CA-C 102.69 -3.078 . . . . 0.0 102.69 179.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -57.52 -21.89 48.34 Favored 'Trans proline' 0 CA--C 1.557 1.648 0 O-C-N 124.415 1.745 . . . . 0.0 111.114 -147.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 54.9 tptt -84.42 -46.21 11.92 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 113.892 -1.503 . . . . 0.0 111.58 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.583 ' SG ' ' HB ' ' A' ' 25' ' ' VAL . 3.9 p -116.65 25.1 10.81 Favored 'General case' 0 N--CA 1.51 2.526 0 CA-C-O 123.755 1.74 . . . . 0.0 115.69 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.413 ' HA ' HG22 ' A' ' 9' ' ' THR . 9.7 ttpp -13.93 97.7 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 108.658 -3.883 . . . . 0.0 117.178 178.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.451 ' HB2' ' CG2' ' A' ' 25' ' ' VAL . 22.8 t -90.62 90.06 0.31 Allowed Pre-proline 0 C--N 1.292 -1.934 0 CA-C-N 109.89 -3.323 . . . . 0.0 105.669 179.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -20.68 -52.8 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.615 1 C-N-CA 126.0 4.467 . . . . 0.0 122.073 -123.997 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.3 p30 -133.8 94.85 3.34 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 123.531 0.732 . . . . 0.0 109.233 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.495 ' HG2' HG23 ' A' ' 9' ' ' THR . 10.7 mm-40 -100.29 74.33 1.74 Allowed 'General case' 0 N--CA 1.497 1.893 0 CA-C-N 114.541 -1.208 . . . . 0.0 107.908 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -96.03 -40.85 9.04 Favored 'General case' 0 N--CA 1.506 2.325 0 N-CA-C 104.805 -2.294 . . . . 0.0 104.805 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -100.01 8.68 59.47 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 106.783 -2.527 . . . . 0.0 106.783 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -124.28 172.84 8.78 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.478 0.656 . . . . 0.0 109.683 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.401 ' O ' ' CB ' ' A' ' 23' ' ' CYS . 9.3 m120 -118.0 -23.16 7.54 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 113.757 -1.565 . . . . 0.0 106.812 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.401 ' CB ' ' O ' ' A' ' 22' ' ' ASN . 38.2 t 127.35 126.82 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.347 0 C-N-CA 126.475 1.91 . . . . 0.0 111.775 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -120.63 38.06 4.12 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 124.164 0.915 . . . . 0.0 109.576 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.583 ' HB ' ' SG ' ' A' ' 13' ' ' CYS . 31.4 t -120.25 -50.66 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.169 -179.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 26.1 p -116.08 -48.74 2.72 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 124.183 0.927 . . . . 0.0 111.348 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 130.29 115.57 1.77 Allowed Glycine 0 N--CA 1.5 2.939 0 N-CA-C 110.879 -0.889 . . . . 0.0 110.879 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.946 0 O-C-N 124.169 0.57 . . . . 0.0 109.518 179.98 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.839 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.7 t -133.15 134.42 44.15 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 124.085 0.52 . . . . 0.0 110.415 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.406 ' O ' ' C ' ' A' ' 4' ' ' ARG . 10.4 p-10 -130.67 59.65 1.66 Allowed 'General case' 0 N--CA 1.504 2.236 0 O-C-N 123.988 0.805 . . . . 0.0 110.335 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.406 ' C ' ' O ' ' A' ' 3' ' ' ASP . 23.0 mtp180 -21.08 -64.13 0.03 OUTLIER 'General case' 0 N--CA 1.513 2.677 0 O-C-N 124.298 0.999 . . . . 0.0 112.812 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . 0.373 2.6 t80 -128.57 164.32 23.09 Favored 'General case' 0 N--CA 1.487 1.404 1 N-CA-C 93.958 -6.312 . . . . 0.0 93.958 179.69 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.453 HG11 ' HG3' ' A' ' 11' ' ' PRO . 2.2 t -102.81 154.14 5.41 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 CA-C-N 113.083 -1.871 . . . . 0.0 106.883 179.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp 3.79 64.09 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.398 0 O-C-N 126.547 2.404 . . . . 0.0 113.076 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.416 ' HA3' ' CE2' ' A' ' 19' ' ' TYR . . . 37.61 28.52 0.04 OUTLIER Glycine 0 N--CA 1.494 2.509 0 N-CA-C 117.828 1.891 . . . . 0.0 117.828 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.538 ' HA ' ' HB2' ' A' ' 18' ' ' GLN . 9.0 m -157.74 164.67 36.86 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 53.3 t -89.08 85.85 0.14 Allowed Pre-proline 0 N--CA 1.493 1.705 0 CA-C-O 122.223 1.011 . . . . 0.0 111.484 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.453 ' HG3' HG11 ' A' ' 6' ' ' VAL . 60.4 Cg_endo -54.08 -26.97 43.78 Favored 'Trans proline' 0 C--N 1.299 -2.032 0 C-N-CA 122.402 2.068 . . . . 0.0 116.735 -138.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 23.9 tptp -74.48 -36.0 63.28 Favored 'General case' 0 N--CA 1.504 2.249 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 27.4 p -100.31 -36.21 9.34 Favored 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.437 ' HA ' ' CG2' ' A' ' 9' ' ' THR 0.318 29.1 tttt 49.82 76.09 0.15 Allowed 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 115.965 -2.294 . . . . 0.0 115.207 178.938 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.448 ' HB2' HG21 ' A' ' 25' ' ' VAL . 13.2 t -90.63 89.4 0.28 Allowed Pre-proline 0 C--N 1.304 -1.382 0 N-CA-C 103.304 -2.85 . . . . 0.0 103.304 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -21.96 -41.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.592 1 C-N-CA 126.112 4.542 . . . . 0.0 121.378 -129.368 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -130.07 84.81 2.23 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -179.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.576 HE21 ' HA ' ' A' ' 23' ' ' CYS . 4.3 mm-40 -100.63 73.77 1.63 Allowed 'General case' 0 N--CA 1.504 2.274 0 CA-C-O 122.841 1.305 . . . . 0.0 108.972 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.416 ' CE2' ' HA3' ' A' ' 8' ' ' GLY . 51.3 m-85 -97.64 -59.54 1.75 Allowed 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 100.838 -3.764 . . . . 0.0 100.838 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -131.69 29.4 3.42 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 105.754 -2.938 . . . . 0.0 105.754 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.525 ' HB2' ' HA ' ' A' ' 18' ' ' GLN . 14.4 m-20 -117.8 45.58 1.93 Allowed 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -8.99 99.06 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.434 0 N-CA-C 116.842 2.164 . . . . 0.0 116.842 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.576 ' HA ' HE21 ' A' ' 18' ' ' GLN . 32.1 t -26.18 107.71 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 116.422 2.008 . . . . 0.0 116.422 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.3 pm0 -110.61 36.68 3.01 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.114 0.483 . . . . 0.0 111.113 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.448 HG21 ' HB2' ' A' ' 15' ' ' SER . 21.7 t -118.53 -58.42 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.258 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 31.4 p -114.35 -49.61 2.83 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 124.088 0.867 . . . . 0.0 109.192 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 119.03 59.24 0.26 Allowed Glycine 0 N--CA 1.498 2.804 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.817 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.504 2.266 0 N-CA-C 116.373 1.99 . . . . 0.0 116.373 179.887 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.515 0 CA-C-O 121.184 0.324 . . . . 0.0 112.326 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.0 m -112.9 68.25 0.67 Allowed 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -114.7 69.51 0.72 Allowed 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 113.304 -1.771 . . . . 0.0 109.272 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.41 ' H ' ' HD3' ' A' ' 4' ' ' ARG . 0.0 OUTLIER -72.64 -44.57 61.71 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.027 -0.988 . . . . 0.0 112.43 -179.897 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . 0.256 3.4 t80 -128.14 -40.31 1.67 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 124.744 1.277 . . . . 0.0 109.773 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -82.17 68.77 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.371 1 N-CA-C 123.865 4.765 . . . . 0.0 123.865 -177.748 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.2 tptt -140.26 40.09 1.92 Allowed 'General case' 0 CA--C 1.587 2.396 3 N-CA-C 90.553 -7.573 . . . . 0.0 90.553 178.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 41.07 10.59 0.01 OUTLIER Glycine 0 N--CA 1.484 1.896 0 C-N-CA 130.48 3.895 . . . . 0.0 118.861 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.602 HG22 ' H ' ' A' ' 10' ' ' CYS . 6.6 m -154.14 -177.04 6.16 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.602 ' H ' HG22 ' A' ' 9' ' ' THR . 53.4 t -89.87 85.15 0.14 Allowed Pre-proline 0 C--N 1.306 -1.324 0 N-CA-C 105.268 -2.123 . . . . 0.0 105.268 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -70.92 3.11 3.54 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 124.458 3.439 . . . . 0.0 113.915 -133.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 53.4 tptt -97.77 -25.46 15.06 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 123.681 0.613 . . . . 0.0 109.747 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 27.7 p -114.47 -40.27 3.65 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.568 ' HA ' ' CG2' ' A' ' 9' ' ' THR 0.264 20.5 tttm 57.3 76.57 0.31 Allowed 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 121.298 3.814 . . . . 0.0 121.298 178.883 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 22.3 t -90.79 91.05 0.36 Allowed Pre-proline 0 N--CA 1.496 1.856 0 N-CA-C 105.493 -2.04 . . . . 0.0 105.493 179.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -27.44 -36.57 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.515 2 C-N-CA 126.167 4.578 . . . . 0.0 122.52 -126.854 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -132.03 79.75 1.88 Allowed 'General case' 0 N--CA 1.503 2.218 0 N-CA-C 116.166 1.913 . . . . 0.0 116.166 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.401 ' H ' HG23 ' A' ' 9' ' ' THR . 72.1 mt-30 -109.4 113.56 26.48 Favored 'General case' 0 N--CA 1.504 2.233 0 CA-C-O 122.067 0.937 . . . . 0.0 109.402 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -113.44 -60.83 1.83 Allowed 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 101.731 -3.433 . . . . 0.0 101.731 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -128.43 45.97 1.11 Allowed Glycine 0 N--CA 1.489 2.19 0 N-CA-C 103.617 -3.793 . . . . 0.0 103.617 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.411 ' O ' ' C ' ' A' ' 22' ' ' ASN . 7.3 m-20 -109.73 39.16 2.18 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 118.643 -0.694 . . . . 0.0 111.474 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.411 ' C ' ' O ' ' A' ' 21' ' ' ASP . 86.1 m-20 1.1 69.23 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.765 0 O-C-N 126.009 2.068 . . . . 0.0 112.949 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 53.1 t -1.84 127.73 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.328 0 N-CA-C 119.423 3.12 . . . . 0.0 119.423 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -116.52 35.82 4.39 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.154 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 10.7 t -124.28 -59.38 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 N-CA-C 114.757 1.392 . . . . 0.0 114.757 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 24.2 p -108.4 -46.08 3.77 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 114.563 1.32 . . . . 0.0 114.563 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 120.84 50.61 0.26 Allowed Glycine 0 N--CA 1.503 3.118 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.274 . . . . . . . 0 N--CA 1.496 1.839 1 N-CA-C 132.421 7.934 . . . . 0.0 132.421 -179.984 . . . . . . . . 2 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.299 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.3 m -117.79 157.27 26.87 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -135.06 175.44 9.58 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 124.31 2.005 . . . . 0.0 106.999 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.537 ' HE ' ' HA ' ' A' ' 4' ' ' ARG . 1.4 mmp_? 96.0 -58.29 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.263 1 CA-C-N 108.071 -4.15 . . . . 0.0 103.602 -179.833 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.406 ' CE1' ' HD3' ' A' ' 11' ' ' PRO . 2.0 t80 -130.67 177.49 7.35 Favored 'General case' 0 N--CA 1.488 1.464 1 N-CA-C 100.052 -4.055 . . . . 0.0 100.052 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.613 ' HB ' ' HB3' ' A' ' 11' ' ' PRO 0.257 3.6 t -105.19 121.81 57.67 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.99 0 CA-C-N 113.501 -1.681 . . . . 0.0 106.608 179.548 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.409 ' HG2' HG12 ' A' ' 6' ' ' VAL . 23.8 pttm 25.45 62.01 0.06 Allowed 'General case' 0 N--CA 1.509 2.483 0 CA-C-O 123.095 1.426 . . . . 0.0 111.602 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.43 ' HA3' ' CE1' ' A' ' 19' ' ' TYR . . . 30.31 38.18 0.02 OUTLIER Glycine 0 N--CA 1.499 2.892 0 CA-C-N 111.193 -2.73 . . . . 0.0 115.952 -179.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.658 ' HA ' ' HB2' ' A' ' 18' ' ' GLN . 35.3 m -152.4 157.64 41.53 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 115.142 1.534 . . . . 0.0 115.142 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.531 ' N ' HG22 ' A' ' 9' ' ' THR . 7.4 t -49.38 91.6 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.805 0 N-CA-C 103.384 -2.821 . . . . 0.0 103.384 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.613 ' HB3' ' HB ' ' A' ' 6' ' ' VAL . 10.8 Cg_endo -41.09 -56.13 1.84 Allowed 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.572 2.182 . . . . 0.0 116.564 -150.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 21.8 ttmm -107.67 -1.17 21.34 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 124.671 1.232 . . . . 0.0 109.536 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -127.33 39.64 3.86 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 126.626 3.108 . . . . 0.0 109.6 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.417 ' HA ' HG22 ' A' ' 9' ' ' THR 0.316 25.9 tttt -44.12 80.34 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.916 3 CA-C-N 104.198 -5.91 . . . . 0.0 119.411 179.657 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.0 m -90.31 169.23 12.57 Favored Pre-proline 0 C--N 1.296 -1.718 1 CA-C-N 107.311 -4.495 . . . . 0.0 108.158 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -38.73 -58.42 0.75 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 123.666 2.911 . . . . 0.0 118.913 -167.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -150.13 86.8 1.44 Allowed 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.658 ' HB2' ' HA ' ' A' ' 9' ' ' THR . 18.6 mp0 -99.08 72.39 1.88 Allowed 'General case' 0 N--CA 1.501 2.104 0 CA-C-O 124.748 2.213 . . . . 0.0 112.488 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.43 ' CE1' ' HA3' ' A' ' 8' ' ' GLY . 79.0 m-85 -101.18 -48.81 4.28 Favored 'General case' 0 N--CA 1.49 1.572 1 N-CA-C 96.783 -5.266 . . . . 0.0 96.783 179.124 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -124.72 1.97 8.64 Favored Glycine 0 CA--C 1.552 2.374 0 CA-C-N 113.185 -1.825 . . . . 0.0 110.572 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.525 ' HB2' ' HA ' ' A' ' 18' ' ' GLN . 8.6 m-20 -92.31 39.76 1.03 Allowed 'General case' 0 N--CA 1.509 2.479 0 CA-C-N 118.699 1.249 . . . . 0.0 112.198 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.411 ' O ' ' C ' ' A' ' 23' ' ' CYS . 37.0 m-20 2.42 65.74 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.813 0 C-N-CA 125.854 1.662 . . . . 0.0 115.316 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.475 ' SG ' ' HD2' ' A' ' 11' ' ' PRO . 2.4 t 26.18 52.24 0.03 OUTLIER 'General case' 0 N--CA 1.521 3.107 0 O-C-N 124.651 1.219 . . . . 0.0 108.175 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.52 52.77 2.42 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-O 123.658 1.694 . . . . 0.0 113.923 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.477 ' CG2' ' SG ' ' A' ' 10' ' ' CYS . 44.6 t -123.57 -39.54 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 102.759 -3.052 . . . . 0.0 102.759 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.437 ' SG ' ' N ' ' A' ' 27' ' ' GLY . 20.6 p -123.77 -52.68 1.79 Allowed 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 110.977 -2.829 . . . . 0.0 109.555 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.437 ' N ' ' SG ' ' A' ' 26' ' ' CYS . . . 138.15 124.99 2.31 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 108.532 -1.827 . . . . 0.0 108.532 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.507 2.413 0 CA-C-O 117.405 -1.284 . . . . 0.0 111.598 -179.964 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.561 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.4 m -121.38 75.42 1.17 Allowed 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -120.89 53.01 1.15 Allowed 'General case' 0 N--CA 1.501 2.085 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.542 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 32.6 mmt-85 -36.73 -63.25 0.42 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 124.605 1.19 . . . . 0.0 108.873 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.582 ' HD1' ' H ' ' A' ' 6' ' ' VAL . 1.5 t80 -140.12 -171.11 3.11 Favored 'General case' 0 CA--C 1.561 1.396 1 N-CA-C 98.295 -4.706 . . . . 0.0 98.295 179.781 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.582 ' H ' ' HD1' ' A' ' 5' ' ' PHE . 55.7 t -119.37 84.01 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 CA-C-N 112.267 -2.242 . . . . 0.0 107.494 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 71.5 tttt 98.03 71.5 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 112.003 -2.362 . . . . 0.0 105.117 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.461 ' HA3' ' CZ ' ' A' ' 19' ' ' TYR . . . 40.47 -58.08 0.0 OUTLIER Glycine 0 N--CA 1.495 2.611 0 C-N-CA 129.176 3.274 . . . . 0.0 118.866 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.572 ' HA ' ' H ' ' A' ' 18' ' ' GLN . 12.3 m -100.92 172.88 6.77 Favored 'General case' 0 C--N 1.295 -1.787 0 O-C-N 124.484 0.755 . . . . 0.0 109.163 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.499 ' HA ' ' CE1' ' A' ' 5' ' ' PHE . 49.5 t -74.08 94.45 0.06 OUTLIER Pre-proline 0 N--CA 1.487 1.38 0 N-CA-C 102.59 -3.115 . . . . 0.0 102.59 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.486 ' HD2' ' CE1' ' A' ' 5' ' ' PHE . 94.9 Cg_endo -62.61 -7.14 10.18 Favored 'Trans proline' 0 CA--C 1.556 1.576 0 O-C-N 124.077 1.567 . . . . 0.0 111.958 -147.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.426 ' N ' ' O ' ' A' ' 10' ' ' CYS . 1.3 ttmp? -95.1 -46.9 6.6 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 124.331 1.02 . . . . 0.0 109.87 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.555 ' SG ' ' HB ' ' A' ' 25' ' ' VAL . 19.3 p -102.11 6.76 41.07 Favored 'General case' 0 N--CA 1.511 2.579 0 C-N-CA 119.439 -0.904 . . . . 0.0 113.137 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.49 ' HA ' ' CG2' ' A' ' 9' ' ' THR 0.343 25.1 tptt 6.52 77.19 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 118.907 2.929 . . . . 0.0 118.907 178.043 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 29.1 t -90.24 94.67 0.61 Allowed Pre-proline 0 C--N 1.3 -1.55 0 CA-C-N 111.155 -2.748 . . . . 0.0 104.119 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -15.45 -40.48 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.357 1 C-N-CA 127.495 5.463 . . . . 0.0 121.978 -136.588 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -142.23 96.5 2.97 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 123.383 0.673 . . . . 0.0 110.538 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.728 HE21 ' HA ' ' A' ' 23' ' ' CYS . 7.8 mm100 -100.94 65.96 1.13 Allowed 'General case' 0 N--CA 1.507 2.417 0 CA-C-O 123.365 1.555 . . . . 0.0 106.912 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.461 ' CZ ' ' HA3' ' A' ' 8' ' ' GLY . 0.5 OUTLIER -109.09 -56.29 2.3 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 103.516 -2.772 . . . . 0.0 103.516 179.831 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -117.0 19.97 11.74 Favored Glycine 0 N--CA 1.496 2.673 0 CA-C-N 113.642 -1.617 . . . . 0.0 110.104 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.463 ' HB2' ' HA ' ' A' ' 18' ' ' GLN . 12.7 m-20 -117.19 -49.78 2.58 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 106.214 -1.773 . . . . 0.0 106.214 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 59.6 m-20 64.94 124.64 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 O-C-N 125.997 2.061 . . . . 0.0 110.142 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.728 ' HA ' HE21 ' A' ' 18' ' ' GLN . 39.2 t -18.43 102.26 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 118.737 2.865 . . . . 0.0 118.737 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -112.01 15.9 20.48 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.528 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.555 ' HB ' ' SG ' ' A' ' 13' ' ' CYS . 16.6 t -112.2 -49.02 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 CA-C-O 118.903 -0.57 . . . . 0.0 112.349 -179.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 26.7 p -116.15 -37.83 3.74 Favored 'General case' 0 N--CA 1.502 2.128 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 124.32 89.99 0.87 Allowed Glycine 0 N--CA 1.501 3.021 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.539 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.261 . . . . . . . 0 N--CA 1.499 1.98 1 N-CA-C 132.072 7.805 . . . . 0.0 132.072 179.82 . . . . . . . . 2 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.378 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.8 m -105.66 170.25 8.0 Favored 'General case' 0 N--CA 1.503 2.214 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -130.24 -168.09 1.92 Allowed 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 123.868 1.794 . . . . 0.0 109.591 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 90.79 -63.22 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.15 0 CA-C-N 108.556 -3.929 . . . . 0.0 101.727 -179.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.482 ' CZ ' ' SG ' ' A' ' 10' ' ' CYS . 1.4 t80 -132.43 -149.15 0.37 Allowed 'General case' 0 C--N 1.306 -1.287 1 N-CA-C 98.574 -4.602 . . . . 0.0 98.574 -179.824 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.519 ' O ' ' HB2' ' A' ' 7' ' ' LYS . 73.9 t -124.12 78.15 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.033 0 N-CA-C 100.476 -3.898 . . . . 0.0 100.476 179.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 6' ' ' VAL . 1.0 OUTLIER 85.17 89.53 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 112.096 -2.32 . . . . 0.0 110.848 -179.948 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 33.69 -54.76 0.0 OUTLIER Glycine 0 N--CA 1.506 3.322 0 C-N-CA 129.879 3.609 . . . . 0.0 120.763 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.503 HG22 ' HA ' ' A' ' 14' ' ' LYS . 19.9 m -103.34 -173.42 2.31 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.482 ' SG ' ' CZ ' ' A' ' 5' ' ' PHE . 46.5 t -85.9 81.75 0.03 OUTLIER Pre-proline 0 N--CA 1.484 1.267 0 CA-C-O 121.34 0.59 . . . . 0.0 110.383 -179.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.404 ' HD2' ' CE1' ' A' ' 5' ' ' PHE . 67.1 Cg_endo -55.97 -20.11 28.56 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.545 2.163 . . . . 0.0 115.121 -132.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 15.5 ttmm -85.1 -34.25 22.24 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 27.4 p -105.04 -47.01 4.11 Favored 'General case' 0 N--CA 1.505 2.292 0 N-CA-C 102.208 -3.256 . . . . 0.0 102.208 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.503 ' HA ' HG22 ' A' ' 9' ' ' THR 0.264 4.1 tttp 52.57 87.83 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.586 1 N-CA-C 122.44 4.237 . . . . 0.0 122.44 178.498 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.429 ' HB3' ' NE2' ' A' ' 18' ' ' GLN . 12.6 t -90.62 118.31 68.6 Favored Pre-proline 0 N--CA 1.49 1.555 0 N-CA-C 101.239 -3.615 . . . . 0.0 101.239 178.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -10.05 -56.59 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.506 1 C-N-CA 125.988 4.459 . . . . 0.0 121.994 -153.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -138.62 94.33 2.83 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 123.335 0.654 . . . . 0.0 111.348 -179.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.665 HE21 ' HA ' ' A' ' 23' ' ' CYS . 3.8 mm100 -102.31 70.72 1.19 Allowed 'General case' 0 N--CA 1.507 2.375 0 CA-C-O 123.694 1.711 . . . . 0.0 111.103 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -102.62 -54.65 2.61 Favored 'General case' 0 N--CA 1.492 1.668 1 N-CA-C 99.848 -4.13 . . . . 0.0 99.848 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -124.77 22.46 6.45 Favored Glycine 0 N--CA 1.491 2.317 0 CA-C-N 113.183 -1.826 . . . . 0.0 109.137 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.447 ' HB2' ' HA ' ' A' ' 18' ' ' GLN . 2.2 m-20 -120.15 39.94 3.57 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.428 HD22 ' H ' ' A' ' 22' ' ' ASN . 2.1 m120 -8.69 82.62 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.54 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.665 ' HA ' HE21 ' A' ' 18' ' ' GLN . 43.8 t -3.19 100.41 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 118.887 2.921 . . . . 0.0 118.887 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -101.46 41.06 1.23 Allowed 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 19.3 t -120.21 -58.17 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 CA-C-N 114.462 -1.244 . . . . 0.0 111.567 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 26.6 p -121.21 -39.03 2.72 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 124.184 0.927 . . . . 0.0 111.557 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 129.22 118.06 2.04 Favored Glycine 0 N--CA 1.496 2.669 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.383 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.916 0 CA-C-O 116.235 -1.841 . . . . 0.0 109.07 179.773 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.272 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.3 m -127.77 161.23 29.46 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -137.58 55.36 1.8 Allowed 'General case' 0 N--CA 1.502 2.135 0 CA-C-N 113.844 -1.525 . . . . 0.0 107.073 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 40.9 mtt-85 -25.96 -66.77 0.05 Allowed 'General case' 0 N--CA 1.506 2.34 0 O-C-N 124.888 1.368 . . . . 0.0 112.164 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.609 ' CZ ' ' HA ' ' A' ' 10' ' ' CYS . 1.1 t80 -144.03 149.12 36.18 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 101.243 -3.614 . . . . 0.0 101.243 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . 0.254 6.3 t -88.32 85.98 2.55 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 N-CA-C 102.043 -3.318 . . . . 0.0 102.043 179.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.481 ' O ' ' N ' ' A' ' 9' ' ' THR . 1.4 tmtp? 101.54 86.01 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 110.444 -3.071 . . . . 0.0 104.049 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 12.55 -52.41 0.0 OUTLIER Glycine 0 N--CA 1.51 3.627 0 N-CA-C 120.485 2.954 . . . . 0.0 120.485 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.491 ' CG2' ' HA ' ' A' ' 14' ' ' LYS . 30.9 m -95.88 175.27 6.56 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.609 ' HA ' ' CZ ' ' A' ' 5' ' ' PHE . 49.3 t -83.55 90.25 0.13 Allowed Pre-proline 0 C--N 1.305 -1.349 0 N-CA-C 104.386 -2.45 . . . . 0.0 104.386 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.48 ' HD2' ' CE1' ' A' ' 5' ' ' PHE . 98.2 Cg_endo -64.24 -7.88 15.06 Favored 'Trans proline' 0 CA--C 1.557 1.673 0 O-C-N 123.756 1.398 . . . . 0.0 111.825 -143.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.406 ' N ' ' O ' ' A' ' 10' ' ' CYS . 21.9 ttmm -86.18 -46.41 10.42 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.715 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.509 ' SG ' ' HB ' ' A' ' 25' ' ' VAL . 23.6 p -104.26 -2.97 24.88 Favored 'General case' 0 N--CA 1.508 2.458 0 C-N-CA 120.25 -0.58 . . . . 0.0 111.435 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.491 ' HA ' ' CG2' ' A' ' 9' ' ' THR 0.338 21.5 tptt 21.73 75.17 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.709 1 N-CA-C 122.055 4.094 . . . . 0.0 122.055 178.36 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.453 ' HB3' ' NE2' ' A' ' 18' ' ' GLN . 16.8 t -90.5 102.44 5.07 Favored Pre-proline 0 N--CA 1.492 1.642 0 CA-C-N 112.09 -2.323 . . . . 0.0 106.355 179.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -14.72 -49.54 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.54 1 C-N-CA 125.976 4.451 . . . . 0.0 121.995 -146.116 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -139.12 92.67 2.61 Favored 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 123.215 0.606 . . . . 0.0 112.568 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.462 ' HA ' ' HB2' ' A' ' 21' ' ' ASP . 98.6 mm-40 -91.91 73.85 5.65 Favored 'General case' 0 N--CA 1.507 2.403 0 CA-C-O 122.894 1.33 . . . . 0.0 112.116 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -107.9 -57.22 2.13 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 101.534 -3.506 . . . . 0.0 101.534 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -125.61 25.73 5.57 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 107.921 -2.072 . . . . 0.0 107.921 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.462 ' HB2' ' HA ' ' A' ' 18' ' ' GLN . 14.7 m-20 -110.64 16.47 21.43 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 119.323 -0.37 . . . . 0.0 111.091 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 55.4 m-20 12.21 74.92 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.648 0 O-C-N 125.055 1.472 . . . . 0.0 113.316 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.459 ' HB3' ' HB2' ' A' ' 28' ' ' ALA . 41.6 t 16.79 91.72 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.045 0 O-C-N 125.377 1.673 . . . . 0.0 114.271 -179.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -90.53 25.58 2.25 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.509 ' HB ' ' SG ' ' A' ' 13' ' ' CYS . 5.4 t -127.94 -49.01 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 114.806 1.41 . . . . 0.0 114.806 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 16.2 p -117.95 -27.9 6.04 Favored 'General case' 0 N--CA 1.503 2.207 0 N-CA-C 115.754 1.761 . . . . 0.0 115.754 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.86 125.57 3.07 Favored Glycine 0 N--CA 1.496 2.695 0 CA-C-N 118.607 0.64 . . . . 0.0 111.996 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.459 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . . . . . . . . 0 N--CA 1.505 2.283 0 O-C-N 124.559 0.799 . . . . 0.0 109.061 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.437 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.4 m 69.33 162.93 0.23 Allowed 'General case' 0 N--CA 1.499 2.02 0 O-C-N 125.185 1.167 . . . . 0.0 113.974 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.404 ' O ' ' C ' ' A' ' 4' ' ' ARG . 0.9 OUTLIER -128.5 52.04 1.95 Allowed 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 112.496 -2.138 . . . . 0.0 107.008 179.885 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.416 ' NH1' ' HB3' ' A' ' 4' ' ' ARG . 0.0 OUTLIER -24.16 -60.79 0.05 Allowed 'General case' 0 N--CA 1.507 2.387 0 O-C-N 125.465 1.728 . . . . 0.0 111.405 -179.827 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.518 ' CE1' ' C ' ' A' ' 9' ' ' THR . 1.7 t80 -136.31 158.55 44.16 Favored 'General case' 0 C--N 1.313 -1.009 1 N-CA-C 100.157 -4.016 . . . . 0.0 100.157 179.895 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.44 ' H ' ' HD1' ' A' ' 5' ' ' PHE . 26.3 t -102.44 114.95 43.41 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 CA-C-N 112.232 -2.258 . . . . 0.0 106.021 179.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 99.5 mttt 40.49 72.47 0.15 Allowed 'General case' 0 N--CA 1.499 1.988 0 CA-C-N 114.537 -1.21 . . . . 0.0 113.096 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 33.15 11.4 0.0 OUTLIER Glycine 0 N--CA 1.503 3.121 0 N-CA-C 122.134 3.614 . . . . 0.0 122.134 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.585 ' HA ' ' HB2' ' A' ' 18' ' ' GLN . 67.4 m -162.43 151.66 15.5 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 119.851 1.825 . . . . 0.0 112.374 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.457 ' HA ' ' HE1' ' A' ' 5' ' ' PHE . 44.7 t -50.65 96.39 0.11 Allowed Pre-proline 0 N--CA 1.502 2.146 0 N-CA-C 105.545 -2.02 . . . . 0.0 105.545 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -59.87 -13.66 23.64 Favored 'Trans proline' 0 CA--C 1.555 1.528 0 O-C-N 124.23 1.647 . . . . 0.0 109.834 -156.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.403 ' N ' ' O ' ' A' ' 10' ' ' CYS . 59.7 tttm -91.73 -47.87 7.12 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 114.491 -1.231 . . . . 0.0 111.237 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.657 ' SG ' ' HB ' ' A' ' 25' ' ' VAL . 14.3 p -117.05 34.21 5.23 Favored 'General case' 0 N--CA 1.509 2.513 0 CA-C-O 124.994 2.33 . . . . 0.0 114.925 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.535 ' HA ' ' CG2' ' A' ' 9' ' ' THR 0.372 1.6 tppp? -15.54 80.82 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.898 1 CA-C-N 106.656 -4.793 . . . . 0.0 114.785 178.225 . . . . . . . . 4 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.419 ' HB2' HG21 ' A' ' 25' ' ' VAL . 41.8 t -88.91 139.96 29.2 Favored Pre-proline 0 N--CA 1.504 2.227 0 CA-C-N 111.025 -2.807 . . . . 0.0 109.913 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_exo -31.74 -56.08 0.27 Allowed 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 124.307 3.338 . . . . 0.0 118.293 -150.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -138.0 83.06 1.95 Allowed 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.585 ' HB2' ' HA ' ' A' ' 9' ' ' THR . 64.7 mm-40 -105.19 77.97 1.35 Allowed 'General case' 0 N--CA 1.514 2.738 0 C-N-CA 118.454 -1.298 . . . . 0.0 107.979 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -101.57 27.1 6.61 Favored 'General case' 0 N--CA 1.505 2.296 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 129.35 50.37 0.12 Allowed Glycine 0 N--CA 1.487 2.054 0 N-CA-C 105.668 -2.973 . . . . 0.0 105.668 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.576 ' HB2' ' HA ' ' A' ' 18' ' ' GLN . 1.2 m-20 -114.09 27.07 9.78 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.489 ' H ' HD22 ' A' ' 22' ' ' ASN . 2.3 m120 22.16 62.16 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.364 0 O-C-N 125.438 1.711 . . . . 0.0 111.421 -179.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.428 ' HA ' ' OE1' ' A' ' 18' ' ' GLN . 30.5 t 11.4 96.24 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.168 0 CA-C-N 112.813 -1.994 . . . . 0.0 115.991 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -93.41 46.82 1.21 Allowed 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.616 0.722 . . . . 0.0 110.893 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.657 ' HB ' ' SG ' ' A' ' 13' ' ' CYS . 13.4 t -126.69 -61.97 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 CA-C-N 114.496 -1.229 . . . . 0.0 111.126 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 27.3 p -116.14 -21.09 9.57 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.989 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.444 ' O ' ' CB ' ' A' ' 28' ' ' ALA . . . 139.89 -50.41 0.77 Allowed Glycine 0 N--CA 1.499 2.834 0 CA-C-O 118.537 -1.146 . . . . 0.0 112.023 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.444 ' CB ' ' O ' ' A' ' 27' ' ' GLY . . . . . . . . 0 N--CA 1.515 2.808 0 C-N-CA 126.064 1.746 . . . . 0.0 108.876 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.155 0 N-CA-C 110.341 -1.104 . . . . 0.0 110.341 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.6 t -111.99 55.06 0.68 Allowed 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 122.114 0.959 . . . . 0.0 111.368 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -123.82 65.38 1.04 Allowed 'General case' 0 N--CA 1.498 1.946 0 CA-C-N 113.613 -1.63 . . . . 0.0 107.462 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 31.5 mtm180 -85.06 -47.69 9.95 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 117.6 2.444 . . . . 0.0 117.6 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.485 ' CE1' ' C ' ' A' ' 9' ' ' THR . 3.6 t80 -113.84 73.45 0.82 Allowed 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 115.474 -2.203 . . . . 0.0 114.603 -178.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.442 HG12 ' H ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER -138.39 145.86 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 121.764 3.987 . . . . 0.0 121.764 179.188 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.442 ' H ' HG12 ' A' ' 6' ' ' VAL . 41.8 mtmt 128.02 39.59 0.0 OUTLIER 'General case' 0 CA--C 1.567 1.628 4 CA-C-N 101.735 -7.029 . . . . 0.0 94.785 -178.491 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 40.36 31.53 0.37 Allowed Glycine 0 N--CA 1.475 1.26 0 C-N-CA 127.282 2.372 . . . . 0.0 115.854 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.493 HG22 ' HA ' ' A' ' 14' ' ' LYS . 9.8 m -151.15 165.43 33.91 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-O 118.46 -0.781 . . . . 0.0 110.454 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.426 ' O ' ' N ' ' A' ' 12' ' ' LYS . 52.1 t -75.77 94.94 0.09 OUTLIER Pre-proline 0 N--CA 1.496 1.859 0 N-CA-C 104.062 -2.57 . . . . 0.0 104.062 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -53.71 -17.93 11.12 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 124.495 1.787 . . . . 0.0 113.428 -148.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.426 ' N ' ' O ' ' A' ' 10' ' ' CYS . 11.8 ttpp -96.32 -43.67 7.58 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 117.213 -1.375 . . . . 0.0 112.989 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.578 ' SG ' ' HB ' ' A' ' 25' ' ' VAL . 17.8 p -102.73 11.18 37.98 Favored 'General case' 0 N--CA 1.511 2.599 0 C-N-CA 117.809 -1.556 . . . . 0.0 112.116 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.493 ' HA ' HG22 ' A' ' 9' ' ' THR 0.31 1.0 OUTLIER 2.04 83.97 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 109.911 -3.313 . . . . 0.0 119.611 178.104 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 30.3 t -90.2 95.78 0.77 Allowed Pre-proline 0 N--CA 1.491 1.61 0 CA-C-N 111.371 -2.65 . . . . 0.0 106.144 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -7.64 -56.36 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.514 2 C-N-CA 127.518 5.478 . . . . 0.0 123.405 -145.338 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -131.85 84.05 2.14 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.483 ' HB2' ' HA ' ' A' ' 9' ' ' THR . 38.8 mt-30 -98.78 98.09 9.24 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 123.157 1.456 . . . . 0.0 112.529 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -112.59 -54.21 2.64 Favored 'General case' 0 N--CA 1.499 1.983 1 N-CA-C 99.193 -4.373 . . . . 0.0 99.193 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -124.06 43.45 1.41 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 106.316 -2.714 . . . . 0.0 106.316 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.435 ' HB2' ' HA ' ' A' ' 18' ' ' GLN . 1.2 m-20 -116.34 20.39 14.25 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 117.74 -1.124 . . . . 0.0 111.44 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.427 ' C ' ' O ' ' A' ' 21' ' ' ASP . 63.4 m-80 8.15 67.73 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.931 0 O-C-N 125.131 1.519 . . . . 0.0 112.606 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.443 ' HA ' ' NE2' ' A' ' 18' ' ' GLN . 21.2 t 10.51 88.39 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 111.894 -2.412 . . . . 0.0 114.556 -179.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.64 44.05 1.18 Allowed 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.578 ' HB ' ' SG ' ' A' ' 13' ' ' CYS . 21.2 t -128.57 -53.58 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 CA-C-N 114.933 -1.031 . . . . 0.0 113.624 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 26.1 p -119.73 -52.97 2.21 Favored 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 126.75 63.39 0.15 Allowed Glycine 0 N--CA 1.498 2.803 0 N-CA-C 108.92 -1.672 . . . . 0.0 108.92 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.502 2.144 0 N-CA-C 115.738 1.755 . . . . 0.0 115.738 179.97 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.431 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.437 ' HA ' HG22 ' A' ' 6' ' ' VAL . 64.8 m 106.1 69.3 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.391 0 O-C-N 126.715 2.068 . . . . 0.0 113.675 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.406 ' O ' ' C ' ' A' ' 4' ' ' ARG . 2.5 p30 -125.76 -154.43 0.62 Allowed 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 105.3 -2.111 . . . . 0.0 105.3 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.406 ' C ' ' O ' ' A' ' 3' ' ' ASP . 13.1 mmm180 -16.54 -60.82 0.01 OUTLIER 'General case' 0 N--CA 1.516 2.871 0 O-C-N 126.787 2.554 . . . . 0.0 109.007 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.653 ' CZ ' ' HA ' ' A' ' 10' ' ' CYS . 2.0 t80 -136.52 154.36 50.75 Favored 'General case' 0 C--N 1.31 -1.127 1 N-CA-C 99.416 -4.29 . . . . 0.0 99.416 179.589 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.442 ' O ' ' CB ' ' A' ' 7' ' ' LYS 0.268 40.6 t -94.61 76.37 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.146 0 N-CA-C 103.209 -2.886 . . . . 0.0 103.209 179.581 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.442 ' CB ' ' O ' ' A' ' 6' ' ' VAL . 55.3 tttp 107.12 87.12 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 111.004 -2.816 . . . . 0.0 103.534 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 21.4 -58.04 0.0 OUTLIER Glycine 0 N--CA 1.507 3.371 0 C-N-CA 128.709 3.052 . . . . 0.0 120.027 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.51 ' HA ' ' H ' ' A' ' 18' ' ' GLN . 12.6 m -104.59 175.59 5.44 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 124.035 0.491 . . . . 0.0 110.573 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.653 ' HA ' ' CZ ' ' A' ' 5' ' ' PHE . 44.8 t -79.9 90.08 0.06 OUTLIER Pre-proline 0 N--CA 1.488 1.448 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.417 ' CD ' ' CE1' ' A' ' 5' ' ' PHE . 88.9 Cg_endo -65.41 -1.2 4.34 Favored 'Trans proline' 0 CA--C 1.559 1.739 0 O-C-N 123.787 1.414 . . . . 0.0 112.511 -144.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.429 ' N ' ' O ' ' A' ' 10' ' ' CYS . 4.0 tppt? -99.56 -41.56 7.3 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 118.53 -0.747 . . . . 0.0 109.151 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.571 ' SG ' ' HB ' ' A' ' 25' ' ' VAL . 17.6 p -111.34 9.48 21.57 Favored 'General case' 0 N--CA 1.512 2.642 0 CA-C-O 123.085 1.421 . . . . 0.0 112.377 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.414 ' HA ' HG22 ' A' ' 9' ' ' THR 0.328 20.9 tttp -2.7 80.97 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 109.388 -3.551 . . . . 0.0 119.1 178.218 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 31.1 t -90.53 96.61 0.96 Allowed Pre-proline 0 C--N 1.301 -1.524 0 CA-C-N 109.566 -3.47 . . . . 0.0 105.253 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -33.86 -24.82 0.03 OUTLIER 'Trans proline' 0 N--CA 1.501 1.933 2 C-N-CA 126.419 4.746 . . . . 0.0 122.889 -125.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -147.52 94.33 2.36 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 119.575 1.08 . . . . 0.0 111.509 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.52 HE21 ' HA ' ' A' ' 23' ' ' CYS . 4.9 mm100 -95.89 71.39 2.96 Favored 'General case' 0 N--CA 1.504 2.254 0 CA-C-O 123.247 1.498 . . . . 0.0 110.333 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -103.92 -56.79 2.14 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 100.645 -3.835 . . . . 0.0 100.645 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -120.32 21.49 8.69 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 107.288 -2.325 . . . . 0.0 107.288 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.425 ' HB2' ' HA ' ' A' ' 18' ' ' GLN . 54.2 m-20 -124.72 49.3 1.85 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 124.039 0.494 . . . . 0.0 110.605 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -29.7 94.12 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.645 0 O-C-N 124.366 1.041 . . . . 0.0 112.821 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.52 ' HA ' HE21 ' A' ' 18' ' ' GLN . 42.1 t -0.09 106.38 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 117.926 2.565 . . . . 0.0 117.926 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -106.87 29.06 7.36 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.571 ' HB ' ' SG ' ' A' ' 13' ' ' CYS . 12.4 t -117.46 -59.71 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -179.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 25.7 p -105.95 -41.69 5.33 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 114.59 1.329 . . . . 0.0 114.59 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 123.53 63.85 0.2 Allowed Glycine 0 N--CA 1.502 3.036 0 C-N-CA 120.373 -0.917 . . . . 0.0 111.776 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.507 2.388 0 N-CA-C 116.367 1.988 . . . . 0.0 116.367 -179.926 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.656 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 43.4 m -121.11 168.6 11.38 Favored 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -130.81 62.68 1.6 Allowed 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 115.712 1.745 . . . . 0.0 115.712 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.401 ' N ' ' HD2' ' A' ' 4' ' ' ARG . 0.0 OUTLIER -101.23 -55.02 2.64 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 101.219 -3.623 . . . . 0.0 101.219 179.344 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.679 ' CE1' ' HA ' ' A' ' 10' ' ' CYS . 0.2 OUTLIER -136.37 -151.95 0.43 Allowed 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 110.891 -2.868 . . . . 0.0 103.764 -179.586 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 92.9 t -131.83 98.54 3.31 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 CA-C-N 112.009 -2.36 . . . . 0.0 108.233 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 69.04 53.13 0.48 Allowed 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 39.86 4.65 0.01 OUTLIER Glycine 0 N--CA 1.496 2.681 0 N-CA-C 120.463 2.945 . . . . 0.0 120.463 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.47 ' CG2' ' HA ' ' A' ' 14' ' ' LYS . 16.6 m -137.84 -177.14 4.68 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.679 ' HA ' ' CE1' ' A' ' 5' ' ' PHE . 49.2 t -89.26 84.1 0.09 OUTLIER Pre-proline 0 N--CA 1.488 1.463 0 CA-C-N 118.388 0.54 . . . . 0.0 109.927 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -52.02 -26.84 26.63 Favored 'Trans proline' 0 CA--C 1.554 1.507 0 O-C-N 124.352 1.712 . . . . 0.0 114.209 -138.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -72.18 -42.78 65.46 Favored 'General case' 0 N--CA 1.501 2.125 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.024 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 31.6 p -97.94 -32.37 11.7 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 124.264 0.978 . . . . 0.0 109.927 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.47 ' HA ' ' CG2' ' A' ' 9' ' ' THR 0.282 22.4 tttp 47.97 71.85 0.31 Allowed 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 121.39 3.848 . . . . 0.0 121.39 178.795 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.409 ' HB2' HG21 ' A' ' 25' ' ' VAL . 19.0 t -90.8 96.72 1.02 Allowed Pre-proline 0 N--CA 1.49 1.537 0 N-CA-C 104.107 -2.553 . . . . 0.0 104.107 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -16.82 -42.09 0.0 OUTLIER 'Trans proline' 0 CA--C 1.554 1.477 2 N-CA-C 124.629 4.819 . . . . 0.0 124.629 -139.219 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -138.89 92.18 2.59 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 118.729 0.695 . . . . 0.0 111.843 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.501 ' HA ' ' HB2' ' A' ' 21' ' ' ASP . 0.7 OUTLIER -102.97 85.1 2.46 Favored 'General case' 0 N--CA 1.511 2.607 0 CA-C-O 123.123 1.439 . . . . 0.0 112.704 179.931 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -112.67 -54.42 2.62 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 101.588 -3.486 . . . . 0.0 101.588 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -121.72 14.95 9.12 Favored Glycine 0 N--CA 1.487 2.063 0 CA-C-N 112.519 -2.128 . . . . 0.0 107.807 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.501 ' HB2' ' HA ' ' A' ' 18' ' ' GLN . 24.5 m-20 -112.25 41.4 1.99 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -19.51 89.05 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.525 0 O-C-N 125.893 1.995 . . . . 0.0 112.925 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.429 ' HA ' HE22 ' A' ' 18' ' ' GLN . 49.0 t -7.46 105.03 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 119.903 3.298 . . . . 0.0 119.903 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -110.95 44.7 1.25 Allowed 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.409 HG21 ' HB2' ' A' ' 15' ' ' SER . 6.5 t -122.03 -59.46 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 CA-C-N 114.541 -1.209 . . . . 0.0 110.475 -179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 23.6 p -117.37 -47.28 2.66 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 124.661 1.226 . . . . 0.0 108.4 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 115.37 47.79 0.53 Allowed Glycine 0 N--CA 1.498 2.815 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.506 2.331 0 N-CA-C 115.939 1.829 . . . . 0.0 115.939 179.853 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 108.928 -1.669 . . . . 0.0 108.928 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 88.4 p -124.01 159.42 29.87 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -152.18 53.79 0.81 Allowed 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 113.612 -1.631 . . . . 0.0 111.272 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 25.2 mmt-85 -111.38 -53.37 2.71 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 100.912 -3.736 . . . . 0.0 100.912 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.722 ' CE1' ' HA ' ' A' ' 10' ' ' CYS . 0.2 OUTLIER -129.2 -154.7 0.65 Allowed 'General case' 0 C--N 1.301 -1.511 1 N-CA-C 99.984 -4.08 . . . . 0.0 99.984 -179.884 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . 0.312 70.3 t -122.82 130.92 74.16 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 1 N-CA-C 99.553 -4.24 . . . . 0.0 99.553 179.823 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 9.9 pttm 25.94 68.27 0.05 Allowed 'General case' 0 N--CA 1.504 2.262 0 CA-C-O 123.249 1.5 . . . . 0.0 112.665 -179.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 40.13 -1.36 0.0 OUTLIER Glycine 0 N--CA 1.497 2.75 0 N-CA-C 121.765 3.466 . . . . 0.0 121.765 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.555 HG22 ' H ' ' A' ' 10' ' ' CYS . 8.8 m -140.71 -179.12 5.86 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 120.091 1.945 . . . . 0.0 109.654 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.722 ' HA ' ' CE1' ' A' ' 5' ' ' PHE . 45.7 t -78.84 91.0 0.06 OUTLIER Pre-proline 0 N--CA 1.484 1.24 0 N-CA-C 102.69 -3.078 . . . . 0.0 102.69 179.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -57.52 -21.89 48.34 Favored 'Trans proline' 0 CA--C 1.557 1.648 0 O-C-N 124.415 1.745 . . . . 0.0 111.114 -147.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 54.9 tptt -84.42 -46.21 11.92 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 113.892 -1.503 . . . . 0.0 111.58 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.583 ' SG ' ' HB ' ' A' ' 25' ' ' VAL . 3.9 p -116.65 25.1 10.81 Favored 'General case' 0 N--CA 1.51 2.526 0 CA-C-O 123.755 1.74 . . . . 0.0 115.69 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.413 ' HA ' HG22 ' A' ' 9' ' ' THR . 9.7 ttpp -13.93 97.7 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 108.658 -3.883 . . . . 0.0 117.178 178.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.451 ' HB2' ' CG2' ' A' ' 25' ' ' VAL . 22.8 t -90.62 90.06 0.31 Allowed Pre-proline 0 C--N 1.292 -1.934 0 CA-C-N 109.89 -3.323 . . . . 0.0 105.669 179.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -20.68 -52.8 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.615 1 C-N-CA 126.0 4.467 . . . . 0.0 122.073 -123.997 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.3 p30 -133.8 94.85 3.34 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 123.531 0.732 . . . . 0.0 109.233 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.495 ' HG2' HG23 ' A' ' 9' ' ' THR . 10.7 mm-40 -100.29 74.33 1.74 Allowed 'General case' 0 N--CA 1.497 1.893 0 CA-C-N 114.541 -1.208 . . . . 0.0 107.908 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -96.03 -40.85 9.04 Favored 'General case' 0 N--CA 1.506 2.325 0 N-CA-C 104.805 -2.294 . . . . 0.0 104.805 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -100.01 8.68 59.47 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 106.783 -2.527 . . . . 0.0 106.783 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -124.28 172.84 8.78 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.478 0.656 . . . . 0.0 109.683 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.401 ' O ' ' CB ' ' A' ' 23' ' ' CYS . 9.3 m120 -118.0 -23.16 7.54 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 113.757 -1.565 . . . . 0.0 106.812 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.401 ' CB ' ' O ' ' A' ' 22' ' ' ASN . 38.2 t 127.35 126.82 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.347 0 C-N-CA 126.475 1.91 . . . . 0.0 111.775 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -120.63 38.06 4.12 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 124.164 0.915 . . . . 0.0 109.576 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.583 ' HB ' ' SG ' ' A' ' 13' ' ' CYS . 31.4 t -120.25 -50.66 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.169 -179.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 26.1 p -116.08 -48.74 2.72 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 124.183 0.927 . . . . 0.0 111.348 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 130.29 115.57 1.77 Allowed Glycine 0 N--CA 1.5 2.939 0 N-CA-C 110.879 -0.889 . . . . 0.0 110.879 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.946 0 O-C-N 124.169 0.57 . . . . 0.0 109.518 179.98 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_